Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,A1BG,Alpha-1B-glycoprotein,35814,180,0.99 [0.43-2.28],0.9754865657547092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AAMDC,Mth938 domain-containing protein,34811,171,1.02 [0.77-1.34],0.912222069955775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AARSD1,Alanyl-tRNA editing protein Aarsd1,40934,210,1.17 [0.95-1.46],0.1465168464816263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABCA2,ATP-binding cassette sub-family A member 2,34635,172,0.89 [0.58-1.35],0.573231069334224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABHD14B,Protein ABHD14B,40690,208,1.07 [0.86-1.33],0.5468867365731476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABL1,Tyrosine-protein kinase ABL1,40934,210,0.97 [0.81-1.17],0.7839731990323278
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABO,Histo-blood group ABO system transferase,35784,179,1.02 [0.92-1.12],0.7396192110010618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABRAXAS2,BRISC complex subunit Abraxas 2,34635,172,0.95 [0.76-1.19],0.6525891676345825
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",40196,207,0.95 [0.81-1.11],0.5100155966929036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",35099,171,1.02 [0.83-1.25],0.8353898372429834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",35759,178,0.94 [0.80-1.11],0.4615976994207901
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACAN,Aggrecan core protein,40721,205,1.11 [0.71-1.75],0.6390841565673303
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACE,Angiotensin-converting enzyme,35784,179,1.39 [0.82-2.34],0.2209337210385915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACE2,Angiotensin-converting enzyme 2,40395,204,0.96 [0.75-1.23],0.7283069044792136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACHE,Acetylcholinesterase,34994,173,0.99 [0.63-1.53],0.9497750767696436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACOT13,Acyl-coenzyme A thioesterase 13,35608,179,0.95 [0.84-1.08],0.467772202337976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,41128,212,0.86 [0.67-1.10],0.2308073908562572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACP1,Low molecular weight phosphotyrosine protein phosphatase,34730,174,1.02 [0.74-1.40],0.922331450927933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACP5,Tartrate-resistant acid phosphatase type 5,41310,209,0.92 [0.63-1.34],0.6598659831449272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACP6,Lysophosphatidic acid phosphatase type 6,41439,211,0.98 [0.82-1.17],0.8175919597343324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACRBP,Acrosin-binding protein,35598,179,0.86 [0.58-1.25],0.4222680065255965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACRV1,Acrosomal protein SP-10,34730,174,0.97 [0.81-1.15],0.6949753233256915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACSL1,Long-chain-fatty-acid--CoA ligase 1,34635,172,1.17 [0.82-1.67],0.3814367520339674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACTA2,"Actin, aortic smooth muscle",40395,204,1.26 [0.98-1.63],0.07153353208734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACTN2,Alpha-actinin-2,34635,172,1.24 [0.99-1.55],0.0594108253724126
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACTN4,Alpha-actinin-4,40393,209,0.65 [0.41-1.04],0.0700271165291473
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACVRL1,Serine/threonine-protein kinase receptor R3,40754,205,1.56 [0.95-2.56],0.0821270873925099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACY1,Aminoacylase-1,41128,212,0.90 [0.73-1.10],0.3039611059345859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,34635,172,0.90 [0.68-1.18],0.4341793031426353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACYP1,Acylphosphatase-1,34863,173,1.09 [0.87-1.36],0.4532964086510636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADA,Adenosine deaminase,41597,213,0.83 [0.59-1.19],0.3122142431183345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADA2,Adenosine deaminase 2,40887,209,1.11 [0.83-1.49],0.4670685958923352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,34730,174,1.68 [1.20-2.36],0.002715408477696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40395,204,1.13 [0.75-1.69],0.5648192448344311
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40826,208,1.34 [0.94-1.90],0.1049764441094137
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,41597,213,1.24 [0.86-1.78],0.2432150659176449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,41420,211,1.49 [0.97-2.29],0.066748872203204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,35608,179,1.41 [0.88-2.25],0.154403700096673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,34730,174,1.48 [1.00-2.18],0.0493039196277946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,41624,209,0.82 [0.49-1.38],0.4561706238655781
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40934,210,0.73 [0.56-0.95],0.0182163309861014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40395,204,1.17 [0.84-1.63],0.3412823326887391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,34730,174,0.82 [0.53-1.25],0.3461654389894255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,41240,212,1.15 [0.88-1.51],0.3152783829049411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTSL2,ADAMTS-like protein 2,35767,181,0.91 [0.58-1.43],0.6908501879174959
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTSL4,ADAMTS-like protein 4,34811,171,0.76 [0.41-1.42],0.3919029410044748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTSL5,ADAMTS-like protein 5,35759,178,0.84 [0.59-1.22],0.3639336639883904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,40196,207,1.02 [0.72-1.44],0.9306744542663624
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADD1,Alpha-adducin,34994,173,1.01 [0.82-1.25],0.8883196590963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRB3,Adhesion G protein-coupled receptor B3,40754,205,1.38 [0.96-2.00],0.0831488909900015
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRD1,Adhesion G-protein coupled receptor D1,34994,173,0.89 [0.61-1.31],0.5498171478669907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRE1,Adhesion G protein-coupled receptor E1,35608,179,1.09 [0.83-1.41],0.5394363354115289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRE2,Adhesion G protein-coupled receptor E2,41291,212,1.15 [0.74-1.77],0.5312683110821212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRE5,Adhesion G protein-coupled receptor E5,41427,209,0.97 [0.65-1.47],0.9013930217055812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRF5,Adhesion G protein-coupled receptor F5,35759,178,1.20 [0.72-2.01],0.4851754309229157
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRG1,Adhesion G-protein coupled receptor G1,40934,210,1.01 [0.86-1.19],0.8959495427769062
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRG2,Adhesion G-protein coupled receptor G2,41128,212,0.82 [0.52-1.30],0.3994077015318041
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRV1,Adhesion G-protein coupled receptor V1,34664,171,0.95 [0.76-1.19],0.662913985794443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADH1B,All-trans-retinol dehydrogenase,34994,173,0.91 [0.74-1.12],0.3660771135495778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40395,204,0.95 [0.82-1.11],0.5362618739200764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADIPOQ,Adiponectin,35814,180,1.02 [0.83-1.26],0.8568364252738592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADM,Pro-adrenomedullin,41501,211,1.35 [0.83-2.19],0.2295882633972362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADRA2A,Alpha-2A adrenergic receptor,34635,172,1.11 [0.92-1.34],0.2632582528982365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AFAP1,Actin filament-associated protein 1,34994,173,1.03 [0.86-1.22],0.749341625294381
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AFM,Afamin,35814,180,0.66 [0.32-1.37],0.2658357149994417
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AFP,Alpha-fetoprotein,40694,205,1.09 [0.91-1.31],0.3599123348637123
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGBL2,Cytosolic carboxypeptidase 2,34664,171,1.00 [0.85-1.17],0.9585473986347252
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGER,Advanced glycosylation end product-specific receptor,41019,212,1.15 [0.85-1.56],0.3509431575526597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGR2,Anterior gradient protein 2 homolog,39837,202,1.11 [0.98-1.26],0.1034733432316542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGR3,Anterior gradient protein 3,40129,206,0.86 [0.69-1.07],0.1688399418196159
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGRN,Agrin,41291,212,1.28 [0.89-1.83],0.1818850693453502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGRP,Agouti-related protein,41597,213,1.09 [0.86-1.38],0.4932330273926927
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGT,Angiotensinogen,35784,179,1.54 [0.84-2.81],0.1637054580220842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGXT,Serine--pyruvate aminotransferase,41128,212,0.89 [0.75-1.05],0.1627765702057744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHCY,Adenosylhomocysteinase,41128,212,1.01 [0.85-1.21],0.8923617029651394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHNAK,Neuroblast differentiation-associated protein AHNAK,34811,171,0.97 [0.61-1.56],0.9092409204185122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHNAK2,Protein AHNAK2,34811,171,1.19 [0.73-1.91],0.4868178095080393
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,35598,179,1.04 [0.84-1.28],0.7237204574645262
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSG,Alpha-2-HS-glycoprotein,35784,179,1.52 [0.90-2.57],0.117924880121501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSP,Alpha-hemoglobin-stabilizing protein,41061,210,1.05 [0.91-1.22],0.498003833621804
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIDA,"Axin interactor, dorsalization-associated protein",34803,173,0.92 [0.76-1.10],0.36978502816151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIF1,Allograft inflammatory factor 1,40196,207,0.94 [0.74-1.19],0.6223542680059669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIF1L,Allograft inflammatory factor 1-like,34811,171,0.94 [0.71-1.24],0.6480280763274179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40866,210,0.95 [0.85-1.07],0.4084682495310257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AK1,Adenylate kinase isoenzyme 1,41128,212,1.04 [0.86-1.25],0.694942192465031
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AK2,"Adenylate kinase 2, mitochondrial",35691,178,1.02 [0.89-1.16],0.8061466844623661
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKAP12,A-kinase anchor protein 12,34994,173,1.04 [0.52-2.06],0.9098563264164872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR1B1,Aldo-keto reductase family 1 member B1,40196,207,1.01 [0.85-1.19],0.9283508488740492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR1B10,Aldo-keto reductase family 1 member B10,34803,173,0.82 [0.63-1.05],0.1193264072828427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR1C4,Aldo-keto reductase family 1 member C4,40395,204,1.06 [0.84-1.33],0.6319396579730197
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR7L,Aflatoxin B1 aldehyde reductase member 4,34730,174,0.91 [0.73-1.14],0.4134684031058263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT1S1,Proline-rich AKT1 substrate 1,40166,203,1.00 [0.83-1.20],0.9753049479950022
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT2,RAC-beta serine/threonine-protein kinase,35709,180,0.94 [0.84-1.06],0.3127850612340312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT3,RAC-gamma serine/threonine-protein kinase,40001,206,0.92 [0.74-1.15],0.4704333885536723
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALCAM,CD166 antigen,41624,209,1.35 [0.71-2.56],0.3534064307763195
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH1A1,Retinal dehydrogenase 1,41134,210,1.16 [0.93-1.44],0.1971795521897384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH2,"Aldehyde dehydrogenase, mitochondrial",35598,179,0.94 [0.70-1.27],0.6969058912362895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",41021,214,0.95 [0.79-1.14],0.5803281191809383
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",35709,180,1.02 [0.75-1.38],0.907814372061041
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALMS1,Alstrom syndrome protein 1,35099,171,1.01 [0.73-1.40],0.9584437310196848
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALPI,Intestinal-type alkaline phosphatase,34730,174,1.01 [0.90-1.14],0.8421865721978584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALPP,"Alkaline phosphatase, placental type",40934,210,1.07 [0.95-1.20],0.2857309299621816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMBN,Ameloblastin,40393,209,1.16 [0.77-1.76],0.4745409525678123
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMBP,Protein AMBP,41442,211,1.34 [0.72-2.49],0.3548727026433574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,35767,181,1.01 [0.58-1.75],0.9641917277313043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMFR,E3 ubiquitin-protein ligase AMFR,40166,203,1.09 [0.91-1.31],0.3582778719219003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMIGO1,Amphoterin-induced protein 1,34803,173,1.14 [0.88-1.49],0.3223012421010938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMIGO2,Amphoterin-induced protein 2,40934,210,0.80 [0.47-1.37],0.4161889572810863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMN,Protein amnionless,40393,209,1.11 [0.86-1.43],0.4383572049667332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMOT,Angiomotin,34994,173,1.69 [1.19-2.41],0.0035794907410455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMOTL2,Angiomotin-like protein 2,35474,179,1.15 [0.88-1.50],0.298899902123684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMPD3,AMP deaminase 3,35691,178,1.15 [0.95-1.40],0.1588251853800701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,33491,168,0.87 [0.64-1.19],0.3756010097053901
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMY2A,Pancreatic alpha-amylase,39551,199,0.85 [0.65-1.11],0.2424025261355098
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMY2B,Alpha-amylase 2B,38340,194,0.88 [0.67-1.15],0.338371590001895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANG,Angiogenin,41020,211,0.92 [0.64-1.34],0.6746528821605232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPT1,Angiopoietin-1,40972,211,0.90 [0.78-1.04],0.1647267971329611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPT2,Angiopoietin-2,41501,211,1.26 [0.91-1.74],0.1564394416312017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL1,Angiopoietin-related protein 1,40542,208,1.36 [0.89-2.08],0.1568084238103829
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL2,Angiopoietin-related protein 2,41155,211,1.06 [0.78-1.45],0.6995711950187449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL3,Angiopoietin-related protein 3,41147,211,1.13 [0.80-1.61],0.4897318490170145
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL4,Angiopoietin-related protein 4,41231,212,1.66 [1.27-2.18],0.0002542266134803
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL7,Angiopoietin-related protein 7,41501,211,1.14 [0.81-1.60],0.4553833428677295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANK2,Ankyrin-2,34635,172,0.78 [0.61-1.01],0.0550014598015799
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,34730,174,0.98 [0.82-1.18],0.8478321335612092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKRA2,Ankyrin repeat family A protein 2,34510,172,0.74 [0.55-0.98],0.0358660360617468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKRD54,Ankyrin repeat domain-containing protein 54,40196,207,1.07 [0.87-1.31],0.5131789211347565
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,34811,171,0.93 [0.64-1.37],0.729797274020342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANPEP,Aminopeptidase N,41211,210,0.89 [0.56-1.39],0.6035259241712223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA1,Annexin A1,34790,173,1.00 [0.72-1.39],0.9955474925654588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA10,Annexin A10,40166,203,0.94 [0.80-1.10],0.4152004729093048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA11,Annexin A11,41017,213,0.95 [0.79-1.13],0.5508202116464628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA2,Annexin A2,34296,170,1.08 [0.88-1.32],0.4654570920553769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA3,Annexin A3,41420,211,0.98 [0.83-1.17],0.8542041176303409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA4,Annexin A4,40933,212,0.95 [0.80-1.13],0.5728983553910265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA5,Annexin A5,40043,203,0.95 [0.62-1.45],0.8208496577890538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40393,209,1.10 [0.90-1.34],0.3542343379718611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AOC3,Membrane primary amine oxidase,41278,211,1.10 [0.73-1.67],0.6393966775469353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP1G2,AP-1 complex subunit gamma-like 2,35598,179,1.04 [0.87-1.25],0.6400613550695629
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP2B1,AP-2 complex subunit beta,34803,173,1.05 [0.78-1.42],0.7531043907642536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP3B1,AP-3 complex subunit beta-1,35608,179,1.03 [0.85-1.24],0.7864009126631444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP3S2,AP-3 complex subunit sigma-2,35691,178,1.18 [0.88-1.58],0.2703509167640784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40934,210,0.94 [0.71-1.24],0.6432090392997334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APCS,Serum amyloid P-component,35487,178,0.90 [0.59-1.37],0.6164029924281998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,41376,210,1.09 [0.89-1.33],0.4094204627964938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APLP1,Amyloid-like protein 1,41128,212,1.00 [0.79-1.27],0.9775697215945256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOA1,Apolipoprotein A-I,35814,180,0.95 [0.55-1.62],0.8434228432615065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOA2,Apolipoprotein A-II,35784,179,1.14 [0.85-1.52],0.3885927915661128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOA4,Apolipoprotein A-IV,35814,180,0.96 [0.63-1.45],0.8316010905393151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOB,Apolipoprotein B-100,35784,179,1.20 [0.64-2.25],0.5753183421111578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOBR,Apolipoprotein B receptor,34811,171,1.01 [0.72-1.43],0.940344793720209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOC1,Apolipoprotein C-I,35744,179,0.88 [0.59-1.31],0.516839304757877
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOD,Apolipoprotein D,34188,173,1.00 [0.70-1.42],0.9845169842615716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOE,Apolipoprotein E,35814,180,0.91 [0.72-1.14],0.4018081866529566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOF,Apolipoprotein F,35784,179,1.24 [0.63-2.43],0.5323529572862624
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOH,Beta-2-glycoprotein 1,41134,210,1.42 [1.04-1.94],0.0263877537904685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOL1,Apolipoprotein L1,35784,179,1.03 [0.80-1.33],0.8132582885174771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOM,Apolipoprotein M,41219,211,0.94 [0.61-1.46],0.7921072864613501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APP,Amyloid-beta precursor protein,41073,207,0.85 [0.70-1.02],0.0866721470222023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APPL2,DCC-interacting protein 13-beta,34994,173,0.99 [0.87-1.13],0.8907610740677767
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APRT,Adenine phosphoribosyltransferase,40766,208,1.15 [0.88-1.50],0.3012729134009905
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARAF,Serine/threonine-protein kinase A-Raf,35099,171,1.05 [0.85-1.29],0.6620333913301035
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AREG,Amphiregulin,40934,210,1.23 [0.92-1.64],0.1598008934400097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARF6,ADP-ribosylation factor 6,35608,179,1.01 [0.89-1.15],0.872446529375658
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARFIP1,Arfaptin-1,35709,180,0.98 [0.79-1.20],0.8259953774947705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARG1,Arginase-1,40924,204,1.05 [0.83-1.33],0.6901326245997365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARG2,"Arginase-2, mitochondrial",35598,179,0.90 [0.63-1.28],0.540590600051537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP1,Rho GTPase-activating protein 1,40196,207,0.95 [0.73-1.24],0.7106791691930914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP25,Rho GTPase-activating protein 25,40196,207,1.04 [0.85-1.28],0.6803303568901625
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP30,Rho GTPase-activating protein 30,35099,171,1.09 [0.78-1.53],0.6194348739014135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP45,Rho GTPase-activating protein 45,34994,173,0.94 [0.78-1.12],0.4939159273320498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP5,Rho GTPase-activating protein 5,34510,172,0.87 [0.71-1.07],0.2009876459337602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF1,Rho guanine nucleotide exchange factor 1,35691,178,0.98 [0.83-1.15],0.788701583101505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF10,Rho guanine nucleotide exchange factor 10,35709,180,1.06 [0.91-1.23],0.4475228119862782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF12,Rho guanine nucleotide exchange factor 12,41085,214,0.97 [0.86-1.09],0.6038691666307869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF5,Rho guanine nucleotide exchange factor 5,34664,171,1.03 [0.84-1.25],0.7890707124728641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARID3A,AT-rich interactive domain-containing protein 3A,34664,171,1.04 [0.73-1.50],0.8148886260038002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARID4B,AT-rich interactive domain-containing protein 4B,40166,203,0.99 [0.73-1.34],0.9366992124637232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARL13B,ADP-ribosylation factor-like protein 13B,34635,172,0.92 [0.74-1.15],0.4533994172068576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,34635,172,1.04 [0.73-1.50],0.8203376616446489
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARMCX2,Armadillo repeat-containing X-linked protein 2,34664,171,1.07 [0.86-1.34],0.5286755827624334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARNT,Aryl hydrocarbon receptor nuclear translocator,40393,209,1.06 [0.77-1.47],0.7214995120734031
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,34635,172,1.18 [0.93-1.50],0.173865407069112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARSA,Arylsulfatase A,41134,210,1.32 [1.01-1.72],0.0433057178440809
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARSB,Arylsulfatase B,40934,210,0.94 [0.75-1.17],0.5710608776629407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ART3,Ecto-ADP-ribosyltransferase 3,41278,211,1.33 [0.94-1.90],0.1089772410377421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ART5,Ecto-ADP-ribosyltransferase 5,34664,171,1.06 [0.86-1.31],0.5982905599853899
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARTN,Artemin,40393,209,1.12 [0.87-1.43],0.3850057151877821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASAH1,Acid ceramidase,35442,180,0.97 [0.71-1.33],0.8375584314720849
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASAH2,Neutral ceramidase,40826,208,1.02 [0.80-1.29],0.8870956394722911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASGR1,Asialoglycoprotein receptor 1,40826,208,1.66 [1.11-2.48],0.0132591610151604
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASGR2,Asialoglycoprotein receptor 2,35784,179,1.94 [1.15-3.28],0.0133370612902916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASPN,Asporin,35759,178,0.73 [0.42-1.25],0.2486735171424704
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASPSCR1,Tether containing UBX domain for GLUT4,35709,180,0.95 [0.76-1.17],0.606293372169779
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASRGL1,Isoaspartyl peptidase/L-asparaginase,34811,171,1.00 [0.87-1.16],0.9888396034250424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASS1,Argininosuccinate synthase,34635,172,0.88 [0.72-1.07],0.1913537656335938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATF2,Cyclic AMP-dependent transcription factor ATF-2,40166,203,0.87 [0.70-1.08],0.211024821343093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATF4,Cyclic AMP-dependent transcription factor ATF-4,34510,172,0.93 [0.60-1.45],0.7449075827813078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATG16L1,Autophagy-related protein 16-1,35608,179,1.02 [0.86-1.21],0.8131220286089279
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATG4A,Cysteine protease ATG4A,40196,207,1.15 [0.94-1.40],0.1879124420008928
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATOX1,Copper transport protein ATOX1,41240,212,0.99 [0.84-1.18],0.9193374828960772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,34635,172,1.12 [0.86-1.47],0.3894861531296689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,34635,172,1.06 [0.67-1.65],0.8151052959798412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,34635,172,0.84 [0.56-1.26],0.4027644536957558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B4,Protein ATP1B4,34510,172,0.85 [0.59-1.23],0.3859877854852352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP2B4,Plasma membrane calcium-transporting ATPase 4,34635,172,1.00 [0.79-1.26],0.9773675810105866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP5F1D,"ATP synthase subunit delta, mitochondrial",34635,172,1.08 [0.84-1.40],0.5347365257043466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP5IF1,"ATPase inhibitor, mitochondrial",41291,212,0.92 [0.82-1.03],0.130435294528617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP5PO,"ATP synthase subunit O, mitochondrial",40166,203,1.07 [0.80-1.44],0.6286837173348352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6AP2,Renin receptor,40196,207,1.28 [0.99-1.66],0.0558538934786854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1D,V-type proton ATPase subunit D,40934,210,1.12 [0.71-1.76],0.6349749399862646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1F,V-type proton ATPase subunit F,40090,203,1.08 [0.90-1.30],0.3958797126057441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1G1,V-type proton ATPase subunit G 1,34811,171,1.09 [0.89-1.33],0.4107634219407934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1G2,V-type proton ATPase subunit G 2,34635,172,0.92 [0.78-1.08],0.304430737408299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATRAID,All-trans retinoic acid-induced differentiation factor,35608,179,1.34 [0.93-1.94],0.1197780356582795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATRN,"Attractin, Isoform 2",35814,180,1.24 [0.53-2.94],0.6182975563482875
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN10,Ataxin-10,40166,203,0.98 [0.83-1.17],0.8511809782358821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN2,Ataxin-2,34664,171,0.96 [0.84-1.11],0.6060664278607701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN2L,Ataxin-2-like protein,35709,180,1.12 [0.85-1.49],0.4144399044377441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN3,Ataxin-3,35691,178,1.13 [0.90-1.41],0.3017965011920447
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AXIN1,Axin-1,41085,214,0.96 [0.84-1.09],0.4931488662979268
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AXL,Tyrosine-protein kinase receptor UFO,41278,211,0.91 [0.58-1.42],0.6661106506661637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AZI2,5-azacytidine-induced protein 2,35709,180,1.13 [0.88-1.45],0.3504235694823496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AZU1,Azurocidin,39863,202,1.03 [0.88-1.20],0.7501172145900833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B2M,Beta-2-microglobulin,35814,180,1.26 [0.90-1.77],0.1800030016675917
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,34635,172,0.84 [0.41-1.76],0.6514677677418399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",34811,171,1.00 [0.67-1.49],0.9821326493822292
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B4GALT1,"Beta-1,4-galactosyltransferase 1",41291,212,1.89 [1.22-2.93],0.0045588164315862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B4GAT1,"Beta-1,4-glucuronyltransferase 1",41134,210,1.40 [0.85-2.30],0.1825798750624568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BABAM1,BRISC and BRCA1-A complex member 1,34730,174,0.78 [0.46-1.34],0.3673607451427432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BACH1,Transcription regulator protein BACH1,41085,214,0.98 [0.83-1.15],0.7807802287684422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAG3,BAG family molecular chaperone regulator 3,40754,205,0.93 [0.69-1.27],0.6544533758337305
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAG4,BAG family molecular chaperone regulator 4,34730,174,1.09 [0.82-1.45],0.5537896021010555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAG6,Large proline-rich protein BAG6,40395,204,1.20 [0.85-1.69],0.295762026292515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,40196,207,1.06 [0.88-1.29],0.5253401662777228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAMBI,BMP and activin membrane-bound inhibitor homolog,40196,207,1.25 [0.82-1.90],0.3062803833383282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BANK1,B-cell scaffold protein with ankyrin repeats,41085,214,0.93 [0.83-1.04],0.1876036259144541
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAP18,Chromatin complexes subunit BAP18,35691,178,1.08 [0.90-1.31],0.4070825627420318
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BATF,Basic leucine zipper transcriptional factor ATF-like,34803,173,0.94 [0.78-1.13],0.508184698083574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAX,Apoptosis regulator BAX,40106,203,0.98 [0.85-1.13],0.8232874335876672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAM,Basal cell adhesion molecule,41134,210,1.62 [0.99-2.67],0.0563298366334237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAN,Brevican core protein,40826,208,1.13 [0.79-1.62],0.5051391172093596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",35759,178,1.38 [0.90-2.13],0.1413359835291875
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",34664,171,0.95 [0.72-1.27],0.7477526497502618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCHE,Cholinesterase,35115,177,0.93 [0.55-1.57],0.7737731108533472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2,Apoptosis regulator Bcl-2,35608,179,1.02 [0.78-1.32],0.9030393227270844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L1,Bcl-2-like protein 1,35691,178,0.97 [0.84-1.13],0.7306300053822208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",41085,214,0.64 [0.50-0.81],0.0003032326288793
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L15,Bcl-2-like protein 15,34730,174,1.05 [0.83-1.34],0.6679053470565248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL7A,B-cell CLL/lymphoma 7 protein family member A,34510,172,1.10 [0.89-1.36],0.3753922647832873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL7B,B-cell CLL/lymphoma 7 protein family member B,35598,179,0.93 [0.68-1.29],0.6713061234664359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCR,Breakpoint cluster region protein,41085,214,0.94 [0.82-1.07],0.337455525754677
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BDNF,Brain-derived neurotrophic factor,35767,181,0.89 [0.75-1.05],0.1503523619351086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BECN1,Beclin-1,34811,171,1.12 [0.88-1.43],0.3460404605803797
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BEX3,Protein BEX3,34510,172,0.94 [0.67-1.32],0.7244103385985579
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BGLAP,Osteocalcin,35767,181,0.98 [0.82-1.16],0.7789496070559583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BGN,Biglycan,40131,207,0.92 [0.83-1.02],0.1196143415116687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BHLHE40,Class E basic helix-loop-helix protein 40,34664,171,0.80 [0.64-1.02],0.0682928816255433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,34635,172,0.92 [0.52-1.62],0.7726429281864955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BID,BH3-interacting domain death agonist,41085,214,1.12 [0.95-1.34],0.1851614921116455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BIN2,Bridging integrator 2,41134,210,0.98 [0.86-1.13],0.8059353929328491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BIRC2,Baculoviral IAP repeat-containing protein 2,40196,207,0.98 [0.80-1.19],0.8345120762661328
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLMH,Bleomycin hydrolase,41624,209,1.07 [0.72-1.58],0.7473348355728857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLNK,B-cell linker protein,34730,174,1.21 [0.85-1.72],0.2882704166508136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,34664,171,1.01 [0.83-1.22],0.9590010665772708
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,35691,178,0.95 [0.66-1.37],0.780293337887403
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLVRB,Flavin reductase,41134,210,1.10 [0.92-1.32],0.2735112075780712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP10,Bone morphogenetic protein 10,34994,173,0.87 [0.52-1.45],0.5952858088388184
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP4,Bone morphogenetic protein 4,40754,205,1.13 [0.86-1.47],0.3816216804169557
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP6,Bone morphogenetic protein 6,40329,204,0.74 [0.55-1.00],0.0471731289001255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMPER,BMP-binding endothelial regulator protein,34994,173,0.88 [0.45-1.70],0.6957480689767418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,35759,178,0.94 [0.61-1.44],0.7723743455812286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,34730,174,1.13 [0.81-1.56],0.4813866931462922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BOC,Brother of CDO,40395,204,0.81 [0.47-1.40],0.4543317378489693
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BOLA1,BolA-like protein 1,34664,171,1.11 [0.85-1.44],0.4457568181774549
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BOLA2_BOLA2B,BolA-like protein 2,34811,171,1.14 [0.87-1.50],0.3364410927139724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BPIFA2,BPI fold-containing family A member 2,33587,167,1.00 [0.87-1.15],0.9828958542656075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BPIFB1,BPI fold-containing family B member 1,41039,208,1.03 [0.85-1.25],0.7709657652942842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BPIFB2,BPI fold-containing family B member 2,35696,177,0.94 [0.75-1.18],0.580530302623386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRAP,BRCA1-associated protein,35275,178,0.98 [0.86-1.12],0.8183915704703104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRD1,Bromodomain-containing protein 1,35099,171,1.45 [0.96-2.17],0.0745811071217716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRD2,Bromodomain-containing protein 2,34664,171,1.11 [0.76-1.64],0.586631283774578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRD3,Bromodomain-containing protein 3,34635,172,1.01 [0.75-1.36],0.9603179385739324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRDT,Bromodomain testis-specific protein,34635,172,0.97 [0.65-1.46],0.896818722311894
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRK1,Protein BRICK1,40166,203,0.98 [0.73-1.29],0.8613851072219156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRME1,Break repair meiotic recombinase recruitment factor 1,34664,171,0.88 [0.59-1.30],0.5173582109189874
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRSK2,Serine/threonine-protein kinase BRSK2,35709,180,0.88 [0.59-1.30],0.5151118382376552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BSG,Basigin,41523,212,1.37 [0.73-2.56],0.3272415037222581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BSND,Barttin,34510,172,0.86 [0.54-1.37],0.5323180496147961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,41490,211,0.93 [0.73-1.19],0.5771443591090136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BST2,Bone marrow stromal antigen 2,41490,211,0.90 [0.70-1.17],0.4281543916947964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTC,Probetacellulin,40196,207,0.92 [0.78-1.09],0.3508312205921511
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTD,Biotinidase,35814,180,0.67 [0.34-1.31],0.2393770374205653
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTLA,B- and T-lymphocyte attenuator,34510,172,0.95 [0.80-1.14],0.6029842441750867
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN1A1,Butyrophilin subfamily 1 member A1,35530,179,1.35 [1.06-1.71],0.0161220644221114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN2A1,Butyrophilin subfamily 2 member A1,41291,212,1.58 [1.00-2.50],0.0515144527507354
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN3A2,Butyrophilin subfamily 3 member A2,41085,214,1.09 [0.79-1.50],0.6144938822790899
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTNL10,Butyrophilin-like protein 10,34510,172,1.10 [0.79-1.53],0.5577782350300129
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C19orf12,Protein C19orf12,40166,203,0.94 [0.77-1.16],0.5625859868289984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1GALT1C1,C1GALT1-specific chaperone 1,34635,172,0.96 [0.60-1.53],0.8566109564358965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QA,Complement C1q subcomponent subunit A,41386,210,1.30 [0.75-2.24],0.3527374413643448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",35709,180,0.94 [0.76-1.17],0.5753601328352429
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QL2,Complement C1q-like protein 2,34730,174,0.80 [0.56-1.15],0.2277015141513929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,41278,211,1.20 [0.90-1.59],0.2069585969196927
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,34994,173,0.73 [0.50-1.07],0.1054550038143082
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,35709,180,1.25 [0.84-1.85],0.267499231288159
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,34928,173,1.06 [0.78-1.45],0.6975179056213192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1R,Complement C1r subcomponent,35814,180,0.60 [0.25-1.44],0.2535970841220815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1RL,Complement C1r subcomponent-like protein,35747,180,0.73 [0.36-1.50],0.396266346257208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1S,Complement C1s subcomponent,35814,180,0.78 [0.39-1.55],0.4791258224650412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2,Complement C2,41219,211,1.37 [0.76-2.46],0.2903783298909919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2CD2L,Phospholipid transfer protein C2CD2L,40090,203,1.20 [0.92-1.57],0.1747276849094071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2orf69,UPF0565 protein C2orf69,34803,173,1.11 [0.89-1.39],0.3502801127379079
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C3,Complement C3,33992,170,0.91 [0.64-1.30],0.6032835482260084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C4BPB,C4b-binding protein beta chain,41240,212,1.05 [0.77-1.43],0.7496464322474454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C5,Complement C5,35814,180,1.23 [0.48-3.14],0.6721374200724428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C7,Complement component C7,34955,175,1.53 [0.95-2.47],0.0774497986046964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C7orf50,Uncharacterized protein C7orf50,35691,178,1.02 [0.56-1.87],0.944802085853234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C8B,Complement component C8 beta chain,35814,180,0.98 [0.61-1.57],0.9406597000429016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C9,Complement component C9,35784,179,1.02 [0.79-1.34],0.859350968913279
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C9orf40,Uncharacterized protein C9orf40,35608,179,1.13 [0.95-1.34],0.1769009494150344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA1,Carbonic anhydrase 1,40234,209,1.19 [0.97-1.46],0.089010351632716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA11,Carbonic anhydrase-related protein 11,40196,207,0.90 [0.59-1.39],0.6395389523663361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA12,Carbonic anhydrase 12,40934,210,0.95 [0.64-1.40],0.78650439185797
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA13,Carbonic anhydrase 13,40668,212,0.92 [0.82-1.03],0.1351327524450361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA14,Carbonic anhydrase 14,41501,211,1.09 [0.77-1.54],0.6415469338149493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA2,Carbonic anhydrase 2,41000,210,1.13 [0.95-1.34],0.1690051466124379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA3,Carbonic anhydrase 3,41560,209,1.39 [1.16-1.68],0.000527979589049
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA4,Carbonic anhydrase 4,41624,209,0.96 [0.58-1.61],0.8843233640306248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA5A,"Carbonic anhydrase 5A, mitochondrial",40395,204,1.04 [0.91-1.19],0.5767035309254844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA6,Carbonic anhydrase 6,41004,210,1.04 [0.85-1.27],0.6940652317213183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA7,Carbonic anhydrase 7,35099,171,0.88 [0.56-1.38],0.5758717930821946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA8,Carbonic anhydrase-related protein,34730,174,1.15 [0.70-1.89],0.5711580754740767
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA9,Carbonic anhydrase 9,41501,211,1.21 [0.94-1.57],0.1371734399951784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CABP2,Calcium-binding protein 2,34803,173,1.03 [0.83-1.28],0.781930710858236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,34664,171,0.88 [0.55-1.41],0.590798049157711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,34635,172,0.91 [0.69-1.21],0.5174453363139804
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,34664,171,1.08 [0.86-1.37],0.4995918208280857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,35709,180,0.95 [0.80-1.13],0.5684006510013151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACYBP,Calcyclin-binding protein,34924,173,0.99 [0.86-1.14],0.8881094270146251
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CADPS,Calcium-dependent secretion activator 1,34803,173,1.00 [0.70-1.43],0.9804742383338146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALB1,Calbindin,40934,210,1.32 [0.99-1.76],0.062851529422513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALB2,Calretinin,40166,203,1.08 [0.71-1.65],0.7103952346206073
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCA,Calcitonin,40750,208,1.16 [0.96-1.40],0.1224111936316083
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCB,Calcitonin gene-related peptide 2,35691,178,1.18 [0.85-1.63],0.3148752883320441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,41374,211,1.01 [0.90-1.14],0.832929190260779
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,34811,171,1.09 [0.90-1.32],0.4046658571868341
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALY,Neuron-specific vesicular protein calcyon,34635,172,0.69 [0.43-1.09],0.107430265766273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,40196,207,0.87 [0.65-1.16],0.3412599527559345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,34803,173,0.78 [0.58-1.05],0.1050986319970083
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,35709,180,1.06 [0.92-1.21],0.4287261557448744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CANT1,Soluble calcium-activated nucleotidase 1,40998,211,1.82 [0.99-3.35],0.0532016101625677
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAPG,Macrophage-capping protein,40857,206,1.05 [0.85-1.30],0.6369564236260321
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAPN3,Calpain-3,35598,179,0.93 [0.62-1.38],0.7187945722046298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAPS,Calcyphosin,35691,178,1.02 [0.89-1.17],0.7511420177494795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CARHSP1,Calcium-regulated heat-stable protein 1,40166,203,1.07 [0.85-1.36],0.5553181266582838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASC3,Protein CASC3,34803,173,0.90 [0.63-1.30],0.5840706683353485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP1,Caspase-1,40166,203,1.00 [0.84-1.20],0.9614726429258053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP10,Caspase-10,40166,203,0.93 [0.78-1.11],0.4398723238066688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP2,Caspase-2,41085,214,0.93 [0.78-1.12],0.4490789710016803
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP3,Caspase-3,41624,209,0.95 [0.82-1.09],0.4263087073253025
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP4,Caspase-4,35099,171,1.07 [0.99-1.16],0.0824203526897658
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP7,Caspase-7,35691,178,0.92 [0.77-1.09],0.3160257513194898
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP8,Caspase-8,41380,211,1.12 [0.93-1.35],0.2459222148651342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP9,Caspase-9,34730,174,0.85 [0.67-1.09],0.2033735695964848
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASQ2,Calsequestrin-2,34635,172,0.93 [0.68-1.28],0.6643363527608742
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAT,Catalase,35245,174,1.23 [0.95-1.59],0.1127185309595602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBLIF,Cobalamin binding intrinsic factor,41074,212,0.92 [0.78-1.07],0.267873008089467
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBLN1,Cerebellin-1,34664,171,1.02 [0.88-1.19],0.7902845397200522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBLN4,Cerebellin-4,41501,211,0.71 [0.49-1.05],0.0885974551550384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBS,Cystathionine beta-synthase,34811,171,0.73 [0.53-1.02],0.0648405493914188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBX2,Chromobox protein homolog 2,34635,172,1.18 [0.86-1.61],0.3139950037730194
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40826,208,1.06 [0.90-1.26],0.4664135108486069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCAR2,Cell cycle and apoptosis regulator protein 2,35691,178,1.07 [0.84-1.36],0.603713436580379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC134,Coiled-coil domain-containing protein 134,35598,179,0.91 [0.67-1.23],0.5481031082937202
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC28A,Coiled-coil domain-containing protein 28A,34803,173,0.77 [0.47-1.27],0.3110692735121083
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC50,Coiled-coil domain-containing protein 50,35709,180,0.92 [0.75-1.12],0.3860587403862215
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC80,Coiled-coil domain-containing protein 80,41128,212,1.38 [0.98-1.92],0.0613134167583919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,34811,171,1.18 [0.93-1.49],0.1690683044648316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL11,Eotaxin,41597,213,0.96 [0.69-1.32],0.7969950528107012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL13,C-C motif chemokine 13,41530,213,0.83 [0.69-0.99],0.0421999891451537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL14,C-C motif chemokine 14,41020,211,1.33 [1.01-1.77],0.0440545207014316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL15,C-C motif chemokine 15,41624,209,1.04 [0.78-1.39],0.7683681379341729
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL16,C-C motif chemokine 16,41624,209,1.29 [1.00-1.67],0.0505421617262672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL17,C-C motif chemokine 17,41038,212,0.92 [0.81-1.05],0.2269098946277982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL18,C-C motif chemokine 18,40557,211,0.94 [0.78-1.13],0.5087496817300583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL19,C-C motif chemokine 19,41490,211,0.90 [0.81-1.01],0.0836934849142179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL2,C-C motif chemokine 2,40754,205,0.97 [0.77-1.23],0.7927026297448099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL20,C-C motif chemokine 20,41597,213,0.96 [0.83-1.10],0.5337730003926029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL21,C-C motif chemokine 21,41291,212,0.84 [0.61-1.17],0.3050786712245071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL22,C-C motif chemokine 22,40687,211,0.91 [0.72-1.16],0.4536031045220398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL23,C-C motif chemokine 23,41291,212,1.40 [1.04-1.87],0.024995758027426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL24,C-C motif chemokine 24,41231,212,1.00 [0.86-1.16],0.9996862804680708
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL25,C-C motif chemokine 25,41597,213,0.99 [0.77-1.27],0.9112830422434124
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL26,C-C motif chemokine 26,41085,214,0.98 [0.85-1.12],0.7167404144805364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL27,C-C motif chemokine 27,41128,212,1.07 [0.87-1.31],0.5440181983921499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL28,C-C motif chemokine 28,40946,213,0.87 [0.70-1.08],0.2075801211991219
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL3,C-C motif chemokine 3,41085,214,1.12 [0.91-1.38],0.2666313358570993
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL4,C-C motif chemokine 4,41165,212,1.11 [0.94-1.30],0.2238313701896294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL5,C-C motif chemokine 5,41278,211,0.88 [0.78-0.99],0.0372263964048627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL7,C-C motif chemokine 7,41085,214,0.89 [0.71-1.11],0.3012528166699837
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL8,C-C motif chemokine 8,41442,211,0.99 [0.81-1.20],0.8937344651626885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN1,CCN family member 1,40868,210,1.02 [0.86-1.20],0.8182118626661239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN2,CCN family member 2,41104,211,0.91 [0.73-1.12],0.3719640700270834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN3,CCN family member 3,41554,209,1.48 [1.04-2.12],0.0313124318800609
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN4,CCN family member 4,41501,211,1.25 [0.92-1.68],0.1504602229965267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN5,CCN family member 5,41134,210,1.51 [1.11-2.06],0.0092255659223763
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCND2,G1/S-specific cyclin-D2,35099,171,1.22 [0.82-1.84],0.329169780126317
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCNE1,G1/S-specific cyclin-E1,34730,174,1.01 [0.87-1.18],0.8507689809805334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCS,Copper chaperone for superoxide dismutase,40826,208,0.98 [0.76-1.28],0.905194836192398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCT5,T-complex protein 1 subunit epsilon,40196,207,0.96 [0.72-1.28],0.7858661999855189
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD101,Immunoglobulin superfamily member 2,35608,179,0.93 [0.68-1.29],0.6820558626011192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD109,CD109 antigen,41134,210,1.45 [1.00-2.10],0.0521200987678716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD14,Monocyte differentiation antigen CD14,40290,209,1.13 [0.84-1.54],0.4126919762064945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD160,CD160 antigen,41597,213,0.98 [0.76-1.28],0.8972476557666622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD163,Scavenger receptor cysteine-rich type 1 protein M130,41278,211,0.84 [0.63-1.13],0.2419561492721655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD164,Sialomucin core protein 24,41134,210,1.44 [1.04-1.99],0.0276486831526748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD164L2,CD164 sialomucin-like 2 protein,34803,173,0.82 [0.54-1.24],0.3494181703778023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD177,CD177 antigen,41073,210,1.05 [0.95-1.16],0.3187113707327287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD1C,T-cell surface glycoprotein CD1c,41240,212,1.40 [0.83-2.35],0.2037597613512586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD2,T-cell surface antigen CD2,34635,172,0.89 [0.59-1.34],0.5900568714162071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD200,OX-2 membrane glycoprotein,41085,214,1.59 [1.01-2.48],0.0434171443740526
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD200R1,Cell surface glycoprotein CD200 receptor 1,40951,214,0.91 [0.64-1.29],0.6052848932085444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD207,C-type lectin domain family 4 member K,40200,207,1.36 [0.99-1.88],0.0579827884991651
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD209,CD209 antigen,41220,209,1.09 [0.80-1.49],0.5883367869981637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD22,B-cell receptor CD22,41597,213,0.81 [0.60-1.10],0.1744274593891001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD226,CD226 antigen,34730,174,0.85 [0.60-1.21],0.3617229323434596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD244,Natural killer cell receptor 2B4,41597,213,0.81 [0.52-1.28],0.3700957824557377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD248,Endosialin,35767,181,1.50 [1.06-2.14],0.0236052257343896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD27,CD27 antigen,41240,212,1.53 [1.14-2.05],0.0042807984311521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD274,Programmed cell death 1 ligand 1,40826,208,1.27 [0.89-1.81],0.1967779206628209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD276,CD276 antigen,41092,212,1.33 [0.93-1.89],0.1149482662611675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD28,T-cell-specific surface glycoprotein CD28,40196,207,1.10 [0.79-1.53],0.5769738672140856
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD2AP,CD2-associated protein,41128,212,1.11 [0.92-1.34],0.2663708170605686
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300A,CMRF35-like molecule 8,34994,173,1.35 [0.83-2.19],0.2280144893782428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300C,CMRF35-like molecule 6,41490,211,1.18 [0.83-1.69],0.3590363537185606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300E,CMRF35-like molecule 2,41367,210,1.52 [1.13-2.04],0.0050638451067325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300LF,CMRF35-like molecule 1,41501,211,1.02 [0.83-1.26],0.8364300925407282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300LG,CMRF35-like molecule 9,41134,210,1.43 [1.03-1.98],0.0311072278500656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD302,CD302 antigen,40934,210,1.66 [1.12-2.46],0.0110991897102635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD33,Myeloid cell surface antigen CD33,41240,212,1.02 [0.88-1.19],0.7731284341231691
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD34,Hematopoietic progenitor cell antigen CD34,41348,211,1.13 [0.68-1.87],0.6448163181439968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD36,Platelet glycoprotein 4,34730,174,0.86 [0.61-1.21],0.3832644207701288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40934,210,1.13 [0.76-1.66],0.5539917770616891
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD3D,T-cell surface glycoprotein CD3 delta chain,34664,171,0.89 [0.56-1.42],0.6323331419095919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD3E,T-cell surface glycoprotein CD3 epsilon chain,35099,171,1.02 [0.69-1.52],0.9087417838673324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD3G,T-cell surface glycoprotein CD3 gamma chain,34730,174,0.80 [0.65-1.00],0.0482628741437131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD4,T-cell surface glycoprotein CD4,41010,213,1.09 [0.73-1.63],0.6605604002068852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD40,Tumor necrosis factor receptor superfamily member 5,41105,212,0.89 [0.69-1.15],0.3759428131550382
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD40LG,CD40 ligand,41597,213,0.93 [0.80-1.09],0.3659876944053025
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD46,Membrane cofactor protein,40883,209,1.14 [0.74-1.75],0.5580472531447449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD48,CD48 antigen,41231,212,1.13 [0.75-1.71],0.5568171146499363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD5,T-cell surface glycoprotein CD5,41442,211,1.34 [0.94-1.92],0.1094628538956464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD55,Complement decay-accelerating factor,39696,206,1.49 [0.96-2.32],0.0749998726131721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD58,Lymphocyte function-associated antigen 3,41024,212,0.89 [0.45-1.77],0.7363228717435266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD59,CD59 glycoprotein,39645,201,1.67 [1.00-2.79],0.0507767018909632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD5L,CD5 antigen-like,35628,179,1.08 [0.80-1.47],0.606381736230686
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD6,T-cell differentiation antigen CD6,41523,212,0.93 [0.74-1.17],0.5141971326978687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD63,CD63 antigen,40754,205,0.88 [0.69-1.12],0.3020303207399448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD69,Early activation antigen CD69,40939,212,0.92 [0.80-1.06],0.2565040761823142
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD7,T-cell antigen CD7,34664,174,0.89 [0.63-1.26],0.519041866728359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD70,CD70 antigen,41085,214,1.38 [1.04-1.82],0.0265324184902291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD72,B-cell differentiation antigen CD72,34994,173,1.18 [0.83-1.69],0.3596778477679493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD74,HLA class II histocompatibility antigen gamma chain,41490,211,1.38 [0.97-1.97],0.072086194695785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD79B,B-cell antigen receptor complex-associated protein beta chain,41597,213,1.39 [1.06-1.83],0.0171012442147501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD80,T-lymphocyte activation antigen CD80,35759,178,1.01 [0.64-1.57],0.9771220531351772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD82,CD82 antigen,35099,171,1.07 [0.76-1.50],0.7037720256297348
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD83,CD83 antigen,41085,214,1.15 [0.80-1.66],0.4454960672982321
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD84,SLAM family member 5,41085,214,0.73 [0.50-1.08],0.1121557424852305
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD86,T-lymphocyte activation antigen CD86,35608,179,1.11 [0.68-1.83],0.6681373302395335
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD8A,T-cell surface glycoprotein CD8 alpha chain,41490,211,1.02 [0.80-1.30],0.8486753477194986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD93,Complement component C1q receptor,39574,209,1.55 [1.05-2.29],0.0281411640687714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD99,CD99 antigen,41134,210,1.73 [0.93-3.21],0.0834669936738675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD99L2,CD99 antigen-like protein 2,41134,210,1.64 [1.00-2.71],0.0522769690927377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDA,Cytidine deaminase,35697,178,1.08 [0.81-1.45],0.59015817036154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDAN1,Codanin-1,35691,178,1.36 [0.80-2.32],0.2615741058470637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC123,Cell division cycle protein 123 homolog,34510,172,1.04 [0.83-1.30],0.7480180987861753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC25A,M-phase inducer phosphatase 1,34510,172,0.96 [0.66-1.40],0.8364515507837728
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC26,Anaphase-promoting complex subunit CDC26,35542,179,1.03 [0.84-1.27],0.7863505371947083
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC27,Cell division cycle protein 27 homolog,40196,207,1.10 [0.90-1.35],0.3478821411126586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC37,Hsp90 co-chaperone Cdc37,41240,212,1.00 [0.87-1.16],0.9807397781831412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC42BPB,Serine/threonine-protein kinase MRCK beta,35608,179,1.03 [0.89-1.18],0.6937007168782982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDCP1,CUB domain-containing protein 1,40826,208,1.05 [0.83-1.32],0.7006422285534588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH1,Cadherin-1,39744,206,1.25 [0.94-1.66],0.1254018619159296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH15,Cadherin-15,41414,211,0.85 [0.69-1.04],0.1206564970127517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH17,Cadherin-17,41128,212,0.95 [0.79-1.14],0.5903830645468282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH2,Cadherin-2,41128,212,0.88 [0.62-1.25],0.4734354802180202
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH22,Cadherin-22,35099,171,0.81 [0.47-1.38],0.429666395604094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH23,Cadherin-23,35691,178,1.21 [0.72-2.02],0.4674918345649712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH3,Cadherin-3,41490,211,1.56 [1.12-2.16],0.0078687402636628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH4,Cadherin-4,34664,171,0.80 [0.56-1.12],0.1929397968801734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH5,Cadherin-5,41624,209,1.35 [0.91-2.01],0.1404033004793914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH6,Cadherin-6,41128,212,1.10 [0.80-1.52],0.5518390063173786
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR1,Cadherin-related family member 1,40166,203,1.17 [0.89-1.55],0.2611794431262972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR2,Cadherin-related family member 2,40934,210,1.05 [0.87-1.25],0.6255046692607231
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR5,Cadherin-related family member 5,41128,212,0.72 [0.53-0.97],0.0284365905764401
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDK1,Cyclin-dependent kinase 1,34510,172,1.28 [0.86-1.90],0.232827604753634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,35709,180,0.89 [0.69-1.15],0.3585693291396581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDKL5,Cyclin-dependent kinase-like 5,34664,171,1.05 [0.81-1.37],0.7084908964337415
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDKN1A,Cyclin-dependent kinase inhibitor 1,40934,210,0.93 [0.83-1.04],0.2022476614203846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40934,210,0.95 [0.83-1.07],0.390053653539542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDNF,Cerebral dopamine neurotrophic factor,40934,210,1.28 [0.90-1.82],0.1647505835584805
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,41164,212,0.55 [0.35-0.85],0.006529526715999
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDSN,Corneodesmosin,41466,213,1.35 [1.02-1.79],0.0342148716845196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,41174,211,1.40 [0.76-2.59],0.2797551879900254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,35608,179,0.90 [0.75-1.08],0.252852370895201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,35099,171,0.80 [0.61-1.04],0.0993113164866295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,35608,179,1.19 [0.84-1.70],0.3311740052408051
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,35099,171,0.88 [0.62-1.26],0.4988888942640556
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,41085,214,1.06 [0.93-1.22],0.389507771084713
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,40196,207,1.10 [0.86-1.41],0.4474034447440084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39655,203,1.16 [0.95-1.40],0.1458293617979192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,35767,181,0.82 [0.56-1.19],0.2947477046446626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40395,204,1.21 [0.95-1.55],0.1225680879946157
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEBPA,CCAAT/enhancer-binding protein alpha,34730,174,0.97 [0.65-1.45],0.8772498266776434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEBPB,CCAAT/enhancer-binding protein beta,40395,204,1.10 [0.80-1.52],0.5584987848746399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CELA2A,Chymotrypsin-like elastase family member 2A,35767,181,0.95 [0.76-1.20],0.671681762321475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CELA3A,Chymotrypsin-like elastase family member 3A,41555,209,1.01 [0.82-1.25],0.9368532393668978
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,34994,173,0.68 [0.40-1.15],0.1476507437734487
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEMIP2,Cell surface hyaluronidase,34730,174,1.48 [1.07-2.04],0.0189209458268699
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEND1,Cell cycle exit and neuronal differentiation protein 1,34664,171,0.82 [0.61-1.11],0.1953084978042043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CENPF,Centromere protein F,35099,171,1.19 [0.92-1.53],0.1792314578719518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CENPJ,Centromere protein J,35099,171,0.95 [0.77-1.18],0.6553213504922096
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP112,Centrosomal protein of 112 kDa,34635,172,0.91 [0.64-1.30],0.6119217597577127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP152,Centrosomal protein of 152 kDa,34510,172,1.28 [0.96-1.71],0.0946127515887484
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP164,Centrosomal protein of 164 kDa,40393,209,1.13 [0.96-1.33],0.1561928798988549
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP170,Centrosomal protein of 170 kDa,34811,171,1.17 [0.97-1.40],0.1000353940524115
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP20,Centrosomal protein 20,40196,207,0.98 [0.83-1.16],0.8155660456696993
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP290,Centrosomal protein of 290 kDa,35099,171,0.92 [0.69-1.23],0.5814023403808244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP350,Centrosome-associated protein 350,34510,172,1.08 [0.74-1.59],0.6874172328293839
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP43,Centrosomal protein 43,40077,202,0.97 [0.81-1.16],0.728026303302109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP85,Centrosomal protein of 85 kDa,40196,207,1.19 [0.99-1.44],0.0695214664468645
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CERT,Ceramide transfer protein,40166,203,0.95 [0.77-1.16],0.598060566803127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CES1,Liver carboxylesterase 1,41214,209,0.94 [0.81-1.10],0.4314591567848658
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CES2,Cocaine esterase,40934,210,1.09 [0.88-1.35],0.4377481414449613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CES3,Carboxylesterase 3,40934,210,1.03 [0.87-1.23],0.7040889110073062
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CETN2,Centrin-2,40166,203,0.92 [0.76-1.11],0.361513862829081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CETN3,Centrin-3,35608,179,1.02 [0.85-1.23],0.8361936872772331
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFB,Complement factor B,35166,177,0.76 [0.49-1.18],0.2210598352080968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFC1,Cryptic protein,40196,207,1.07 [0.82-1.39],0.6200983061581602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFD,Complement factor D,35814,180,1.64 [0.87-3.07],0.1248358501020521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFH,Complement factor H,33739,166,0.81 [0.42-1.56],0.5376675158719053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFHR2,Complement factor H-related protein 2,35558,180,0.97 [0.75-1.24],0.78474019740803
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFHR4,Complement factor H-related protein 4,35749,180,1.03 [0.84-1.25],0.7840881866478859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFHR5,Complement factor H-related protein 5,35318,177,1.07 [0.75-1.53],0.70933512917976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFI,Complement factor I,35814,180,0.58 [0.28-1.20],0.1435630227562827
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFP,Properdin,35814,180,0.94 [0.49-1.80],0.8436928564861688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGA,Glycoprotein hormones alpha chain,41134,210,1.15 [0.96-1.38],0.139401566594938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,35784,179,1.20 [0.85-1.69],0.3083800744684952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGN,Cingulin,34803,173,1.13 [0.81-1.58],0.4866334952193971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGREF1,Cell growth regulator with EF hand domain protein 1,41128,212,1.11 [0.83-1.48],0.4830497182381139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,40196,207,1.08 [0.89-1.33],0.4345210640727501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHAD,Chondroadherin,34994,173,1.02 [0.76-1.38],0.8867883318170493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",35691,178,1.26 [0.89-1.78],0.1941483344676179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHCHD6,MICOS complex subunit MIC25,35598,179,1.04 [0.63-1.74],0.8696991752879607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHEK2,Serine/threonine-protein kinase Chk2,40395,204,1.16 [0.80-1.68],0.4434900258093247
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHGA,Chromogranin-A,35767,181,1.00 [0.85-1.17],0.981950596816146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHGB,Secretogranin-1,41348,210,0.92 [0.68-1.25],0.6072137801982218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHI3L1,Chitinase-3-like protein 1,40225,208,1.07 [0.92-1.25],0.3578132943022141
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHIT1,Chitotriosidase-1,41303,209,1.05 [0.96-1.14],0.3213695690143768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHL1,Neural cell adhesion molecule L1-like protein,41214,211,1.14 [0.76-1.69],0.5298776440840905
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHM,Rab proteins geranylgeranyltransferase component A 1,34803,173,0.91 [0.71-1.17],0.4733221826866687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHMP1A,Charged multivesicular body protein 1a,40826,208,0.93 [0.80-1.09],0.3678876039304725
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHMP6,Charged multivesicular body protein 6,35759,178,0.95 [0.74-1.23],0.722470947978507
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHP1,Calcineurin B homologous protein 1,34664,171,0.86 [0.69-1.07],0.1838650487888593
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHRDL1,Chordin-like protein 1,41231,212,1.13 [0.76-1.68],0.5355056940803349
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHRDL2,Chordin-like protein 2,41128,212,1.00 [0.78-1.29],0.976509488311612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHRM1,Muscarinic acetylcholine receptor M1,34803,173,1.34 [0.97-1.86],0.0730526691747759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CIAPIN1,Anamorsin,41240,212,1.05 [0.86-1.28],0.6294103279364326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CILP,Cartilage intermediate layer protein 1,35767,181,1.08 [0.83-1.41],0.5717990611406234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CINP,Cyclin-dependent kinase 2-interacting protein,35099,171,1.02 [0.73-1.41],0.9253813635112536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CIRBP,Cold-inducible RNA-binding protein,35608,179,1.00 [0.86-1.17],0.9610621099549672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CIT,Citron Rho-interacting kinase,34803,173,1.33 [1.01-1.75],0.0416730957407364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CKAP4,Cytoskeleton-associated protein 4,41397,212,1.69 [1.15-2.48],0.007243180157988
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CKB,Creatine kinase B-type,35767,181,1.16 [0.91-1.49],0.2263337529283471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40965,212,0.89 [0.76-1.05],0.1848984334982171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLASP1,CLIP-associating protein 1,34510,172,0.95 [0.77-1.16],0.6080232117031349
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLC,Galectin-10,41063,211,1.02 [0.85-1.23],0.8344024444241546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC10A,C-type lectin domain family 10 member A,40826,208,1.22 [0.87-1.72],0.2572989624276027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC11A,C-type lectin domain family 11 member A,41058,210,1.06 [0.82-1.37],0.6730450149917726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC12A,C-type lectin domain family 12 member A,34730,174,1.16 [0.57-2.34],0.6882270060994615
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC14A,C-type lectin domain family 14 member A,41134,210,1.42 [0.98-2.08],0.0673250103648285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC1A,C-type lectin domain family 1 member A,40395,204,1.87 [1.31-2.68],0.0005612466186236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC1B,C-type lectin domain family 1 member B,41490,211,0.91 [0.80-1.03],0.1384870140436222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC2L,C-type lectin domain family 2 member L,34803,173,1.10 [0.85-1.43],0.4499256422616576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC3B,Tetranectin,34979,176,0.60 [0.30-1.20],0.1490197755805763
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4A,C-type lectin domain family 4 member A,41085,214,0.87 [0.62-1.23],0.4227391188438665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4C,C-type lectin domain family 4 member C,41085,214,1.02 [0.79-1.32],0.8820334399544649
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4D,C-type lectin domain family 4 member D,41085,214,0.94 [0.77-1.15],0.5354945671508916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4G,C-type lectin domain family 4 member G,41085,214,1.01 [0.70-1.45],0.9712277578244364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4M,C-type lectin domain family 4 member M,35706,181,0.99 [0.74-1.32],0.9419218628412852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC5A,C-type lectin domain family 5 member A,41001,212,1.30 [0.86-1.95],0.2122239088706802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC6A,C-type lectin domain family 6 member A,40196,207,1.34 [1.03-1.73],0.0262406761250104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC7A,C-type lectin domain family 7 member A,41597,213,0.89 [0.75-1.06],0.1809011612595634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLGN,Calmegin,34803,173,1.08 [0.78-1.48],0.639866576052988
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLIC5,Chloride intracellular channel protein 5,34803,173,1.31 [0.88-1.95],0.1873620407488306
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLINT1,Clathrin interactor 1,34510,172,0.84 [0.59-1.19],0.334063447958939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLIP2,CAP-Gly domain-containing linker protein 2,41085,214,0.98 [0.88-1.09],0.653064691105937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLMP,CXADR-like membrane protein,41501,211,1.17 [0.65-2.12],0.5940646883379603
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLNS1A,Methylosome subunit pICln,34803,173,1.28 [0.86-1.92],0.2257971489850322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40750,208,0.87 [0.76-0.99],0.0338579163292275
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLPS,Colipase,41061,210,1.21 [1.02-1.44],0.0302388749889293
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSPN,Claspin,40090,203,1.19 [0.89-1.59],0.2418942184404545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSTN1,Calsyntenin-1,40166,203,0.95 [0.74-1.22],0.6983099904417731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSTN2,Calsyntenin-2,41597,213,0.92 [0.67-1.27],0.6110996923654626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSTN3,Calsyntenin-3,35691,178,1.05 [0.65-1.68],0.8462783093174074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLTA,Clathrin light chain A,40395,204,1.07 [0.82-1.39],0.6118153327040672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLU,Clusterin,35814,180,0.70 [0.36-1.35],0.2860298374248222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLUL1,Clusterin-like protein 1,41061,210,1.08 [0.82-1.42],0.6004689264667171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CMC1,COX assembly mitochondrial protein homolog,35759,178,0.95 [0.81-1.12],0.539053084057471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CMIP,C-Maf-inducing protein,35598,179,0.98 [0.82-1.16],0.7930150203253707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNDP1,Beta-Ala-His dipeptidase,41278,211,1.01 [0.77-1.33],0.9457598288443708
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNGB3,Cyclic nucleotide-gated cation channel beta-3,34664,171,1.19 [0.96-1.49],0.1177086668239398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",34745,170,1.05 [0.87-1.27],0.603473450963612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNPY2,Protein canopy homolog 2,40395,204,0.85 [0.67-1.08],0.1861191493375351
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNPY4,Protein canopy homolog 4,40934,210,0.90 [0.77-1.06],0.206437005658389
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNST,Consortin,41128,212,0.95 [0.85-1.06],0.3300101022041587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTF,Ciliary neurotrophic factor,34664,171,1.17 [0.77-1.78],0.4640878418648128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN1,Contactin-1,41624,209,0.79 [0.50-1.23],0.2893800886457363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN2,Contactin-2,41501,211,0.81 [0.61-1.07],0.1405762456309347
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN3,Contactin-3,41134,210,0.92 [0.61-1.38],0.682428722627739
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN4,Contactin-4,41134,210,1.13 [0.67-1.89],0.6481655989549624
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN5,Contactin-5,41227,211,1.17 [0.84-1.62],0.3616890073425296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTNAP2,Contactin-associated protein-like 2,41085,214,1.14 [0.85-1.53],0.3679398856047589
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTNAP4,Contactin-associated protein-like 4,34803,173,1.06 [0.94-1.21],0.3443038293648961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COCH,Cochlin,35759,178,1.27 [0.94-1.73],0.1186722243461183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL15A1,Collagen alpha-1(XV) chain,35767,181,1.21 [0.70-2.08],0.4968511218231396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL18A1,Collagen alpha-1(XVIII) chain,41293,209,1.27 [0.75-2.17],0.3759465531271047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL1A1,Collagen alpha-1(I) chain,41624,209,1.17 [0.72-1.92],0.5288413444068546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL24A1,Collagen alpha-1(XXIV) chain,35608,179,0.89 [0.69-1.13],0.3377597451258987
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL28A1,Collagen alpha-1(XXVIII) chain,34803,173,1.03 [0.85-1.25],0.7519577359562584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL2A1,Collagen alpha-1(II) chain,34811,171,0.95 [0.79-1.15],0.5954020934117138
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL3A1,Collagen alpha-1(III) chain,35767,181,1.41 [0.77-2.58],0.2593847802808053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL4A1,Collagen alpha-1(IV) chain,41128,212,1.06 [0.77-1.45],0.7366500497895534
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL4A4,Collagen alpha-4(IV) chain,35039,171,1.00 [0.76-1.32],0.9873046032554754
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL5A1,Collagen alpha-1(V) chain,34994,173,1.00 [0.69-1.46],0.9961320859803776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL6A3,Collagen alpha-3(VI) chain,41624,209,1.47 [1.04-2.07],0.0299230311104964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL9A1,Collagen alpha-1(IX) chain,41085,214,0.96 [0.74-1.25],0.7746992410964483
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL9A2,Collagen alpha-2(IX) chain,35099,171,1.11 [0.83-1.50],0.4803211862625873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COLEC12,Collectin-12,41092,212,1.46 [0.91-2.32],0.1160167549018219
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMMD1,COMM domain-containing protein 1,34811,171,1.07 [0.84-1.36],0.5880921755496262
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMMD9,COMM domain-containing protein 9,35598,179,1.01 [0.70-1.44],0.972032092279899
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMP,Cartilage oligomeric matrix protein,40690,210,1.34 [0.92-1.94],0.1228454161354009
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMT,Catechol O-methyltransferase,39961,202,1.05 [0.90-1.22],0.5268746635197581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COPB2,Coatomer subunit beta',34635,172,0.97 [0.69-1.36],0.8401974842551944
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COPE,Coatomer subunit epsilon,40166,203,0.97 [0.74-1.27],0.8193865096503872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",34811,171,1.20 [0.89-1.62],0.2370712534074835
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CORO1A,Coronin-1A,40273,203,1.05 [0.92-1.21],0.4543632787910158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CORO6,Coronin-6,34664,171,1.18 [0.81-1.72],0.3870617966435279
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40934,210,0.89 [0.74-1.06],0.2008499537213829
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COX6B1,Cytochrome c oxidase subunit 6B1,35759,178,0.84 [0.54-1.32],0.4568006296259145
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPA1,Carboxypeptidase A1,41624,209,1.05 [0.87-1.28],0.5977052682204376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPA2,Carboxypeptidase A2,41351,211,1.01 [0.84-1.22],0.8996147301281303
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPA4,Carboxypeptidase A4,34302,171,1.22 [0.86-1.73],0.2659471779590006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPB1,Carboxypeptidase B,41624,209,1.07 [0.87-1.31],0.5035240053551701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPB2,Carboxypeptidase B2,35744,179,0.59 [0.31-1.12],0.1053046607600731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPE,Carboxypeptidase E,41179,211,0.90 [0.66-1.21],0.4731781215363975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPLX2,Complexin-2,34510,172,0.56 [0.33-0.93],0.026443439099663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPM,Carboxypeptidase M,41296,210,0.86 [0.59-1.24],0.4085876178508532
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",34730,174,0.92 [0.53-1.58],0.7562879515264875
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPPED1,Serine/threonine-protein phosphatase CPPED1,41490,211,1.00 [0.83-1.20],0.9836117099444774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPQ,Carboxypeptidase Q,35698,181,0.82 [0.55-1.22],0.333963958719222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPTP,Ceramide-1-phosphate transfer protein,34635,172,0.86 [0.58-1.27],0.4442965129650297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPVL,Probable serine carboxypeptidase CPVL,41437,210,0.90 [0.67-1.21],0.4920630043594169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPXM1,Probable carboxypeptidase X1,41240,212,0.92 [0.77-1.09],0.334991865971224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPXM2,Inactive carboxypeptidase-like protein X2,35759,178,1.32 [0.77-2.25],0.3114050625677444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CR1,Complement receptor type 1,35647,179,1.06 [0.70-1.60],0.7864474917945736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CR2,Complement receptor type 2,41278,211,0.85 [0.65-1.10],0.2153178926274969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,40196,207,1.12 [0.97-1.28],0.115134446886594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRADD,Death domain-containing protein CRADD,40750,208,1.01 [0.86-1.19],0.880137424512177
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CREB3,Cyclic AMP-responsive element-binding protein 3,34510,172,0.94 [0.72-1.24],0.6783016535645212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CREBZF,CREB/ATF bZIP transcription factor,34510,172,1.30 [0.77-2.21],0.3266917205441084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CREG1,Protein CREG1,40584,208,1.11 [0.81-1.52],0.5111132610004379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRELD1,Protein disulfide isomerase CRELD1,34994,173,0.95 [0.64-1.42],0.8182554364082452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRELD2,Protein disulfide isomerase CRELD2,41231,212,0.93 [0.73-1.18],0.5351489258466002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRH,Corticoliberin,40129,207,0.98 [0.84-1.13],0.7319974845312485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRHBP,Corticotropin-releasing factor-binding protein,41092,212,1.03 [0.66-1.61],0.8976730081328714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRHR1,Corticotropin-releasing factor receptor 1,40395,204,0.95 [0.77-1.17],0.6436321058998984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRIM1,Cysteine-rich motor neuron 1 protein,41291,212,2.12 [1.16-3.84],0.0139481447473614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRIP2,Cysteine-rich protein 2,40826,208,1.08 [0.78-1.49],0.6543278872375046
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRISP2,Cysteine-rich secretory protein 2,41501,211,0.83 [0.68-1.02],0.0766028599906581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRISP3,Cysteine-rich secretory protein 3,35449,178,1.01 [0.59-1.72],0.9835140109636384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRKL,Crk-like protein,41163,212,0.97 [0.87-1.09],0.6324679576446888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRLF1,Cytokine receptor-like factor 1,41291,212,1.66 [1.02-2.71],0.042379763538978
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRNN,Cornulin,39956,201,1.00 [0.83-1.20],0.979993499204254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRTAC1,Cartilage acidic protein 1,41624,209,0.95 [0.64-1.42],0.7973239153886685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRTAM,Cytotoxic and regulatory T-cell molecule,40826,208,1.05 [0.82-1.34],0.7141743899072781
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRTAP,Cartilage-associated protein,34803,173,1.06 [0.80-1.40],0.7034860515623221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRX,Cone-rod homeobox protein,40395,204,1.07 [0.97-1.19],0.1856615403727327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYBB1,Beta-crystallin B1,35759,178,0.97 [0.78-1.21],0.8015245290372623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYBB2,Beta-crystallin B2,35691,178,0.97 [0.79-1.20],0.7878165757661897
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYGD,Gamma-crystallin D,35691,178,1.10 [0.95-1.28],0.201412721706822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYM,Ketimine reductase mu-crystallin,34664,171,1.17 [0.98-1.39],0.0825867444044509
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYZL1,Quinone oxidoreductase-like protein 1,34811,171,0.99 [0.84-1.16],0.9003502697424646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSDE1,Cold shock domain-containing protein E1,34635,172,1.05 [0.94-1.18],0.3720800170754333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF1,Macrophage colony-stimulating factor 1,41291,212,1.87 [1.20-2.90],0.005761978310601
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF1R,Macrophage colony-stimulating factor 1 receptor,35784,179,1.15 [0.80-1.65],0.450356443650352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2,Granulocyte-macrophage colony-stimulating factor,34635,172,0.84 [0.55-1.29],0.4312251051567445
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40826,208,0.82 [0.66-1.00],0.0525799131239608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2RB,Cytokine receptor common subunit beta,34730,174,1.23 [0.87-1.73],0.2461190097739826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF3,Granulocyte colony-stimulating factor,40393,209,0.93 [0.72-1.20],0.5655525575633822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF3R,Granulocyte colony-stimulating factor receptor,34730,174,0.96 [0.58-1.61],0.8886034781617731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSH1,Chorionic somatomammotropin hormone 1,35784,179,1.61 [1.28-2.02],5.10706738686978e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSNK1D,Casein kinase I isoform delta,34730,174,0.91 [0.72-1.16],0.4449482799949461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSNK2A1,Casein kinase II subunit alpha,35709,180,1.08 [0.79-1.48],0.6465865451759669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSPG4,Chondroitin sulfate proteoglycan 4,35767,181,1.61 [1.05-2.49],0.0297595883949665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSPG5,Chondroitin sulfate proteoglycan 5,34664,171,0.91 [0.67-1.25],0.5637806620971761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSRP3,Cysteine and glycine-rich protein 3,34635,172,1.10 [0.95-1.26],0.1922796711538007
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST1,Cystatin-SN,31044,158,1.10 [0.95-1.28],0.2117509690934542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST3,Cystatin-C,41210,211,1.59 [1.04-2.43],0.0314848191856092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST5,Cystatin-D,40360,203,1.12 [0.90-1.40],0.3158352665086003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST6,Cystatin-M,40073,204,1.12 [0.87-1.46],0.3732930493883382
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST7,Cystatin-F,41165,212,1.10 [0.99-1.24],0.0849419850444066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSTB,Cystatin-B,40558,204,1.25 [0.94-1.66],0.1268305594598325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTAG1A_CTAG1B,Cancer/testis antigen 1,35029,171,1.14 [0.86-1.51],0.3497916695880019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTBS,Di-N-acetylchitobiase,35268,178,1.27 [0.73-2.21],0.4017803430737352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTF1,Cardiotrophin-1,40395,204,0.97 [0.84-1.13],0.6943858152269495
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTHRC1,Collagen triple helix repeat-containing protein 1,35767,181,1.38 [0.84-2.27],0.2078566331166154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTLA4,Cytotoxic T-lymphocyte protein 4,35767,181,0.72 [0.44-1.16],0.1737941380352262
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTNNA1,Catenin alpha-1,34664,171,1.13 [0.77-1.66],0.5280719608961393
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTRB1,Chymotrypsinogen B,41134,210,0.91 [0.73-1.14],0.4075245326161412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTRC,Chymotrypsin-C,41100,211,0.96 [0.79-1.16],0.6384787937949326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTRL,Chymotrypsin-like protease CTRL-1,35691,178,1.05 [0.85-1.29],0.6563828896663508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSB,Cathepsin B,41149,209,1.37 [1.10-1.70],0.0053936501729765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSC,Dipeptidyl peptidase 1,41022,211,1.11 [0.85-1.46],0.4330345242575139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSD,Cathepsin D,38421,202,1.10 [0.81-1.49],0.5561087034565657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSE,Cathepsin E,34994,173,0.87 [0.65-1.15],0.3252003015513179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSF,Cathepsin F,41240,212,1.06 [0.78-1.44],0.7082706474628806
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSH,Pro-cathepsin H,40271,204,0.89 [0.75-1.05],0.1694149222592002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSL,Cathepsin L1,41128,212,1.35 [0.82-2.23],0.236956914365171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSO,Cathepsin O,41597,213,1.37 [0.92-2.02],0.1170254394598546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSS,Cathepsin S,32368,165,1.57 [0.84-2.93],0.1561351698488236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSV,Cathepsin L2,41372,210,1.15 [0.86-1.54],0.3436450760689972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSZ,Cathepsin Z,41140,210,1.43 [0.97-2.11],0.0682289732805445
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CUZD1,CUB and zona pellucida-like domain-containing protein 1,34803,173,0.94 [0.62-1.41],0.7483069468173345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CWC15,Spliceosome-associated protein CWC15 homolog,35399,179,1.13 [0.93-1.38],0.2178967144645096
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CX3CL1,Fractalkine,40826,208,1.30 [0.90-1.87],0.1590161658723065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXADR,Coxsackievirus and adenovirus receptor,41085,214,1.11 [0.88-1.41],0.3765906624633254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL1,Growth-regulated alpha protein,41038,212,1.00 [0.88-1.13],0.9634770291165872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL10,C-X-C motif chemokine 10,41291,212,1.11 [0.93-1.33],0.2404657244065298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL11,C-X-C motif chemokine 11,41490,211,1.05 [0.90-1.22],0.5221355106129171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL12,Stromal cell-derived factor 1,40393,209,0.96 [0.70-1.31],0.8012211902557813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL13,C-X-C motif chemokine 13,41490,211,1.19 [1.00-1.41],0.0545929643779746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL14,C-X-C motif chemokine 14,40393,209,1.11 [0.92-1.35],0.2801636722096065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL16,C-X-C motif chemokine 16,41554,209,1.85 [1.10-3.11],0.0211612449625827
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL17,C-X-C motif chemokine 17,41597,213,0.70 [0.52-0.95],0.0205310873544406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL3,C-X-C motif chemokine 3,41105,212,0.92 [0.81-1.05],0.2080816489067576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL5,C-X-C motif chemokine 5,40993,212,0.87 [0.78-0.97],0.0099027489053663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL6,C-X-C motif chemokine 6,41597,213,0.82 [0.70-0.96],0.0147954639778731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL8,Interleukin-8,40843,208,0.97 [0.80-1.16],0.7094194053993879
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL9,C-X-C motif chemokine 9,41291,212,1.18 [0.99-1.41],0.0614031386788282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYB5A,Cytochrome b5,34510,172,0.92 [0.74-1.14],0.4415702430801459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYB5R2,NADH-cytochrome b5 reductase 2,35200,177,1.09 [0.84-1.41],0.517203708804005
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",34635,172,1.03 [0.87-1.21],0.754802086676815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYTH3,Cytohesin-3,34510,172,1.00 [0.82-1.22],0.9686995865325818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYTL1,Cytokine-like protein 1,35767,181,1.40 [0.79-2.51],0.2522872828562283
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAAM1,Disheveled-associated activator of morphogenesis 1,34994,173,1.02 [0.85-1.21],0.8575218833336756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAB2,Disabled homolog 2,41501,211,0.97 [0.87-1.08],0.6245047885879612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAG1,Dystroglycan,41291,212,0.85 [0.65-1.10],0.2239589262932047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAND5,DAN domain family member 5,34730,174,1.08 [0.84-1.39],0.530769042098445
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAPK2,Death-associated protein kinase 2,34730,174,1.16 [0.92-1.46],0.218272247593202
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,41085,214,0.94 [0.86-1.04],0.2174686966810209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40750,208,1.00 [0.84-1.18],0.9975402255137428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBH,Dopamine beta-hydroxylase,35722,179,0.95 [0.84-1.07],0.3752722091701466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBI,Acyl-CoA-binding protein,40946,208,1.00 [0.86-1.18],0.9672838321431796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBN1,Drebrin,34730,174,1.03 [0.77-1.38],0.8399565596285532
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBNL,Drebrin-like protein,41291,212,0.96 [0.84-1.10],0.5494391675069104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",41240,212,1.51 [1.07-2.12],0.018716865886607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCC,Netrin receptor DCC,34803,173,0.76 [0.37-1.56],0.4558711957777334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCDC2C,Doublecortin domain-containing protein 2C,34510,172,0.98 [0.77-1.24],0.8746560230843338
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCLRE1C,Protein artemis,34510,172,1.27 [0.82-1.98],0.2884081523538989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCN,Decorin,40395,204,1.39 [0.81-2.39],0.2287573486510654
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTD,Deoxycytidylate deaminase,34994,173,0.96 [0.82-1.12],0.6250239915689024
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTN1,Dynactin subunit 1,41501,211,1.02 [0.85-1.24],0.8031839318260114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTN2,Dynactin subunit 2,40934,210,1.02 [0.89-1.16],0.7913284288345516
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTN6,Dynactin subunit 6,40166,203,0.94 [0.79-1.13],0.524656637646502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTPP1,dCTP pyrophosphatase 1,41128,212,0.94 [0.64-1.40],0.7665154549623759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCUN1D1,DCN1-like protein 1,34664,171,1.02 [0.84-1.23],0.8400048467416339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCUN1D2,DCN1-like protein 2,34510,172,1.15 [0.98-1.35],0.0923982999858681
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCXR,L-xylulose reductase,41240,212,0.87 [0.68-1.09],0.2277437686484121
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDA1,DET1- and DDB1-associated protein 1,34635,172,1.01 [0.70-1.46],0.961643923746996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40934,210,1.02 [0.78-1.35],0.8625021604931252
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDC,Aromatic-L-amino-acid decarboxylase,41074,212,1.01 [0.78-1.31],0.9338088019610724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDHD2,Phospholipase DDHD2,35709,180,1.01 [0.81-1.25],0.948190686370488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDI2,Protein DDI1 homolog 2,34994,173,1.04 [0.86-1.25],0.6930123683014113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDR1,Epithelial discoidin domain-containing receptor 1,41490,211,1.64 [0.97-2.78],0.0627304748262236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDT,D-dopachrome decarboxylase,35767,181,1.12 [0.80-1.57],0.4960764109636363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX1,ATP-dependent RNA helicase DDX1,35608,179,1.09 [0.83-1.43],0.522067910574853
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX25,ATP-dependent RNA helicase DDX25,34803,173,0.97 [0.65-1.46],0.8998292975796381
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX39A,ATP-dependent RNA helicase DDX39A,34730,174,1.08 [0.59-1.98],0.8022191714448079
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX4,Probable ATP-dependent RNA helicase DDX4,34730,174,0.96 [0.73-1.27],0.79461386377894
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX53,Probable ATP-dependent RNA helicase DDX53,34803,173,1.20 [0.83-1.74],0.3431474016121869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX58,Antiviral innate immune response receptor RIG-I,40196,207,0.99 [0.79-1.22],0.8984723187543373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",41085,214,0.94 [0.82-1.06],0.2998200961970541
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFA1_DEFA1B,Neutrophil defensin 1,40302,207,1.09 [0.87-1.37],0.4389987980692963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB103A_DEFB103B,Beta-defensin 103,34470,173,1.16 [0.85-1.58],0.3568964780283941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB104A_DEFB104B,Beta-defensin 104,34664,171,1.09 [0.84-1.40],0.5224085359250457
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB116,Beta-defensin 116,34664,171,1.08 [0.90-1.29],0.4123012683773759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB118,Beta-defensin 118,34664,171,1.12 [0.89-1.39],0.3320218313264581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB4A_DEFB4B,Beta-defensin 4A,40534,210,1.08 [1.00-1.18],0.0558825217518383
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DENND2B,DENN domain-containing protein 2B,34635,172,0.91 [0.66-1.25],0.5451835335197306
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DENR,Density-regulated protein,34730,174,0.93 [0.71-1.21],0.590032440178617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DFFA,DNA fragmentation factor subunit alpha,41597,213,0.96 [0.80-1.15],0.6774102700606242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGCR6,Protein DGCR6,34664,171,1.24 [0.95-1.63],0.119527460870101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGKA,Diacylglycerol kinase alpha,34730,174,1.05 [0.80-1.37],0.7234440803770421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGKZ,Diacylglycerol kinase zeta,40393,209,0.88 [0.62-1.25],0.4726948300568759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHODH,Dihydroorotate dehydrogenase,34635,172,1.05 [0.77-1.41],0.7699868506809009
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHPS,Deoxyhypusine synthase,35598,179,1.00 [0.70-1.42],0.9886708184962736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,35691,178,0.89 [0.64-1.23],0.4697114031389954
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DIABLO,"Diablo homolog, mitochondrial",41001,212,0.93 [0.84-1.04],0.2199751819934065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DIPK1C,Divergent protein kinase domain 1C,34803,173,1.03 [0.73-1.45],0.8681781680494843
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DIPK2B,Divergent protein kinase domain 2B,34994,173,1.52 [0.95-2.42],0.0812292637480688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKK1,Dickkopf-related protein 1,41490,211,0.87 [0.70-1.06],0.1658926335664016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKK3,Dickkopf-related protein 3,41624,209,1.17 [0.77-1.78],0.4585061203202512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKK4,Dickkopf-related protein 4,40760,206,1.06 [0.81-1.39],0.6502243777063126
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKKL1,Dickkopf-like protein 1,40934,210,1.01 [0.88-1.16],0.8942266666332327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLG4,Disks large homolog 4,35691,178,1.08 [0.88-1.31],0.4613736336849185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLGAP5,Disks large-associated protein 5,35709,180,0.89 [0.65-1.22],0.4706913617641453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLK1,Protein delta homolog 1,41624,209,1.09 [0.88-1.36],0.4404824156804358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLL1,Delta-like protein 1,41240,212,1.75 [1.17-2.61],0.0066714363165545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLL4,Delta-like protein 4,34811,171,1.04 [0.90-1.20],0.5860525584692463
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DMD,Dystrophin,34811,171,1.23 [0.95-1.61],0.1227559946578412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DMP1,Dentin matrix acidic phosphoprotein 1,34811,171,0.95 [0.74-1.21],0.6689913074303181
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJA1,DnaJ homolog subfamily A member 1,34510,172,1.13 [0.84-1.52],0.4080129775164568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJA2,DnaJ homolog subfamily A member 2,41471,213,0.98 [0.84-1.13],0.7363379102213814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJA4,DnaJ homolog subfamily A member 4,35691,178,1.07 [0.88-1.30],0.5167598770508315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB1,DnaJ homolog subfamily B member 1,40934,210,1.00 [0.87-1.16],0.9616435229081876
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB14,DnaJ homolog subfamily B member 14,35608,179,1.11 [0.89-1.38],0.346702316999419
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB2,DnaJ homolog subfamily B member 2,34994,173,1.19 [0.91-1.55],0.2067105174520069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB6,DnaJ homolog subfamily B member 6,34660,172,1.01 [0.85-1.21],0.8913164339188002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB8,DnaJ homolog subfamily B member 8,40395,204,1.02 [0.82-1.26],0.8556766187966738
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJC21,DnaJ homolog subfamily C member 21,35691,178,1.00 [0.69-1.45],0.991785188853846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJC6,Putative tyrosine-protein phosphatase auxilin,34811,171,1.03 [0.86-1.23],0.7654692519317973
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJC9,DnaJ homolog subfamily C member 9,35608,179,1.12 [0.93-1.35],0.2335473163389949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNER,Delta and Notch-like epidermal growth factor-related receptor,41030,211,0.80 [0.50-1.30],0.3741549678352158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNLZ,DNL-type zinc finger protein,34664,171,1.04 [0.89-1.22],0.6076037862649577
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNM1,Dynamin-1,35608,179,0.88 [0.78-0.99],0.0345892717160268
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNM3,Dynamin-3,35709,180,1.03 [0.79-1.34],0.8159885406118265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNMBP,Dynamin-binding protein,40826,208,1.02 [0.84-1.25],0.8225614719513061
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNPEP,Aspartyl aminopeptidase,35691,178,1.17 [0.91-1.51],0.2203311540250971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,41223,212,1.08 [0.86-1.37],0.5089945184598049
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOC2B,Double C2-like domain-containing protein beta,34803,173,0.87 [0.56-1.36],0.5536358913489217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOCK9,Dedicator of cytokinesis protein 9,34664,171,0.96 [0.84-1.10],0.565779179110997
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOK1,Docking protein 1,35691,178,0.97 [0.87-1.07],0.5422378384772251
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOK2,Docking protein 2,41128,212,0.96 [0.87-1.06],0.4626681953978006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPEP1,Dipeptidase 1,40750,208,0.91 [0.71-1.17],0.4659183679680616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPEP2,Dipeptidase 2,40934,210,1.17 [0.77-1.78],0.4595318330923541
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP10,Inactive dipeptidyl peptidase 10,41085,214,1.10 [0.78-1.55],0.5901173946358584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP4,Dipeptidyl peptidase 4,40361,209,0.62 [0.40-0.95],0.029838954762234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP6,Dipeptidyl aminopeptidase-like protein 6,40934,210,1.04 [0.73-1.50],0.8146254048732188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP7,Dipeptidyl peptidase 2,40800,211,1.19 [0.97-1.45],0.0880940649882804
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPT,Dermatopontin,41624,209,1.22 [0.75-1.98],0.4273482215924533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPY30,Protein dpy-30 homolog,41376,210,0.97 [0.79-1.20],0.7951152748797428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DRAXIN,Draxin,40826,208,0.97 [0.73-1.30],0.8525196221805339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DRG2,Developmentally-regulated GTP-binding protein 2,40934,210,0.95 [0.77-1.19],0.6696901926310262
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSC2,Desmocollin-2,40656,206,1.44 [1.01-2.06],0.0433494496936775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSCAM,Down syndrome cell adhesion molecule,35709,180,1.43 [0.96-2.12],0.0781109121949739
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSG2,Desmoglein-2,41134,210,1.26 [0.80-1.98],0.3175735842025162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSG3,Desmoglein-3,41373,210,1.34 [0.94-1.91],0.1094970906394944
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSG4,Desmoglein-4,40788,209,0.90 [0.70-1.16],0.4280241973531985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTD1,D-aminoacyl-tRNA deacylase 1,34994,173,0.98 [0.82-1.16],0.7798958335341291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTNB,Dystrobrevin beta,35532,179,1.54 [1.14-2.08],0.004489013676279
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTX2,Probable E3 ubiquitin-protein ligase DTX2,34803,173,0.86 [0.66-1.12],0.2693559619265939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40934,210,1.33 [0.80-2.21],0.269115907229695
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTYMK,Thymidylate kinase,35759,178,1.12 [0.91-1.38],0.2750505893840431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUOX2,Dual oxidase 2,40395,204,1.02 [0.86-1.21],0.8493835721968783
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUSP13,Dual specificity protein phosphatase 13 isoform A,35598,179,0.89 [0.62-1.26],0.5029700975960457
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUSP29,Dual specificity phosphatase 29,34803,173,1.17 [0.97-1.42],0.1081338984982078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUSP3,Dual specificity protein phosphatase 3,40166,203,0.93 [0.79-1.08],0.3259713359927255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",35608,179,0.94 [0.82-1.09],0.4208195865434149
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DXO,Decapping and exoribonuclease protein,35691,178,1.18 [0.87-1.61],0.2946165584859456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,35598,179,0.96 [0.70-1.31],0.8055521612261459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DYNLT1,Dynein light chain Tctex-type 1,34803,173,1.00 [0.84-1.20],0.9800877615379892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DYNLT3,Dynein light chain Tctex-type 3,35598,179,0.98 [0.70-1.36],0.8813872024698883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40826,208,0.97 [0.85-1.11],0.6597176477789046
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EBI3_IL27,Interleukin-27,41439,211,1.34 [0.90-2.00],0.1512563698476837
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECE1,Endothelin-converting enzyme 1,40166,203,1.00 [0.70-1.42],0.9940884177272888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",35759,178,0.90 [0.74-1.11],0.3372900931524782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECHS1,"Enoyl-CoA hydratase, mitochondrial",34811,171,0.86 [0.73-1.01],0.0593343423141278
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECI2,Enoyl-CoA delta isomerase 2,34635,172,0.99 [0.78-1.26],0.9266205040628724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECM1,Extracellular matrix protein 1,34825,174,0.73 [0.51-1.05],0.088301964399013
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECSCR,Endothelial cell-specific chemotaxis regulator,34664,171,0.84 [0.61-1.17],0.3060845457091072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDA2R,Tumor necrosis factor receptor superfamily member 27,41501,211,1.41 [1.01-1.96],0.0425247378508625
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDAR,Tumor necrosis factor receptor superfamily member EDAR,41085,214,0.92 [0.81-1.05],0.2370936592146273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDDM3B,Epididymal secretory protein E3-beta,35598,179,1.01 [0.77-1.31],0.9678609977889794
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,34635,172,1.08 [0.74-1.57],0.7038273449982715
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDF1,Endothelial differentiation-related factor 1,35709,180,1.01 [0.83-1.24],0.8895581270503863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40395,204,1.09 [0.77-1.56],0.6189718040000436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDN1,Endothelin-1,34811,171,0.93 [0.56-1.56],0.7840170326200381
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDNRB,Endothelin receptor type B,34730,174,1.19 [0.90-1.58],0.2235262512251924
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EEF1D,Elongation factor 1-delta,35759,178,1.09 [0.93-1.27],0.2941994869902675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFCAB14,EF-hand calcium-binding domain-containing protein 14,35608,179,1.42 [0.93-2.18],0.1050291288575865
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFCAB2,Dynein regulatory complex protein 8,35099,171,1.03 [0.67-1.56],0.904413251234052
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,41209,211,1.59 [1.07-2.34],0.0203928227007539
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFHD1,EF-hand domain-containing protein D1,35709,180,0.87 [0.57-1.34],0.5229934160559029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFNA1,Ephrin-A1,41067,208,1.78 [1.17-2.71],0.0070976934896548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFNA4,Ephrin-A4,40754,205,1.62 [1.08-2.42],0.0188974234679236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFNB2,Ephrin-B2,34803,173,1.11 [0.87-1.40],0.4032651285344445
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGF,Pro-epidermal growth factor,41041,211,0.92 [0.82-1.03],0.1394092073456374
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGFL7,Epidermal growth factor-like protein 7,40196,207,1.04 [0.76-1.43],0.7850871154954187
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGFLAM,Pikachurin,35608,179,1.09 [0.69-1.72],0.7242284624157901
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGFR,Epidermal growth factor receptor,41624,209,0.90 [0.42-1.92],0.7823409740236259
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGLN1,Egl nine homolog 1,41085,214,0.97 [0.77-1.21],0.7802137979181938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EHBP1,EH domain-binding protein 1,35759,178,0.98 [0.80-1.19],0.815754428095045
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EHD3,EH domain-containing protein 3,34811,171,0.93 [0.82-1.05],0.2242984227796435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",35691,178,0.98 [0.75-1.27],0.8573643312562318
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",35484,179,1.01 [0.89-1.15],0.8838367532742746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,34635,172,1.08 [0.86-1.35],0.5150748087251558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,34811,171,1.12 [0.80-1.55],0.5162186524469985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4B,Eukaryotic translation initiation factor 4B,40826,208,1.00 [0.80-1.23],0.9739874570325866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4E,Eukaryotic translation initiation factor 4E,34730,174,1.00 [0.85-1.17],0.963863347170301
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,41128,212,1.06 [0.88-1.28],0.5256235636438187
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,41597,213,1.03 [0.91-1.16],0.648301033413156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,35709,180,1.08 [0.87-1.34],0.4823493124760175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF5,Eukaryotic translation initiation factor 5,34635,172,0.98 [0.69-1.37],0.8869889390961511
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF5A,Eukaryotic translation initiation factor 5A-1,40393,209,1.33 [0.93-1.89],0.1146231729612738
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELAC1,Zinc phosphodiesterase ELAC protein 1,35709,180,0.93 [0.79-1.10],0.4044905542360327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELAVL4,ELAV-like protein 4,34664,171,0.91 [0.76-1.10],0.3424887773434413
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELN,Elastin,35759,178,1.64 [1.09-2.48],0.0179272907698407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELOA,Elongin-A,40934,210,1.13 [0.93-1.38],0.2244755979425635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELOB,Elongin-B,34635,172,0.85 [0.56-1.29],0.4453901304939855
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENAH,Protein enabled homolog,40393,209,1.06 [0.82-1.38],0.6381163683867122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENDOU,Poly(U)-specific endoribonuclease,33018,171,1.41 [1.09-1.83],0.0092536640705396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENG,Endoglin,41624,209,1.13 [0.55-2.30],0.7438406558346207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENO1,Alpha-enolase,41078,211,0.92 [0.79-1.07],0.2903278290760585
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENO2,Gamma-enolase,41490,211,0.93 [0.77-1.12],0.4162073576552759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENO3,Beta-enolase,34811,171,0.94 [0.72-1.21],0.613360451619491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENOPH1,Enolase-phosphatase E1,35598,179,0.99 [0.76-1.29],0.9509118543722632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,34635,172,1.19 [0.71-1.98],0.5074360806502952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPEP,Glutamyl aminopeptidase,34635,172,1.15 [0.86-1.53],0.3525407717241776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41624,209,1.16 [0.73-1.85],0.5347528636800738
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,41291,212,1.03 [0.77-1.37],0.8401149208057564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,34811,171,0.71 [0.48-1.06],0.0968896505570247
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39845,205,1.07 [0.92-1.24],0.3565305179882156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENSA,Alpha-endosulfine,35598,179,1.24 [0.97-1.58],0.0880591060516522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,40196,207,1.09 [0.82-1.45],0.5537102549104511
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40395,204,1.05 [0.58-1.87],0.8813158128479722
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40395,204,0.91 [0.59-1.41],0.6624871341024113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTR1,Endosome-associated-trafficking regulator 1,34811,171,1.19 [0.95-1.50],0.1379929847012922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EP300,Histone acetyltransferase p300,34730,174,1.17 [0.76-1.81],0.4762169359736647
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPB41L5,Band 4.1-like protein 5,34803,173,1.06 [0.85-1.32],0.595126763293445
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPCAM,Epithelial cell adhesion molecule,41091,212,1.07 [0.94-1.21],0.3110798274227906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPGN,Epigen,35598,179,0.76 [0.51-1.14],0.1810836651448792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA1,Ephrin type-A receptor 1,41223,212,1.45 [0.99-2.13],0.055404410815765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA10,Ephrin type-A receptor 10,40166,203,1.01 [0.83-1.22],0.9329751324098752
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA2,Ephrin type-A receptor 2,39675,204,1.28 [0.85-1.92],0.2344152051887912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA4,Ephrin type-A receptor 4,34994,173,1.42 [0.85-2.36],0.1831715720663621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHB4,Ephrin type-B receptor 4,41624,209,2.07 [1.30-3.30],0.0022157570308169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHB6,Ephrin type-B receptor 6,40750,208,1.72 [1.17-2.53],0.0061667105867473
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHX2,Bifunctional epoxide hydrolase 2,40395,204,0.91 [0.73-1.13],0.3933567781529465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPN1,Epsin-1,35099,171,0.98 [0.70-1.38],0.9196345470921584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPO,Erythropoietin,41085,214,1.08 [0.92-1.27],0.3286943349394357
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPPK1,Epiplakin,34811,171,1.05 [0.85-1.29],0.6471560522479798
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41438,210,1.01 [0.67-1.53],0.9474811153003512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBB2,Receptor tyrosine-protein kinase erbB-2,41240,212,0.97 [0.59-1.62],0.9197163884336272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBB3,Receptor tyrosine-protein kinase erbB-3,40970,212,1.07 [0.58-1.99],0.8337330541170015
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBB4,Receptor tyrosine-protein kinase erbB-4,41240,212,0.89 [0.53-1.48],0.6432865404244184
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBIN,Erbin,40934,210,0.93 [0.83-1.05],0.2608344131780259
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERC2,ERC protein 2,34803,173,1.00 [0.82-1.21],0.9834501931701748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERCC1,DNA excision repair protein ERCC-1,34510,172,0.94 [0.60-1.47],0.7944248972880922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EREG,Proepiregulin,40750,208,0.88 [0.75-1.04],0.1269958292198952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERI1,3'-5' exoribonuclease 1,35099,171,1.21 [0.81-1.83],0.3519643122351149
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERMAP,Erythroid membrane-associated protein,34730,174,1.05 [0.76-1.47],0.7568945670939433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,35598,179,1.14 [0.79-1.65],0.4787452896368603
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERP29,Endoplasmic reticulum resident protein 29,34994,173,0.97 [0.86-1.10],0.6254372024463275
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERP44,Endoplasmic reticulum resident protein 44,40868,210,0.89 [0.55-1.43],0.6309144768526765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,34635,172,1.04 [0.75-1.44],0.8118439792916256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESAM,Endothelial cell-selective adhesion molecule,41624,209,1.11 [0.76-1.64],0.5922174237387478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESM1,Endothelial cell-specific molecule 1,41092,212,1.01 [0.71-1.45],0.9444725597063108
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESPL1,Separin,34510,172,1.15 [0.92-1.44],0.205267655110102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESR1,Estrogen receptor,34730,174,0.82 [0.60-1.10],0.1851265758471391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESYT2,Extended synaptotagmin-2,35691,178,1.02 [0.86-1.22],0.7842540834873241
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EVI2B,Protein EVI2B,34510,172,0.86 [0.57-1.28],0.4507226638098223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EVI5,Ecotropic viral integration site 5 protein homolog,34730,174,1.01 [0.86-1.19],0.8697681774217509
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EVPL,Envoplakin,35099,171,1.03 [0.66-1.60],0.9047736258995948
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EXOSC10,Exosome component 10,34635,172,0.98 [0.75-1.27],0.8612612324978304
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EXTL1,Exostosin-like 1,34635,172,0.87 [0.62-1.22],0.4139659270841623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EZR,Ezrin,41490,211,1.03 [0.62-1.72],0.9082248768636924
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F10,Coagulation factor X,35784,179,1.13 [0.68-1.85],0.6426042480835821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F11,Coagulation factor XI,35300,178,0.94 [0.58-1.52],0.7975625552662591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F11R,Junctional adhesion molecule A,41134,210,1.01 [0.81-1.25],0.9548363824577948
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F12,Coagulation factor XII,35814,180,0.91 [0.64-1.27],0.5660397797304285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F13B,Coagulation factor XIII B chain,35628,179,0.61 [0.35-1.06],0.0810207439144155
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F2,Prothrombin,35814,180,1.24 [0.48-3.20],0.6507250230931596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F2R,Proteinase-activated receptor 1,41231,212,0.89 [0.72-1.11],0.2947475132651471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F3,Tissue factor,41244,209,1.27 [0.80-2.02],0.3033575768669952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F7,Coagulation factor VII,41220,211,1.07 [0.72-1.61],0.7265626619964929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F9,Coagulation factor IX,41219,211,0.97 [0.49-1.91],0.9348432045433428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP1,"Fatty acid-binding protein, liver",41092,212,1.03 [0.90-1.17],0.6930724976030744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP2,"Fatty acid-binding protein, intestinal",41128,212,0.98 [0.84-1.15],0.8260841514918215
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP3,"Fatty acid-binding protein, heart",35759,178,1.29 [0.99-1.68],0.0608523054346074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP4,"Fatty acid-binding protein, adipocyte",41624,209,0.91 [0.70-1.18],0.4701962335641225
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP5,Fatty acid-binding protein 5,41363,211,0.97 [0.81-1.16],0.7286619547737763
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP6,Gastrotropin,40332,204,1.22 [0.99-1.50],0.0595527669258952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP9,Fatty acid-binding protein 9,41085,214,0.97 [0.78-1.21],0.78787930930361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FADD,FAS-associated death domain protein,41128,212,0.95 [0.81-1.11],0.4989146541492371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM13A,Protein FAM13A,35608,179,1.13 [0.92-1.40],0.2378717164592969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM171A2,Protein FAM171A2,35709,180,0.97 [0.88-1.06],0.4971067206810488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM171B,Protein FAM171B,35598,179,1.48 [1.00-2.20],0.0508091372102618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM172A,Cotranscriptional regulator FAM172A,34811,171,1.04 [0.82-1.33],0.7385348600592145
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM20A,Pseudokinase FAM20A,35759,178,0.62 [0.37-1.05],0.0731303448777256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM3B,Protein FAM3B,40934,210,1.07 [0.74-1.53],0.7184917792589829
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM3C,Protein FAM3C,41074,212,1.32 [0.87-1.99],0.1936723928568784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM3D,Protein FAM3D,35608,179,1.00 [0.85-1.18],0.9969465244730544
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAP,Prolyl endopeptidase FAP,41624,209,0.91 [0.58-1.44],0.7005748516255966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FARSA,Phenylalanine--tRNA ligase alpha subunit,34803,173,1.00 [0.81-1.23],0.9741198126989988
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAS,Tumor necrosis factor receptor superfamily member 6,41496,209,1.00 [0.69-1.45],0.9874179907487828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FASLG,Tumor necrosis factor ligand superfamily member 6,41597,213,1.04 [0.75-1.45],0.8128024864637257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FBLN2,Fibulin-2,35767,181,1.50 [0.94-2.38],0.0879695646673648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FBN2,Fibrillin-2,34803,173,1.08 [0.84-1.38],0.5463966018449604
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FBP1,"Fructose-1,6-bisphosphatase 1",41128,212,0.92 [0.78-1.09],0.3405614219673006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,35759,178,1.03 [0.84-1.26],0.7875297555873343
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCAR,Immunoglobulin alpha Fc receptor,41085,214,1.11 [0.86-1.43],0.4238807203060903
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,35709,180,1.53 [0.87-2.71],0.1415892123742436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCER2,Low affinity immunoglobulin epsilon Fc receptor,41134,210,1.31 [1.03-1.67],0.0267121625351771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40957,211,1.10 [0.89-1.37],0.3725351138338535
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,40196,207,0.93 [0.74-1.15],0.4914613158348681
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,41154,211,1.08 [0.84-1.39],0.5244645805362339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCN1,Ficolin-1,35722,179,1.30 [0.98-1.72],0.0702961546334876
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCN2,Ficolin-2,40939,209,0.91 [0.67-1.22],0.511853978811955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL1,Fc receptor-like protein 1,41128,212,0.94 [0.71-1.25],0.673907329949018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL2,Fc receptor-like protein 2,41404,211,1.17 [0.91-1.50],0.2169387800164946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL3,Fc receptor-like protein 3,40393,209,1.10 [0.88-1.38],0.4174591576490044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL5,Fc receptor-like protein 5,41134,210,1.21 [0.98-1.50],0.0770249157452494
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL6,Fc receptor-like protein 6,41085,214,1.18 [0.98-1.41],0.0742788380458062
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRLB,Fc receptor-like B,40196,207,1.02 [0.84-1.26],0.8150783136698403
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FDX1,"Adrenodoxin, mitochondrial",34635,172,1.00 [0.79-1.26],0.9961198195596828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FDX2,"Ferredoxin-2, mitochondrial",34635,172,0.88 [0.67-1.17],0.3862705716087923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FEN1,Flap endonuclease 1,40196,207,1.09 [0.92-1.29],0.3031067524913539
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FES,Tyrosine-protein kinase Fes/Fps,40196,207,1.24 [0.99-1.55],0.062459518264648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FETUB,Fetuin-B,41219,211,1.19 [0.81-1.75],0.3683735288390141
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGA,Fibrinogen alpha chain,34976,174,0.82 [0.51-1.33],0.4236549407190315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",35709,180,1.01 [0.85-1.21],0.9041534271217858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF12,Fibroblast growth factor 12,34730,174,1.05 [0.79-1.41],0.7222319734620203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF16,Fibroblast growth factor 16,34730,174,0.97 [0.70-1.33],0.8308897476851693
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF19,Fibroblast growth factor 19,41291,212,1.04 [0.89-1.21],0.6431619772051731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF2,Fibroblast growth factor 2,41085,214,0.91 [0.76-1.10],0.3343757681731288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF20,Fibroblast growth factor 20,34730,174,1.00 [0.73-1.39],0.9771473356560022
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF21,Fibroblast growth factor 21,41439,211,0.98 [0.88-1.08],0.6529785155583879
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF23,Fibroblast growth factor 23,41438,210,1.20 [0.98-1.48],0.0843840724094051
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF3,Fibroblast growth factor 3,34730,174,0.64 [0.36-1.14],0.1289812328448667
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF5,Fibroblast growth factor 5,40393,209,1.15 [0.80-1.67],0.4524885848695427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF6,Fibroblast growth factor 6,34730,174,1.03 [0.72-1.47],0.8795139874266555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF7,Fibroblast growth factor 7,34510,172,0.95 [0.78-1.16],0.6243451975290845
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF9,Fibroblast growth factor 9,34445,172,1.06 [0.73-1.52],0.7658837581668676
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFBP1,Fibroblast growth factor-binding protein 1,41240,212,0.81 [0.56-1.17],0.2645341698452347
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFBP2,Fibroblast growth factor-binding protein 2,35767,181,1.15 [0.87-1.52],0.3228829403193406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFBP3,Fibroblast growth factor-binding protein 3,35691,178,0.91 [0.61-1.34],0.627619387572756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFR2,Fibroblast growth factor receptor 2,41240,212,1.63 [0.94-2.83],0.0816489817288533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFR4,Fibroblast growth factor receptor 4,34994,173,0.99 [0.75-1.31],0.9267487588420018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGL1,Fibrinogen-like protein 1,35784,179,1.09 [0.87-1.37],0.4360059764831621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGR,Tyrosine-protein kinase Fgr,40166,203,1.12 [0.93-1.35],0.2170593749963562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FH,"Fumarate hydratase, mitochondrial",34664,171,0.96 [0.80-1.16],0.6975283909887617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FHIP2A,FHF complex subunit HOOK interacting protein 2A,34635,172,1.14 [0.87-1.50],0.3474779233688139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FHIT,Bis(5'-adenosyl)-triphosphatase,40166,203,1.07 [0.90-1.27],0.4484513778719877
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FIS1,Mitochondrial fission 1 protein,41097,212,0.98 [0.84-1.15],0.8184545878312471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,35709,180,0.98 [0.85-1.13],0.7504911170699171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,41263,211,0.95 [0.85-1.06],0.3802590790209984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40826,208,1.11 [0.83-1.47],0.4794640319143786
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40826,208,0.98 [0.86-1.11],0.7340923474539838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,40090,203,0.88 [0.66-1.17],0.3828878941049352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBPL,FK506-binding protein-like,35608,179,1.10 [0.87-1.40],0.4230015838361205
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLI1,Friend leukemia integration 1 transcription factor,40196,207,0.98 [0.87-1.09],0.6976697334533206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40826,208,1.06 [0.68-1.65],0.7909197476550693
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT1,Vascular endothelial growth factor receptor 1,40857,210,1.96 [1.20-3.20],0.0072514515207614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT3,Receptor-type tyrosine-protein kinase FLT3,40196,207,0.87 [0.57-1.32],0.5193375375253497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT3LG,Fms-related tyrosine kinase 3 ligand,41597,213,1.00 [0.70-1.43],0.9894176829920917
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT4,Vascular endothelial growth factor receptor 3,41240,212,1.01 [0.71-1.45],0.9410363131490568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FMNL1,Formin-like protein 1,40166,203,1.11 [0.94-1.31],0.203169226154573
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FMR1,Synaptic functional regulator FMR1,40196,207,0.91 [0.64-1.30],0.6125307942960396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FN1,Fibronectin,35814,180,0.61 [0.36-1.05],0.0758189700253971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FNDC1,Fibronectin type III domain-containing protein 1,35691,178,0.90 [0.66-1.22],0.4978626921134897
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,35598,179,0.87 [0.57-1.34],0.5326499262395308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLH1,Glutamate carboxypeptidase 2,34730,174,0.99 [0.86-1.14],0.8574837517897365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLR1,Folate receptor alpha,41050,211,1.37 [0.90-2.10],0.1431767020162206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLR2,Folate receptor beta,41490,211,1.29 [0.85-1.96],0.2284151620546987
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLR3,Folate receptor gamma,41110,211,1.07 [1.01-1.13],0.0279729056960271
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOS,Proto-oncogene c-Fos,34445,172,1.22 [0.82-1.83],0.3223701781304603
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOSB,Protein fosB,40166,203,1.28 [0.99-1.64],0.0566040044474139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXJ3,Forkhead box protein J3,34730,174,1.18 [0.87-1.59],0.2925458767640742
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXO1,Forkhead box protein O1,41085,214,0.93 [0.80-1.07],0.3092379087258919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXO3,Forkhead box protein O3,40196,207,1.02 [0.90-1.16],0.7546749685110675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FRMD4B,FERM domain-containing protein 4B,34635,172,1.11 [0.90-1.37],0.3268040455429187
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FRMD7,FERM domain-containing protein 7,34803,173,0.90 [0.58-1.40],0.6389515859642493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FRZB,Secreted frizzled-related protein 3,40690,203,0.78 [0.48-1.28],0.3333741323890546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FSHB,Follitropin subunit beta,34811,171,0.89 [0.69-1.16],0.39174372806862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FST,Follistatin,41231,212,1.22 [0.96-1.55],0.1041359142045325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FSTL1,Follistatin-related protein 1,34811,171,1.13 [0.58-2.18],0.722325378821981
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FSTL3,Follistatin-related protein 3,41029,212,1.61 [1.10-2.37],0.0146700444865471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FTCD,Formimidoyltransferase-cyclodeaminase,35625,178,0.91 [0.76-1.08],0.2773923918587715
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUCA1,Tissue alpha-L-fucosidase,41367,208,1.02 [0.88-1.18],0.7952948726850481
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUOM,Fucose mutarotase,34994,173,0.86 [0.68-1.09],0.1989635001046815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FURIN,Furin,41240,212,1.06 [0.74-1.54],0.7395392240959278
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUS,RNA-binding protein FUS,40134,206,1.25 [0.93-1.68],0.1353110594436666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",35029,171,0.98 [0.77-1.25],0.871818610792957
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41490,211,1.09 [0.84-1.43],0.5216965792530108
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUT8,"Alpha-(1,6)-fucosyltransferase",40826,208,0.80 [0.65-1.00],0.0491478607362784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FXN,"Frataxin, mitochondrial",41501,211,1.01 [0.86-1.19],0.9079192161059088
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FXYD5,FXYD domain-containing ion transport regulator 5,40393,209,0.95 [0.78-1.15],0.6042397566542481
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FYB1,FYN-binding protein 1,41061,210,0.95 [0.84-1.09],0.4927399987690455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FZD10,Frizzled-10,34803,173,0.97 [0.75-1.25],0.8042187730830133
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FZD8,Frizzled-8,34664,171,1.07 [0.77-1.48],0.6840899501737816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GABARAP,Gamma-aminobutyric acid receptor-associated protein,35598,179,1.06 [0.80-1.42],0.6762867987402149
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,35099,171,1.14 [0.94-1.39],0.1704393030085661
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,34664,171,1.06 [0.85-1.32],0.588500439551203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAD1,Glutamate decarboxylase 1,34510,172,1.24 [0.71-2.18],0.4559119806645407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAD2,Glutamate decarboxylase 2,34730,174,0.94 [0.68-1.31],0.7279453846156796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,35099,171,1.08 [0.82-1.42],0.571092040634116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,34811,171,0.86 [0.64-1.15],0.2998884222346593
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAGE2A,G antigen 2A,34510,172,1.07 [0.87-1.32],0.5251997142030627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAL,Galanin peptides,41291,212,1.07 [0.89-1.29],0.4906568748769541
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40934,210,1.32 [0.85-2.05],0.2231544940646548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,41501,211,1.27 [0.80-2.02],0.3154305883735641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40393,209,1.21 [0.91-1.62],0.1803737082816228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,35759,178,1.47 [0.91-2.40],0.1177670462102082
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT7,N-acetylgalactosaminyltransferase 7,40934,210,1.07 [0.59-1.92],0.8272843931290552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAMT,Guanidinoacetate N-methyltransferase,34635,172,0.87 [0.56-1.36],0.5466308928860226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,34227,169,0.73 [0.48-1.11],0.1376998464628977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GART,Trifunctional purine biosynthetic protein adenosine-3,35709,180,0.96 [0.56-1.68],0.898733987058076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAS2,Growth arrest-specific protein 2,35099,171,1.09 [0.84-1.42],0.5234726807284373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAS6,Growth arrest-specific protein 6,41357,208,0.97 [0.59-1.58],0.8925480081169674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GASK1A,Golgi-associated kinase 1A,34635,172,0.87 [0.62-1.23],0.4395111006827722
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAST,Gastrin,35691,178,0.98 [0.88-1.09],0.7104704613706918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,34510,172,0.74 [0.42-1.30],0.2950115629805375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",34811,171,0.89 [0.73-1.08],0.2465670547713242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBA,Lysosomal acid glucosylceramidase,34803,173,1.07 [0.82-1.40],0.6020626925206103
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP1,Guanylate-binding protein 1,35626,178,1.03 [0.83-1.29],0.78453930995289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP2,Guanylate-binding protein 2,40393,209,0.94 [0.76-1.15],0.5355425959659392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP4,Guanylate-binding protein 4,40166,203,0.96 [0.74-1.24],0.7532894340052584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP6,Guanylate-binding protein 6,34635,172,0.84 [0.58-1.22],0.3588889117556768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GC,Vitamin D-binding protein,35814,180,0.86 [0.49-1.48],0.5786144888928493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCC1,GRIP and coiled-coil domain-containing protein 1,35691,178,0.99 [0.87-1.13],0.8876123029012752
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCG,Pro-glucagon,40196,207,0.99 [0.90-1.09],0.8476672144863917
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,34150,170,1.04 [0.78-1.40],0.7728645566907713
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCLM,Glutamate--cysteine ligase regulatory subunit,34635,172,1.10 [0.82-1.48],0.5275222842335621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40934,210,0.99 [0.69-1.42],0.960376554019424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GDF15,Growth/differentiation factor 15,41624,209,1.49 [1.16-1.91],0.0020134506617675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GDF2,Growth/differentiation factor 2,41128,212,0.68 [0.48-0.96],0.0274809748660122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GDNF,Glial cell line-derived neurotrophic factor,40166,203,1.30 [0.95-1.77],0.1063433055860088
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GET3,ATPase GET3,35759,178,0.90 [0.68-1.19],0.4736832381283675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFAP,Glial fibrillary acidic protein,40129,206,0.97 [0.74-1.26],0.799744026047905
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFER,FAD-linked sulfhydryl oxidase ALR,40196,207,0.99 [0.81-1.20],0.895725367778629
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,40196,207,1.02 [0.92-1.12],0.7607333434095167
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA1,GDNF family receptor alpha-1,41439,211,1.20 [0.77-1.87],0.4202048968111582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA2,GDNF family receptor alpha-2,40934,210,0.86 [0.48-1.54],0.6011591536911545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA3,GDNF family receptor alpha-3,40704,208,0.92 [0.59-1.43],0.7028916745750025
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRAL,GDNF family receptor alpha-like,34639,175,1.06 [0.84-1.34],0.6230644731606957
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGA1,ADP-ribosylation factor-binding protein GGA1,40166,203,0.95 [0.79-1.16],0.6296044394329503
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGACT,Gamma-glutamylaminecyclotransferase,35759,178,0.98 [0.80-1.20],0.8258999222057539
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGCT,Gamma-glutamylcyclotransferase,35689,178,1.15 [0.86-1.54],0.3435295548177844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGH,Gamma-glutamyl hydrolase,40434,210,0.99 [0.69-1.42],0.9493961622099912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGT1,Glutathione hydrolase 1 proenzyme,41067,208,0.79 [0.61-1.04],0.0886636240001913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGT5,Glutathione hydrolase 5 proenzyme,40826,208,1.22 [0.71-2.08],0.4752646482103986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GH1,Somatotropin,41074,212,1.04 [0.98-1.12],0.2175677771701255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GH2,Growth hormone variant,40196,207,0.95 [0.88-1.03],0.2538112958867565
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GHR,Growth hormone receptor,34994,173,0.77 [0.46-1.30],0.3280943275541628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GHRHR,Growth hormone-releasing hormone receptor,40166,203,0.90 [0.70-1.15],0.3946899168715818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GHRL,Appetite-regulating hormone,41128,212,1.10 [0.94-1.27],0.2309016664716008
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GID8,Glucose-induced degradation protein 8 homolog,35709,180,0.71 [0.42-1.18],0.1854539894256267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIGYF2,GRB10-interacting GYF protein 2,35709,180,1.08 [0.90-1.30],0.4174235774205586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIMAP7,GTPase IMAP family member 7,34994,173,0.87 [0.54-1.40],0.5588046158558709
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIMAP8,GTPase IMAP family member 8,34510,172,1.20 [0.93-1.55],0.1544439500806381
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIP,Gastric inhibitory polypeptide,34811,171,1.08 [0.83-1.40],0.5867382715478381
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIPC2,PDZ domain-containing protein GIPC2,35691,178,1.69 [1.08-2.63],0.0216194937530833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIPC3,PDZ domain-containing protein GIPC3,35608,179,0.96 [0.83-1.11],0.5960446708000413
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIPR,Gastric inhibitory polypeptide receptor,34730,174,0.82 [0.57-1.16],0.2598161650238326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIT1,ARF GTPase-activating protein GIT1,34730,174,1.01 [0.86-1.17],0.9401651586211872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GJA8,Gap junction alpha-8 protein,34510,172,0.97 [0.77-1.24],0.8294378294645874
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GKN1,Gastrokine-1,39398,201,1.18 [0.75-1.86],0.4655847862133208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLA,Alpha-galactosidase A,34924,173,0.89 [0.60-1.33],0.5696320754317707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLB1,Beta-galactosidase,40826,208,1.02 [0.76-1.36],0.9157956726869791
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLI2,Zinc finger protein GLI2,34730,174,1.00 [0.64-1.56],0.9883800391201868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLO1,Lactoylglutathione lyase,40395,204,1.09 [0.88-1.35],0.4109764915248491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLOD4,Glyoxalase domain-containing protein 4,41037,212,1.15 [0.81-1.62],0.4341682932192316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLP1R,Glucagon-like peptide 1 receptor,34664,171,1.09 [0.75-1.58],0.6651446084239485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLRX,Glutaredoxin-1,40856,210,1.09 [0.88-1.34],0.4361664678904022
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",34994,173,0.93 [0.79-1.10],0.4009715026501755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,40166,203,0.93 [0.70-1.24],0.6382370296213251
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLYR1,Putative oxidoreductase GLYR1,35598,179,1.08 [0.86-1.36],0.5195336689397871
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GM2A,Ganglioside GM2 activator,34902,176,1.31 [0.95-1.81],0.1001414676850649
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GMFG,Glia maturation factor gamma,35759,178,0.97 [0.79-1.18],0.7626197833503164
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GMPR,GMP reductase 1,41597,213,1.09 [0.85-1.39],0.5158153305371975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GMPR2,GMP reductase 2,34994,173,1.04 [0.83-1.29],0.7581666282987642
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNAS,Neuroendocrine secretory protein 55,35709,180,1.02 [0.86-1.20],0.8416837698544959
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,40196,207,0.93 [0.77-1.13],0.488903911233734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,34803,173,1.07 [0.82-1.41],0.6033102406304431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNLY,Granulysin,41134,210,1.16 [0.92-1.46],0.2039629998847263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNPDA1,Glucosamine-6-phosphate isomerase 1,34811,171,0.99 [0.64-1.54],0.9601764477120246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNPDA2,Glucosamine-6-phosphate isomerase 2,34994,173,0.80 [0.53-1.20],0.2814833740113498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOLGA3,Golgin subfamily A member 3,35709,180,0.98 [0.81-1.18],0.8357189982920016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOLM2,Protein GOLM2,41490,211,1.14 [0.67-1.97],0.6236368627445799
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,41085,214,0.94 [0.83-1.06],0.2875407727146288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GORASP2,Golgi reassembly-stacking protein 2,35608,179,1.04 [0.77-1.41],0.7909964558512792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOT1,"Aspartate aminotransferase, cytoplasmic",35767,181,1.01 [0.72-1.43],0.9539194713022342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP1BA,Platelet glycoprotein Ib alpha chain,40948,210,0.99 [0.68-1.44],0.9551119616698026
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP1BB,Platelet glycoprotein Ib beta chain,34635,172,0.91 [0.73-1.13],0.3969074170817152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39886,200,1.17 [1.02-1.34],0.0277373091848618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP5,Platelet glycoprotein V,34994,173,0.78 [0.52-1.16],0.2158555178857255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP6,Platelet glycoprotein VI,41061,210,0.93 [0.81-1.06],0.2717733799157787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPA33,Cell surface A33 antigen,40934,210,1.04 [0.95-1.14],0.3683913418055412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPC1,Glypican-1,41501,211,1.40 [0.92-2.12],0.1162840420320771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPC5,Glypican-5,40826,208,0.94 [0.75-1.17],0.5624170571548776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPD1,Glycerol-3-phosphate dehydrogenase,35598,179,0.76 [0.57-1.02],0.0723971726568782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPHA2,Glycoprotein hormone alpha-2,35608,179,1.15 [0.87-1.53],0.3225361675894277
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPI,Glucose-6-phosphate isomerase,35784,179,0.95 [0.70-1.29],0.7410143719420976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,35608,179,1.14 [0.92-1.41],0.2304781405798125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPKOW,G-patch domain and KOW motifs-containing protein,40166,203,1.28 [0.90-1.81],0.1694523001169147
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPNMB,Transmembrane glycoprotein NMB,40024,208,0.75 [0.49-1.16],0.1929044867096735
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR101,Probable G-protein coupled receptor 101,34664,171,1.01 [0.78-1.29],0.9592453144245672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR158,Probable G-protein coupled receptor 158,35709,180,1.06 [0.71-1.58],0.7696762165107609
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR15L,Protein GPR15L,35608,179,1.02 [0.81-1.29],0.8777349974438338
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR37,Prosaposin receptor GPR37,40395,204,1.06 [0.87-1.29],0.5455330939421563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPRC5C,G-protein coupled receptor family C group 5 member C,35598,179,1.01 [0.78-1.30],0.9621568945366946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRAP2,GRB2-related adapter protein 2,41128,212,0.96 [0.87-1.06],0.4003250066627736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,35759,178,1.01 [0.81-1.27],0.8984400964903501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRIK2,"Glutamate receptor ionotropic, kainate 2",35709,180,1.21 [0.91-1.62],0.1843075508035238
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",34664,171,1.24 [1.01-1.51],0.0382992593621434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRK5,G protein-coupled receptor kinase 5,40395,204,0.99 [0.77-1.27],0.9219839789922096
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRN,Progranulin,40936,208,1.66 [1.01-2.73],0.0465118471982196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRP,Gastrin-releasing peptide,34811,171,0.94 [0.71-1.23],0.6482707381239117
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRPEL1,"GrpE protein homolog 1, mitochondrial",40934,210,0.90 [0.72-1.12],0.3403944229865354
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRSF1,G-rich sequence factor 1,34316,171,0.98 [0.82-1.18],0.8692984171207729
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSAP,Gamma-secretase-activating protein,40196,207,0.99 [0.86-1.15],0.9125386687674144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSN,Gelsolin,35646,178,1.94 [0.92-4.09],0.0796661001241791
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSR,"Glutathione reductase, mitochondrial",35581,179,0.76 [0.40-1.46],0.4085003731958746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTA1,Glutathione S-transferase A1,41063,211,0.95 [0.82-1.10],0.4745105648116302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTA3,Glutathione S-transferase A3,40196,207,0.94 [0.80-1.11],0.4686799572607212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTM4,Glutathione S-transferase Mu 4,34635,172,1.06 [0.88-1.28],0.5592720182506177
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTP1,Glutathione S-transferase P,39915,201,1.03 [0.86-1.23],0.7716751786000475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTT2B,Glutathione S-transferase theta-2B,35691,178,1.04 [0.98-1.11],0.1802244969991868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,35099,171,0.94 [0.75-1.18],0.5873724102411271
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GTPBP2,GTP-binding protein 2,34803,173,0.93 [0.77-1.12],0.4311923152537043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUCA2A,Guanylin,40921,207,1.28 [0.88-1.84],0.1955240785445613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUCY2C,Heat-stable enterotoxin receptor,35099,171,0.95 [0.79-1.15],0.6290031479225382
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUK1,Guanylate kinase,34635,172,1.27 [0.94-1.71],0.1139165231481451
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUSB,Beta-glucuronidase,41310,209,1.11 [0.91-1.35],0.3193009464101163
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GYS1,"Glycogen [starch] synthase, muscle",40395,204,1.00 [0.87-1.14],0.9825728027851348
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GZMA,Granzyme A,41597,213,1.18 [0.84-1.67],0.3390406962445457
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GZMB,Granzyme B,41085,214,0.93 [0.76-1.12],0.43349788121932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GZMH,Granzyme H,40395,204,1.13 [0.98-1.31],0.0963849887396933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,H2AP,Huntingtin-interacting protein M,34510,172,1.04 [0.79-1.38],0.7788953099971788
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",34635,172,0.86 [0.66-1.12],0.2628001472157517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",41380,211,1.16 [0.99-1.37],0.0718168355826058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAO1,Hydroxyacid oxidase 1,41501,211,0.92 [0.83-1.02],0.0971569510505722
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HARS1,"Histidine--tRNA ligase, cytoplasmic",41134,210,0.97 [0.83-1.14],0.6905772065087279
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAVCR1,Hepatitis A virus cellular receptor 1,41442,211,1.22 [1.00-1.48],0.0476933245335826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAVCR2,Hepatitis A virus cellular receptor 2,41134,210,1.51 [1.07-2.12],0.0184670962321309
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBEGF,Proheparin-binding EGF-like growth factor,41380,211,0.80 [0.68-0.95],0.0090953135562092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBQ1,Hemoglobin subunit theta-1,41501,211,1.15 [0.95-1.39],0.1631679745378989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBZ,Hemoglobin subunit zeta,35759,178,1.10 [0.96-1.25],0.1739457247430382
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HCG22,Protein PBMUCL2,34635,172,1.00 [0.77-1.32],0.9732179993010404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HCLS1,Hematopoietic lineage cell-specific protein,41597,213,0.98 [0.79-1.22],0.8427367968614463
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDAC8,Histone deacetylase 8,34730,174,0.94 [0.73-1.22],0.6640072310087213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDAC9,Histone deacetylase 9,34664,171,0.98 [0.78-1.24],0.8886546856165372
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDDC2,5'-deoxynucleotidase HDDC2,35608,179,1.15 [0.84-1.59],0.3796626144649135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDGF,Hepatoma-derived growth factor,41437,211,0.98 [0.86-1.11],0.7344130461178091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDGFL2,Hepatoma-derived growth factor-related protein 2,35691,178,1.11 [0.89-1.37],0.3461335036990218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEBP1,Heme-binding protein 1,40395,204,1.17 [0.96-1.43],0.1130356437758712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEG1,Protein HEG homolog 1,34994,173,0.86 [0.50-1.49],0.5900309463646112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEPACAM2,HEPACAM family member 2,35691,178,0.84 [0.60-1.18],0.309618466896775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEPH,Hephaestin,35759,178,1.16 [0.67-2.01],0.5889662306673663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEXIM1,Protein HEXIM1,41085,214,0.95 [0.81-1.10],0.4704810190592581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HGF,Hepatocyte growth factor,41597,213,1.17 [0.82-1.67],0.3899687874873726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HGFAC,Hepatocyte growth factor activator,35449,177,0.69 [0.45-1.05],0.0858175266359649
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,40196,207,1.05 [0.89-1.23],0.5692225481230351
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HHEX,Hematopoietically-expressed homeobox protein HHEX,35691,178,0.99 [0.82-1.19],0.91328065290388
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HIF1A,Hypoxia-inducible factor 1-alpha,34730,174,1.10 [0.90-1.35],0.3676708197949524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HIP1,Huntingtin-interacting protein 1,34635,172,1.12 [0.75-1.67],0.582967125918617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HIP1R,Huntingtin-interacting protein 1-related protein,35620,177,1.24 [0.96-1.61],0.1041226620041536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HJV,Hemojuvelin,35709,180,0.98 [0.70-1.37],0.908077212193122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HK2,Hexokinase-2,40395,204,1.10 [0.71-1.72],0.6605684868346761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",35709,180,0.99 [0.64-1.52],0.949296854830961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",40956,213,1.05 [0.75-1.46],0.7832804292598085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",41085,214,1.56 [1.04-2.32],0.0302820883532718
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMBS,Porphobilinogen deaminase,41501,211,1.12 [0.84-1.49],0.4355009450098408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMCN2,Hemicentin-2,34928,173,0.92 [0.71-1.18],0.4954031292023465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",34811,171,0.98 [0.73-1.33],0.9213053690990498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",34635,172,1.09 [0.79-1.50],0.5994067262223736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMMR,Hyaluronan mediated motility receptor,34444,172,1.11 [0.84-1.46],0.46744027185696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMOX1,Heme oxygenase 1,40681,211,1.08 [0.84-1.39],0.5541727557320859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMOX2,Heme oxygenase 2,40166,203,0.94 [0.71-1.24],0.6728023410726566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNF1A,Hepatocyte nuclear factor 1-alpha,34803,173,0.98 [0.79-1.21],0.8251368751838781
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNMT,Histamine N-methyltransferase,40621,205,1.00 [0.77-1.31],0.9938352547212208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,40264,203,1.03 [0.88-1.21],0.6967773851397445
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,35709,180,1.16 [0.89-1.51],0.2704846688749588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPCAL1,Hippocalcin-like protein 1,41597,213,0.92 [0.78-1.08],0.2877979504316587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPGDS,Hematopoietic prostaglandin D synthase,40196,207,0.84 [0.60-1.17],0.3027234758330047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPSE,Heparanase,35294,179,0.90 [0.78-1.05],0.1939357039548991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HRAS,GTPase Hras,35034,171,0.99 [0.85-1.15],0.8729202715883715
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,34811,171,1.35 [0.92-1.98],0.1238978120452031
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HRG,Histidine-rich glycoprotein,35628,179,0.64 [0.41-1.01],0.0540242461339417
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS1BP3,HCLS1-binding protein 3,34811,171,1.00 [0.84-1.17],0.9563709644247912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40934,210,0.71 [0.51-0.99],0.0432699082973873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,41501,211,1.64 [1.28-2.09],9.122960858615928e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,34730,174,1.15 [0.76-1.76],0.5112868444559706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSBP1,Heat shock factor-binding protein 1,34811,171,1.07 [0.92-1.25],0.3613791209667204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,41085,214,1.18 [0.87-1.60],0.2969295285104157
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,35691,178,1.24 [0.99-1.55],0.065046140566415
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD17B3,Testosterone 17-beta-dehydrogenase 3,34635,172,0.94 [0.69-1.29],0.7210513169722682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,34811,171,0.97 [0.71-1.32],0.8373655419148227
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSP90B1,Endoplasmin,39980,202,0.93 [0.75-1.14],0.4688851124971758
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPA1A,Heat shock 70 kDa protein 1A,41223,212,0.98 [0.83-1.17],0.8520368098732072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPA2,Heat shock-related 70 kDa protein 2,35598,179,1.19 [0.80-1.77],0.3897734656206212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPB1,Heat shock protein beta-1,40470,209,1.04 [0.87-1.25],0.6517857082647234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPB6,Heat shock protein beta-6,41501,211,1.46 [1.08-1.98],0.0129502515479566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40820,210,1.89 [1.22-2.95],0.0045540955861475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HTR1A,5-hydroxytryptamine receptor 1A,34664,171,1.02 [0.84-1.23],0.8310554256213254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HTR1B,5-hydroxytryptamine receptor 1B,34664,171,0.95 [0.67-1.34],0.7636136842308229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HTRA2,"Serine protease HTRA2, mitochondrial",41240,212,0.97 [0.79-1.18],0.7578509914238779
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HYAL1,Hyaluronidase-1,40889,211,0.85 [0.49-1.46],0.5441274146150727
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HYOU1,Hypoxia up-regulated protein 1,41624,209,2.40 [1.40-4.11],0.0013964215355201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICA1,Islet cell autoantigen 1,40393,209,1.00 [0.86-1.17],0.96553254529169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM1,Intercellular adhesion molecule 1,40954,210,1.23 [0.80-1.90],0.3466892899903009
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM2,Intercellular adhesion molecule 2,41624,209,1.14 [0.78-1.67],0.5069158677892359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM3,Intercellular adhesion molecule 3,41624,209,1.15 [0.71-1.85],0.5705747475087206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM4,Intercellular adhesion molecule 4,41085,214,1.14 [0.91-1.44],0.2532001823444493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM5,Intercellular adhesion molecule 5,41128,212,0.85 [0.65-1.11],0.2191774946680701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICOSLG,ICOS ligand,40934,210,1.52 [0.80-2.89],0.2054852389174604
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ID4,DNA-binding protein inhibitor ID-4,35099,171,1.10 [0.82-1.49],0.522704255036391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDI2,Isopentenyl-diphosphate delta-isomerase 2,40166,203,1.26 [1.00-1.59],0.0525083940573425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDO1,"Indoleamine 2,3-dioxygenase 1",34811,171,1.04 [0.82-1.31],0.747208048949854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDS,Iduronate 2-sulfatase,41597,213,0.97 [0.24-3.82],0.9611731398812204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDUA,Alpha-L-iduronidase,41501,211,0.92 [0.71-1.19],0.5186854703128583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,34759,173,1.26 [0.87-1.82],0.2285165883283281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,35099,171,1.08 [0.82-1.42],0.5747583195907011
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,35099,171,1.23 [0.86-1.77],0.251526273503856
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNAR1,Interferon alpha/beta receptor 1,35608,179,1.20 [0.70-2.04],0.505335395090067
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNG,Interferon gamma,40393,209,0.99 [0.89-1.10],0.8252928351769382
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNGR1,Interferon gamma receptor 1,41291,212,1.86 [1.08-3.18],0.024145290264672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNGR2,Interferon gamma receptor 2,40826,208,0.98 [0.77-1.25],0.8740406606058259
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNL1,Interferon lambda-1,40166,203,1.04 [0.79-1.38],0.7762317912657849
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNL2,Interferon lambda-2,34664,171,1.07 [0.86-1.33],0.548070875502433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNLR1,Interferon lambda receptor 1,41085,214,1.13 [0.82-1.57],0.4450964509703552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNW1,Interferon omega-1,34635,172,0.85 [0.54-1.33],0.4692031829948706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFT20,Intraflagellar transport protein 20 homolog,34803,173,1.12 [0.81-1.54],0.493116636724117
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGBP1,Immunoglobulin-binding protein 1,35709,180,1.12 [0.89-1.42],0.3259451295622132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,34664,171,1.20 [0.94-1.54],0.1453247140756464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,35767,181,1.01 [0.59-1.73],0.9752625639432484
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGF1R,Insulin-like growth factor 1 receptor,40934,210,1.08 [0.61-1.91],0.7861814278764448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,34635,172,1.14 [0.85-1.51],0.3866001736742618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGF2R,Cation-independent mannose-6-phosphate receptor,41134,210,1.90 [1.13-3.18],0.0149444246696962
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP1,Insulin-like growth factor-binding protein 1,41560,209,1.10 [0.99-1.22],0.0665783096926503
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP2,Insulin-like growth factor-binding protein 2,41555,209,1.18 [0.96-1.45],0.1198710309678436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP3,Insulin-like growth factor-binding protein 3,41278,211,0.98 [0.66-1.47],0.9348051236406848
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP4,Insulin-like growth factor-binding protein 4,40614,208,1.70 [1.31-2.19],5.079241585318025e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP6,Insulin-like growth factor-binding protein 6,40948,211,1.73 [1.19-2.52],0.0042631149013698
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP7,Insulin-like growth factor-binding protein 7,41624,209,1.12 [0.75-1.69],0.5767762714428317
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBPL1,Insulin-like growth factor-binding protein-like 1,41128,212,1.62 [1.14-2.30],0.0071785366677143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFL4,Insulin growth factor-like family member 4,34730,174,1.02 [0.84-1.24],0.831958739015589
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGHMBP2,DNA-binding protein SMUBP-2,34635,172,0.98 [0.76-1.28],0.8916390860711711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGLC2,Immunoglobulin lambda constant 2,35753,180,1.34 [0.88-2.04],0.1750070306732709
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGLON5,IgLON family member 5,34510,172,1.18 [1.05-1.33],0.0056340231989369
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF21,Immunoglobulin superfamily member 21,34811,171,0.90 [0.61-1.33],0.5947029423833152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF3,Immunoglobulin superfamily member 3,40934,210,1.84 [1.37-2.48],5.49434921038497e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF8,Immunoglobulin superfamily member 8,41128,212,1.12 [0.75-1.68],0.5735883060396515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF9,Protein turtle homolog A,35759,178,0.96 [0.81-1.15],0.6529537378910912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IKBKG,NF-kappa-B essential modulator,41085,214,0.96 [0.84-1.10],0.5896472253204227
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IKZF2,Zinc finger protein Helios,40196,207,0.99 [0.86-1.14],0.8462399564312155
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL10,Interleukin-10,40393,209,1.05 [0.91-1.22],0.5026689700199971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL10RA,Interleukin-10 receptor subunit alpha,40393,209,0.96 [0.77-1.19],0.6874493496958882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL10RB,Interleukin-10 receptor subunit beta,41291,212,1.62 [1.10-2.40],0.0151459463740368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL11,Interleukin-11,40393,209,1.04 [0.86-1.26],0.6989129891667547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12A_IL12B,Interleukin-12,40934,210,1.08 [0.92-1.27],0.3201510738885089
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12B,Interleukin-12 subunit beta,41597,213,1.11 [0.88-1.39],0.3754307017139224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12RB1,Interleukin-12 receptor subunit beta-1,40393,209,0.92 [0.66-1.29],0.6383961423841478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12RB2,Interleukin-12 receptor subunit beta-2,34730,174,1.26 [0.90-1.74],0.1729830975252219
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL13,Interleukin-13,40393,209,0.94 [0.72-1.23],0.6534996300955517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL13RA1,Interleukin-13 receptor subunit alpha-1,40596,206,1.40 [0.81-2.41],0.2322228474551598
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL13RA2,Interleukin-13 receptor subunit alpha-2,34664,171,1.12 [0.67-1.85],0.6665842522514582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL15,Interleukin-15,41085,214,1.52 [1.07-2.16],0.0195773232400991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL15RA,Interleukin-15 receptor subunit alpha,40393,209,1.06 [0.74-1.51],0.761842905402297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL16,Pro-interleukin-16,41597,213,1.13 [0.86-1.48],0.3763358937946814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17A,Interleukin-17A,40329,209,1.16 [0.89-1.51],0.260392424990537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17C,Interleukin-17C,40393,209,1.18 [1.01-1.38],0.0371627844819909
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17D,Interleukin-17D,40393,209,1.19 [0.88-1.61],0.2524928505305817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17F,Interleukin-17F,40393,209,1.03 [0.88-1.21],0.6841294410804332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17RA,Interleukin-17 receptor A,41134,210,1.10 [0.83-1.45],0.5062137451527782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17RB,Interleukin-17 receptor B,40564,209,1.04 [0.82-1.31],0.753973031425523
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18,Interleukin-18,40954,212,0.99 [0.75-1.29],0.928837401709055
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18BP,Interleukin-18-binding protein,41278,211,1.48 [1.00-2.18],0.0501865353730686
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18R1,Interleukin-18 receptor 1,41597,213,1.31 [0.90-1.89],0.1560095335121648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18RAP,Interleukin-18 receptor accessory protein,40564,205,0.97 [0.90-1.05],0.4296452558186475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL19,Interleukin-19,40098,207,1.11 [0.94-1.32],0.2282246331092152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1A,Interleukin-1 alpha,40393,209,0.95 [0.76-1.18],0.624544633857018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1B,Interleukin-1 beta,40204,206,0.92 [0.73-1.16],0.4760302551109666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1R1,Interleukin-1 receptor type 1,41067,208,1.50 [0.88-2.57],0.134462493030806
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1R2,Interleukin-1 receptor type 2,41034,212,0.74 [0.40-1.36],0.3314282145041637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RAP,Interleukin-1 receptor accessory protein,41134,210,1.08 [0.83-1.41],0.5796461493894333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RL1,Interleukin-1 receptor-like 1,41496,209,1.01 [0.77-1.32],0.9331469777697562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RL2,Interleukin-1 receptor-like 2,40393,209,1.17 [0.85-1.63],0.3369468721593521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RN,Interleukin-1 receptor antagonist protein,41027,212,1.05 [0.84-1.32],0.6388787541761738
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2,Interleukin-2,40393,209,0.89 [0.60-1.31],0.5555333985323299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL20,Interleukin-20,40393,209,0.90 [0.69-1.18],0.4419640925939708
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL20RA,Interleukin-20 receptor subunit alpha,40393,209,0.97 [0.73-1.28],0.8152856000611656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL20RB,Interleukin-20 receptor subunit beta,34730,174,0.94 [0.66-1.35],0.7535921534839324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL21R,Interleukin-21 receptor,34730,174,1.09 [0.86-1.39],0.4518168301281419
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL22,Interleukin-22,35598,179,1.02 [0.82-1.25],0.8866736842425879
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL22RA1,Interleukin-22 receptor subunit alpha-1,40393,209,1.08 [0.83-1.40],0.5865189731557143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL24,Interleukin-24,40393,209,0.96 [0.74-1.24],0.7632016478859908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL25,Interleukin-25,34382,172,1.27 [0.83-1.95],0.2771561883168217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2RA,Interleukin-2 receptor subunit alpha,40834,204,1.00 [0.73-1.38],0.984099914913043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2RB,Interleukin-2 receptor subunit beta,40393,209,0.84 [0.60-1.20],0.3410009152530333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2RG,Cytokine receptor common subunit gamma,35598,179,1.15 [0.81-1.64],0.4261348037788561
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL3,Interleukin-3,34510,172,0.97 [0.77-1.22],0.7965180354159069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL31,Interleukin-31,34730,174,1.08 [0.85-1.38],0.5263676024444602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL31RA,Interleukin-31 receptor subunit alpha,34597,172,1.00 [0.68-1.46],0.9795096148824284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL32,Interleukin-32,41085,214,0.88 [0.66-1.19],0.4134795307080756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL33,Interleukin-33,40393,209,1.03 [0.75-1.41],0.8411994921371703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL34,Interleukin-34,40106,203,1.03 [0.73-1.46],0.8551635083625885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL36A,Interleukin-36 alpha,34730,174,0.84 [0.63-1.13],0.2482400555657618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL36G,Interleukin-36 gamma,34603,174,1.07 [0.87-1.32],0.5036738016009257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL3RA,Interleukin-3 receptor subunit alpha,40393,209,1.27 [0.87-1.85],0.2176887174569842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL4,Interleukin-4,40393,209,1.14 [0.98-1.33],0.0938946525832535
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL4R,Interleukin-4 receptor subunit alpha,41085,214,1.38 [0.99-1.92],0.0564334597135088
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL5,Interleukin-5,40393,209,1.02 [0.94-1.11],0.6591056612626945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL5RA,Interleukin-5 receptor subunit alpha,41085,214,0.99 [0.79-1.23],0.901747734032845
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL6,Interleukin-6,40934,210,1.05 [0.89-1.23],0.5666768940307376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL6R,Interleukin-6 receptor subunit alpha,40885,210,1.40 [0.98-1.99],0.0668783950607699
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL6ST,Interleukin-6 receptor subunit beta,41128,212,1.00 [0.49-2.02],0.9951750988058656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL7,Interleukin-7,41085,214,0.86 [0.71-1.04],0.1158872621994353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL7R,Interleukin-7 receptor subunit alpha,41134,210,0.91 [0.72-1.14],0.40469194995222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL9,Interleukin-9,35099,171,0.95 [0.72-1.25],0.6993508669387725
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,40110,203,1.04 [0.84-1.29],0.7341830637732667
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMMT,MICOS complex subunit MIC60,35598,179,1.32 [1.00-1.74],0.0478696973348534
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMPA1,Inositol monophosphatase 1,40826,208,0.95 [0.77-1.16],0.5910961253843806
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMPACT,Protein IMPACT,35691,178,1.14 [0.88-1.47],0.3257694117657695
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMPG1,Interphotoreceptor matrix proteoglycan 1,34664,171,0.84 [0.50-1.40],0.4962323399737631
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ING1,Inhibitor of growth protein 1,40090,203,1.05 [0.81-1.36],0.7341358644914344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INHBB,Inhibin beta B chain,34994,173,1.18 [0.89-1.56],0.2407012352385897
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INHBC,Inhibin beta C chain,41134,210,1.00 [0.74-1.35],0.9853468825360698
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPP1,Inositol polyphosphate 1-phosphatase,40934,210,1.13 [0.91-1.42],0.2685101737613929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",34811,171,1.17 [0.90-1.51],0.2346512640710482
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",35709,180,0.75 [0.51-1.10],0.1408465283207729
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40934,210,0.93 [0.82-1.05],0.2519950321162714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL3,Insulin-like 3,35691,178,0.96 [0.80-1.15],0.6445639863139615
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL4,Early placenta insulin-like peptide,35598,179,1.27 [1.02-1.59],0.0337159943013638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL5,Insulin-like peptide INSL5,35608,179,0.98 [0.84-1.13],0.7494011749432623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSR,Insulin receptor,34730,174,1.60 [0.67-3.82],0.2864573873732503
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IPCEF1,Interactor protein for cytohesin exchange factors 1,40754,205,0.93 [0.81-1.07],0.296343036555256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40934,210,0.97 [0.77-1.22],0.8120074836757945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40395,204,1.10 [0.96-1.26],0.1526420852318948
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IRAK1,Interleukin-1 receptor-associated kinase 1,40393,209,0.95 [0.79-1.13],0.543611348316128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IRAK4,Interleukin-1 receptor-associated kinase 4,41085,214,0.95 [0.85-1.07],0.4030608651946742
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39583,202,0.76 [0.55-1.07],0.1138024272634846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISM1,Isthmin-1,41085,214,1.14 [0.83-1.56],0.417127807667437
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISM2,Isthmin-2,35767,181,1.20 [0.89-1.61],0.2389433193162089
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IST1,IST1 homolog,35342,179,1.01 [0.88-1.17],0.8718544218607079
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA11,Integrin alpha-11,41085,214,0.78 [0.55-1.12],0.1790801478570593
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA2,Integrin alpha-2,34994,173,1.06 [0.69-1.63],0.7948012330801928
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA5,Integrin alpha-5,41134,210,1.11 [0.67-1.82],0.6923676698246937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA6,Integrin alpha-6,41085,214,1.07 [0.85-1.34],0.5535777014686556
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAL,Integrin alpha-L,34730,174,1.30 [0.92-1.85],0.1377637055827786
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAM,Integrin alpha-M,41134,210,1.30 [0.89-1.91],0.1705397029629171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAV,Integrin alpha-V,41501,211,0.92 [0.44-1.95],0.8339266567505598
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAX,Integrin alpha-X,35099,171,1.30 [1.03-1.63],0.0247632507474372
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1,Integrin beta-1,41085,211,1.17 [0.66-2.08],0.5920131664310384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1BP1,Integrin beta-1-binding protein 1,40196,207,0.94 [0.69-1.28],0.7022936279938112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1BP2,Integrin beta-1-binding protein 2,40395,204,0.97 [0.87-1.08],0.5926864757381314
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB2,Integrin beta-2,40886,207,1.07 [0.69-1.66],0.7702257626155968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB5,Integrin beta-5,41240,212,1.01 [0.73-1.40],0.9441606857172128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB6,Integrin beta-6,40393,209,1.03 [0.68-1.55],0.8847325677829845
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB7,Integrin beta-7,41501,211,0.97 [0.74-1.27],0.8189176774847666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGBL1,Integrin beta-like protein 1,35767,181,1.15 [0.78-1.71],0.4728798775644162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,35814,180,1.09 [0.51-2.31],0.8214566160327682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,41278,211,1.10 [0.80-1.53],0.5480241143012952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,35814,180,0.87 [0.49-1.56],0.6470597897781153
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,35598,179,1.35 [1.05-1.74],0.0180388620328948
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITM2A,Integral membrane protein 2A,41085,214,1.10 [0.90-1.34],0.3643656252573777
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITPA,Inosine triphosphate pyrophosphatase,34635,172,0.97 [0.78-1.22],0.8179294226620353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",34811,171,1.06 [0.86-1.30],0.5948505508096567
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",34664,171,1.08 [0.79-1.47],0.6441115469966825
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",40166,203,1.03 [0.81-1.32],0.8049899801568958
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IZUMO1,Izumo sperm-egg fusion protein 1,34510,172,0.89 [0.63-1.25],0.498619062667588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JAM2,Junctional adhesion molecule B,41490,211,1.45 [0.92-2.30],0.1136164836404541
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JAM3,Junctional adhesion molecule C,34994,173,0.90 [0.67-1.22],0.5144182246903964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JCHAIN,Immunoglobulin J chain,40393,209,1.08 [0.88-1.32],0.4585742745898145
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,34510,172,1.05 [0.82-1.35],0.6911643139162309
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JPT2,Jupiter microtubule associated homolog 2,35608,179,1.00 [0.85-1.17],0.9622857267116964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JUN,Transcription factor AP-1,40393,209,1.03 [0.81-1.31],0.7990897472792755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40934,210,1.01 [0.77-1.33],0.9319936732772276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KAZN,Kazrin,35608,179,1.00 [0.88-1.15],0.952068942706609
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCNC4,Potassium voltage-gated channel subfamily C member 4,34664,171,1.12 [0.88-1.42],0.3642943711364158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCNH2,Potassium voltage-gated channel subfamily H member 2,34803,173,0.97 [0.79-1.18],0.7364394565445871
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCNIP4,Kv channel-interacting protein 4,40166,203,0.79 [0.59-1.06],0.122454877725828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCTD5,BTB/POZ domain-containing protein KCTD5,35014,177,1.10 [0.80-1.49],0.5641904178810158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KDM3A,Lysine-specific demethylase 3A,34730,174,0.93 [0.78-1.11],0.4352341264704111
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KDR,Vascular endothelial growth factor receptor 2,41240,212,1.13 [0.70-1.83],0.6161934305867056
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KEL,Kell blood group glycoprotein,40166,203,0.94 [0.66-1.33],0.7265407824165102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KHDC3L,KH domain-containing protein 3,34510,172,0.93 [0.74-1.17],0.5377416103265364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KHK,Ketohexokinase,34811,171,0.86 [0.68-1.08],0.1950865137299356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA0319,Dyslexia-associated protein KIAA0319,35691,178,1.38 [0.91-2.09],0.1265419391289527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA1549,UPF0606 protein KIAA1549,35099,171,0.95 [0.77-1.17],0.6265583704942148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA1549L,UPF0606 protein KIAA1549L,35099,171,1.77 [1.18-2.66],0.0061710253102771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA2013,Uncharacterized protein KIAA2013,35598,179,1.06 [0.83-1.35],0.6630347063885025
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIF1C,Kinesin-like protein KIF1C,34635,172,0.99 [0.65-1.52],0.9707188603135116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIF20B,Kinesin-like protein KIF20B,34664,171,1.11 [0.93-1.33],0.2275626614526436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIF22,Kinesin-like protein KIF22,34635,172,1.00 [0.88-1.12],0.9364464344403136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIFBP,KIF-binding protein,40934,210,0.93 [0.80-1.07],0.2997144300056622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,35598,179,0.99 [0.84-1.17],0.914350911946844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,40196,207,1.04 [0.89-1.21],0.6543305089808285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,35608,179,0.96 [0.88-1.04],0.298545886829509
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,40196,207,0.95 [0.86-1.05],0.3491895353764277
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,34510,172,1.04 [0.89-1.22],0.6381580732544629
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIRREL1,Kin of IRRE-like protein 1,34664,171,1.04 [0.82-1.33],0.7303443017401674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIRREL2,Kin of IRRE-like protein 2,40166,203,1.44 [1.09-1.90],0.0107061212596014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIT,Mast/stem cell growth factor receptor Kit,41219,211,1.16 [0.76-1.75],0.4887277640389342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KITLG,Kit ligand,41128,212,0.85 [0.61-1.19],0.3439386002144035
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLB,Beta-klotho,40166,203,0.95 [0.81-1.13],0.5903585497155835
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLF4,Krueppel-like factor 4,34664,171,0.88 [0.60-1.28],0.4960230821693032
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLHL41,Kelch-like protein 41,35709,180,1.18 [0.90-1.54],0.2249380289345403
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK1,Kallikrein-1,40712,208,1.02 [0.93-1.12],0.680952801838411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK10,Kallikrein-10,41114,211,1.22 [0.92-1.64],0.1698212693181651
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK11,Kallikrein-11,40830,209,1.34 [0.95-1.90],0.0937592051160294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK12,Kallikrein-12,40196,207,1.02 [0.93-1.12],0.689625280076321
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK13,Kallikrein-13,40198,208,1.20 [0.91-1.58],0.1994525401719834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK14,Kallikrein-14,41501,211,1.00 [0.77-1.30],0.98514112248757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK15,Kallikrein-15,35542,179,1.10 [0.84-1.45],0.4899460826316548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK3,Prostate-specific antigen,35767,181,1.31 [1.14-1.51],0.0001607230011111
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK4,Kallikrein-4,41501,211,1.04 [0.85-1.27],0.6994528103302027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK6,Kallikrein-6,41175,211,1.22 [0.81-1.82],0.3378366485793784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK7,Kallikrein-7,34092,171,1.04 [0.71-1.53],0.8428527422233736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK8,Kallikrein-8,39729,193,1.50 [1.07-2.12],0.0198684052525047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLKB1,Plasma kallikrein,35097,176,0.73 [0.41-1.32],0.298963656743442
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRB1,Killer cell lectin-like receptor subfamily B member 1,41597,213,1.28 [0.93-1.76],0.1342593683491608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,34664,171,1.06 [0.84-1.34],0.6376570449994039
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRD1,Natural killer cells antigen CD94,41597,213,1.13 [0.87-1.47],0.3430663325916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRF1,Killer cell lectin-like receptor subfamily F member 1,34730,174,1.17 [0.86-1.58],0.3169769417290515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRK1,NKG2-D type II integral membrane protein,35691,178,1.11 [0.82-1.51],0.5059697099611266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT14,"Keratin, type I cytoskeletal 14",38887,197,1.10 [0.72-1.67],0.670577034335739
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT17,"Keratin, type I cytoskeletal 17",34635,172,0.83 [0.56-1.25],0.3728647025465906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT18,"Keratin, type I cytoskeletal 18",40934,210,1.03 [0.88-1.20],0.7034092651817743
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT19,"Keratin, type I cytoskeletal 19",41021,214,1.01 [0.84-1.21],0.9441158664495308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT5,"Keratin, type II cytoskeletal 5",40166,203,1.47 [1.18-1.83],0.0005186851537593
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT6C,"Keratin, type II cytoskeletal 6C",34635,172,1.24 [0.89-1.72],0.2034122090976691
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT8,"Keratin, type II cytoskeletal 8",34664,171,1.01 [0.83-1.23],0.9309554865127796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KYAT1,Kynurenine--oxoglutarate transaminase 1,41058,212,1.08 [0.88-1.34],0.4532498796054813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KYNU,Kynureninase,41597,213,0.82 [0.62-1.08],0.1579830288401048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,L1CAM,Neural cell adhesion molecule L1,41240,212,1.22 [0.80-1.85],0.3607880687065281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,35759,178,0.89 [0.76-1.05],0.1647832390693654
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LACRT,Extracellular glycoprotein lacritin,35527,179,1.16 [0.90-1.51],0.2585703767313002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LACTB2,Endoribonuclease LACTB2,41128,212,0.96 [0.80-1.16],0.6628522381935636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAG3,Lymphocyte activation gene 3 protein,40934,210,1.44 [1.09-1.90],0.0110180057304265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,41092,212,1.12 [0.79-1.57],0.5238880661361154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40826,208,1.10 [0.97-1.24],0.1286742473196043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMA1,Laminin subunit alpha-1,34635,172,1.15 [0.91-1.46],0.2496467269458657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMA4,Laminin subunit alpha-4,41291,212,0.99 [0.69-1.42],0.9468287404872512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMB1,Laminin subunit beta-1,34811,171,0.79 [0.49-1.28],0.3306895971643951
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMP1,Lysosome-associated membrane glycoprotein 1,34781,174,0.75 [0.40-1.40],0.3627718612313564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMP2,Lysosome-associated membrane glycoprotein 2,39875,199,0.84 [0.45-1.57],0.5801459208937443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMP3,Lysosome-associated membrane glycoprotein 3,41523,212,1.03 [0.82-1.31],0.7786996448080086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMTOR5,Ragulator complex protein LAMTOR5,35598,179,1.32 [0.98-1.78],0.0690274018334449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAP3,Cytosol aminopeptidase,40393,209,1.05 [0.81-1.35],0.7236297460221202
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LARP1,La-related protein 1,35598,179,1.12 [0.91-1.38],0.2912360380051312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAT,Linker for activation of T-cells family member 1,41597,213,0.89 [0.76-1.03],0.1210117314157705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAT2,Linker for activation of T-cells family member 2,40934,210,0.97 [0.88-1.07],0.569710011714551
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LATS1,Serine/threonine-protein kinase LATS1,34730,174,1.02 [0.86-1.21],0.8445815252332398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAYN,Layilin,40750,208,1.55 [1.10-2.20],0.0130491301406434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LBP,Lipopolysaccharide-binding protein,41278,211,1.11 [0.90-1.37],0.3175498687490472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LBR,Delta(14)-sterol reductase LBR,41490,211,1.04 [0.88-1.24],0.6336948386613372
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCAT,Phosphatidylcholine-sterol acyltransferase,35784,179,1.03 [0.53-1.99],0.9278312899665716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCN15,Lipocalin-15,35709,180,1.06 [0.85-1.33],0.6093909355764144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCN2,Neutrophil gelatinase-associated lipocalin,39895,206,1.28 [0.94-1.75],0.1141858392861438
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCP1,Plastin-2,35767,181,0.85 [0.62-1.16],0.3092253130593433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LDLR,Low-density lipoprotein receptor,41233,209,0.92 [0.73-1.17],0.5140422188420664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LDLRAP1,Low density lipoprotein receptor adapter protein 1,35709,180,0.93 [0.80-1.07],0.3003599565249513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LECT2,Leukocyte cell-derived chemotaxin-2,35759,178,1.16 [0.93-1.44],0.1907093774208562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEFTY2,Left-right determination factor 2,41439,211,1.03 [0.81-1.31],0.8106244906226003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEG1,Protein LEG1 homolog,33793,170,0.97 [0.78-1.21],0.801805802555233
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LELP1,Late cornified envelope-like proline-rich protein 1,34664,171,0.82 [0.65-1.04],0.1038400824058193
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEO1,RNA polymerase-associated protein LEO1,35709,180,1.42 [1.07-1.90],0.016730558926074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEP,Leptin,41128,212,0.94 [0.78-1.12],0.4868649192122528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEPR,Leptin receptor,41128,212,0.83 [0.56-1.24],0.3712620608948753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LETM1,Mitochondrial proton/calcium exchanger protein,35709,180,0.98 [0.74-1.28],0.8592457520635018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS1,Galectin-1,41128,212,1.15 [0.81-1.64],0.4323760384840521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS3,Galectin-3,41232,208,1.07 [0.71-1.62],0.7380434856632065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS3BP,Galectin-3-binding protein,35814,180,1.04 [0.65-1.66],0.8609180766876283
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS4,Galectin-4,41092,212,1.02 [0.81-1.27],0.8779667724027281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS7_LGALS7B,Galectin-7,41058,208,1.29 [0.98-1.70],0.0726922595481273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS8,Galectin-8,41490,211,0.97 [0.79-1.18],0.7325933270828597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS9,Galectin-9,41105,212,1.31 [0.89-1.94],0.173551808393729
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGMN,Legumain,41291,212,1.01 [0.72-1.41],0.9629672317721232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LHB,Lutropin subunit beta,40196,207,0.98 [0.85-1.13],0.8282089218914945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,41153,212,1.15 [0.94-1.40],0.1757058944244657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LIF,Leukemia inhibitory factor,40166,203,0.92 [0.71-1.19],0.5075441973441901
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LIFR,Leukemia inhibitory factor receptor,41085,214,1.21 [0.73-2.01],0.4655558217415211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,41134,210,1.22 [0.86-1.74],0.2698999534082048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,35767,181,1.11 [0.98-1.27],0.096140687638452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,34635,172,1.03 [0.77-1.36],0.8634768877428196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,41074,212,1.12 [0.77-1.64],0.5564823254639168
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,35759,178,1.01 [0.83-1.23],0.9056363382123316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41624,209,1.32 [0.84-2.07],0.2280688946080689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41427,209,1.33 [0.92-1.91],0.1273384742498425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40393,209,1.30 [0.99-1.72],0.0621089699324499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,41624,209,1.02 [0.85-1.21],0.8643101117847516
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LIPF,Gastric triacylglycerol lipase,34811,171,0.90 [0.70-1.15],0.3940200751323041
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMNB1,Lamin-B1,35538,179,1.12 [0.91-1.38],0.2757767850689019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMNB2,Lamin-B2,35691,178,1.33 [0.80-2.19],0.2694678126650252
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMOD1,Leiomodin-1,35709,180,0.96 [0.62-1.47],0.8356947763130983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMOD2,Leiomodin-2,34664,171,0.91 [0.71-1.17],0.4622165823206052
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LONP1,"Lon protease homolog, mitochondrial",34811,171,0.93 [0.78-1.11],0.4058033871701636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPA,Apolipoprotein(a),34964,174,0.99 [0.92-1.08],0.8912681483144425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40934,210,1.21 [0.98-1.50],0.0835769162358035
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPL,Lipoprotein lipase,41128,212,0.88 [0.68-1.13],0.3125376631174703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPO,Lactoperoxidase,39778,201,1.00 [0.81-1.24],0.9976183021390485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPP,Lipoma-preferred partner,34635,172,0.99 [0.79-1.24],0.916427770129033
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,34635,172,1.03 [0.83-1.28],0.7548084403482234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,34803,173,1.15 [0.87-1.52],0.3212918323690335
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRG1,Leucine-rich alpha-2-glycoprotein,35814,180,1.05 [0.61-1.81],0.8610925655580529
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,41380,211,1.21 [0.85-1.72],0.2936166753650462
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,34607,174,0.79 [0.45-1.39],0.4112559488996474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP1,Prolow-density lipoprotein receptor-related protein 1,40934,210,0.91 [0.57-1.45],0.6846340430396864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP11,Low-density lipoprotein receptor-related protein 11,41128,212,1.32 [0.94-1.85],0.1053305601602613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP2,Low-density lipoprotein receptor-related protein 2,34803,173,0.86 [0.57-1.31],0.4880295487450542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP2BP,LRP2-binding protein,34803,173,0.96 [0.80-1.15],0.6468490335771423
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,41490,211,0.92 [0.73-1.15],0.4606381556327107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC25,Leucine-rich repeat-containing protein 25,40934,210,1.25 [0.92-1.70],0.1562761254364645
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC37A2,Leucine-rich repeat-containing protein 37A2,35608,179,1.29 [0.93-1.79],0.1337594342428925
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC38,Leucine-rich repeat-containing protein 38,34803,173,0.78 [0.56-1.08],0.1347922190626204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC59,Leucine-rich repeat-containing protein 59,35759,178,1.05 [0.78-1.42],0.7318807252341104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,35598,179,1.25 [0.94-1.65],0.1196065346888696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRN1,Leucine-rich repeat neuronal protein 1,40393,209,1.05 [0.77-1.44],0.7515385271166135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,34803,173,0.86 [0.58-1.25],0.4224082079277277
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,35709,180,1.08 [0.63-1.86],0.7792233498944185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LSM1,U6 snRNA-associated Sm-like protein LSm1,40196,207,1.11 [0.91-1.37],0.3088906625767835
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LSM8,U6 snRNA-associated Sm-like protein LSm8,35099,171,1.01 [0.86-1.20],0.8722046480639774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LSP1,Lymphocyte-specific protein 1,41085,214,0.90 [0.67-1.23],0.5139229911979162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTA,Lymphotoxin-alpha,41085,214,1.20 [0.89-1.63],0.2294454991501712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTA4H,Leukotriene A-4 hydrolase,41501,211,1.08 [0.88-1.33],0.4444759366758308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTB,Lymphotoxin-beta,35598,179,1.26 [0.90-1.78],0.1819251345819064
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTBP2,Latent-transforming growth factor beta-binding protein 2,41624,209,1.20 [0.80-1.79],0.3825420653591951
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTBP3,Latent-transforming growth factor beta-binding protein 3,40196,207,1.26 [1.03-1.55],0.0245936051877481
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTBR,Tumor necrosis factor receptor superfamily member 3,40898,212,1.65 [1.09-2.49],0.0179063228103442
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTO1,Protein LTO1 homolog,40393,209,1.24 [0.96-1.60],0.0996289804067963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LUZP2,Leucine zipper protein 2,35598,179,1.19 [0.89-1.61],0.24478986451589
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LXN,Latexin,40640,208,1.19 [1.01-1.41],0.0371858256053947
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY6D,Lymphocyte antigen 6D,40904,211,1.39 [1.03-1.89],0.0336750507625133
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY75,Lymphocyte antigen 75,41085,214,1.19 [0.86-1.64],0.2856300361817787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY9,T-lymphocyte surface antigen Ly-9,40678,208,1.45 [0.95-2.23],0.0844687508940296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY96,Lymphocyte antigen 96,40826,208,1.16 [0.83-1.62],0.3896157219706653
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYAR,Cell growth-regulating nucleolar protein,40196,207,1.22 [1.03-1.45],0.0227397746888742
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYN,Tyrosine-protein kinase Lyn,40934,210,0.94 [0.82-1.09],0.4281078461681616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPD1,Ly6/PLAUR domain-containing protein 1,40166,203,0.90 [0.72-1.12],0.3435908783816798
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPD3,Ly6/PLAUR domain-containing protein 3,40909,208,1.06 [0.73-1.54],0.7530309689431918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPD8,Ly6/PLAUR domain-containing protein 8,40196,207,0.96 [0.74-1.25],0.7782255871018966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPLA2,Acyl-protein thioesterase 2,34664,171,1.03 [0.90-1.18],0.6388211779207347
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,34803,173,1.08 [0.95-1.23],0.2378563513325012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,35814,180,1.05 [0.50-2.17],0.9019586580507696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYZL2,Lysozyme-like protein 2,34510,172,1.26 [0.87-1.82],0.2135126734283354
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LZTFL1,Leucine zipper transcription factor-like protein 1,34994,173,0.96 [0.78-1.19],0.7280452137915038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,M6PR,Cation-dependent mannose-6-phosphate receptor,34811,171,0.93 [0.63-1.38],0.7239337272085616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40683,206,1.22 [1.00-1.50],0.0519805202097491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAEA,E3 ubiquitin-protein transferase MAEA,40196,207,1.20 [0.90-1.61],0.20706688891597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAG,Myelin-associated glycoprotein,34803,173,1.14 [0.84-1.54],0.4105018326106512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAGEA3,Melanoma-associated antigen 3,35099,171,0.90 [0.77-1.05],0.1956413992218158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAGED1,Melanoma-associated antigen D1,40196,207,0.89 [0.68-1.16],0.3875434733211275
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAMDC2,MAM domain-containing protein 2,35759,178,1.79 [1.20-2.67],0.0041416343502014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAMDC4,Apical endosomal glycoprotein,35598,179,0.87 [0.67-1.13],0.2959035748770904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",34811,171,1.47 [0.82-2.63],0.1997365344748172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAN2B2,Epididymis-specific alpha-mannosidase,35759,178,1.12 [0.88-1.43],0.3489216318059912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",34510,172,1.09 [0.82-1.45],0.5695667063677587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANF,Mesencephalic astrocyte-derived neurotrophic factor,41291,212,0.94 [0.85-1.04],0.2089668505838371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANSC1,MANSC domain-containing protein 1,41240,212,1.31 [0.84-2.04],0.2273092563294504
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANSC4,MANSC domain-containing protein 4,34635,172,0.90 [0.72-1.12],0.3534320124286498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,34664,171,0.78 [0.49-1.24],0.2915594113086213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,34635,172,1.11 [0.92-1.34],0.2902594231301899
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP2,Microtubule-associated protein 2,35691,178,1.31 [0.98-1.74],0.0667143970989695
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,35608,179,1.10 [0.88-1.38],0.3945030685193562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,41085,214,0.95 [0.84-1.07],0.3598124945592968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,40196,207,1.02 [0.90-1.16],0.7058911595045576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40750,208,0.96 [0.86-1.08],0.5203125673813387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPK13,Mitogen-activated protein kinase 13,34510,172,1.35 [1.04-1.75],0.0223312905504247
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPK9,Mitogen-activated protein kinase 9,41085,214,1.03 [0.78-1.37],0.8327843128259822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPKAPK2,MAP kinase-activated protein kinase 2,35099,171,1.02 [0.84-1.25],0.8158817120894181
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPRE3,Microtubule-associated protein RP/EB family member 3,34510,172,1.03 [0.93-1.13],0.5909054123647559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPT,Microtubule-associated protein tau,40166,203,1.06 [0.83-1.34],0.6527175128144262
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MARCO,Macrophage receptor MARCO,41128,212,0.89 [0.55-1.42],0.6135405387505561
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MARS1,"Methionine--tRNA ligase, cytoplasmic",34924,173,1.01 [0.85-1.20],0.9075631375241936
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MASP1,Mannan-binding lectin serine protease 1,40750,208,1.61 [0.94-2.75],0.0819601118500887
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MATN2,Matrilin-2,41164,212,1.02 [0.67-1.55],0.9333800864447396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MATN3,Matrilin-3,40754,205,1.30 [0.89-1.89],0.1688578571434494
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAVS,Mitochondrial antiviral-signaling protein,40196,207,1.00 [0.87-1.15],0.9905454899089312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAX,Protein max,40166,203,0.94 [0.83-1.06],0.2916808324711297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MB,Myoglobin,41624,209,1.39 [1.13-1.70],0.0017106701837011
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MBL2,Mannose-binding protein C,35310,177,1.09 [0.95-1.24],0.2327475636966093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCAM,Cell surface glycoprotein MUC18,41278,211,1.36 [0.94-1.96],0.0991590152597787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",35709,180,1.23 [0.91-1.66],0.1766783659854832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCEMP1,Mast cell-expressed membrane protein 1,34730,174,0.93 [0.79-1.10],0.3929899152362904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCFD2,Multiple coagulation factor deficiency protein 2,40931,209,1.00 [0.75-1.32],0.9853287862397628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCTS1,Malignant T-cell-amplified sequence 1,35608,179,0.65 [0.35-1.20],0.1652842312515746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40826,208,0.89 [0.75-1.06],0.2061710522950176
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDH1,"Malate dehydrogenase, cytoplasmic",35581,179,1.25 [0.89-1.76],0.2005094415594764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDK,Midkine,41116,210,1.07 [0.85-1.35],0.5874711572281932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDM1,Nuclear protein MDM1,34803,173,0.72 [0.44-1.18],0.1915970223869457
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",34811,171,0.91 [0.77-1.08],0.2755531982599938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MED18,Mediator of RNA polymerase II transcription subunit 18,40196,207,0.94 [0.80-1.10],0.448849297624399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MED21,Mediator of RNA polymerase II transcription subunit 21,34635,172,0.95 [0.70-1.30],0.7478852031930852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEGF10,Multiple epidermal growth factor-like domains protein 10,41092,212,1.05 [0.77-1.43],0.7778672317592803
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEGF11,Multiple epidermal growth factor-like domains protein 11,34635,172,0.55 [0.32-0.95],0.0323137160758213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEGF9,Multiple epidermal growth factor-like domains protein 9,41496,209,1.88 [1.05-3.35],0.032542836002773
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MELTF,Melanotransferrin,35759,178,1.20 [0.74-1.95],0.4551826617997331
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MENT,Protein MENT,34994,173,0.75 [0.39-1.41],0.3676375272247417
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEP1A,Meprin A subunit alpha,35608,179,0.98 [0.80-1.20],0.8597673332050901
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEP1B,Meprin A subunit beta,41128,212,0.95 [0.85-1.05],0.2777729902110566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEPE,Matrix extracellular phosphoglycoprotein,41092,212,0.79 [0.49-1.28],0.3427972102955104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MERTK,Tyrosine-protein kinase Mer,41597,213,1.34 [0.82-2.17],0.2421643055524552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MESD,LRP chaperone MESD,41134,210,0.95 [0.86-1.05],0.2938941843519274
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MET,Hepatocyte growth factor receptor,41227,208,0.95 [0.51-1.76],0.8604320678177132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,METAP1,Methionine aminopeptidase 1,40166,203,0.85 [0.55-1.31],0.4495496443448101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",41085,214,0.92 [0.79-1.07],0.2622637776939638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,METAP2,Methionine aminopeptidase 2,41439,211,0.94 [0.76-1.16],0.5773555152304806
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP3,Microfibril-associated glycoprotein 3,40395,204,1.00 [0.77-1.29],0.9914202207226702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP3L,Microfibrillar-associated protein 3-like,34803,173,0.86 [0.67-1.11],0.260275357430625
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP4,Microfibril-associated glycoprotein 4,34994,173,1.37 [0.86-2.16],0.1838233567701558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP5,Microfibrillar-associated protein 5,41624,209,1.44 [1.06-1.96],0.0209012190610747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFGE8,Lactadherin,41134,210,1.13 [0.86-1.50],0.3831758532776326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MGLL,Monoglyceride lipase,41231,212,0.90 [0.79-1.03],0.1199647095413432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MGMT,Methylated-DNA--protein-cysteine methyltransferase,41085,214,0.93 [0.85-1.03],0.1452631392320192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MIA,Melanoma-derived growth regulatory protein,41240,212,1.18 [0.85-1.63],0.3202330897208182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MICALL2,MICAL-like protein 2,34803,173,1.10 [0.90-1.35],0.3501311934243412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,41085,214,1.01 [0.93-1.09],0.8858869381460277
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MIF,Macrophage migration inhibitory factor,41068,209,1.01 [0.84-1.21],0.8999223248417272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MILR1,Allergin-1,40393,209,1.02 [0.80-1.31],0.8540892400527614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,35598,179,1.01 [0.89-1.16],0.8494678623554255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MINK1,Misshapen-like kinase 1,35691,178,0.99 [0.85-1.15],0.8841276333919987
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MITD1,MIT domain-containing protein 1,40826,208,0.94 [0.83-1.06],0.300395668287015
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MKI67,Proliferation marker protein Ki-67,34730,174,1.19 [0.87-1.63],0.2657145681825254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MLLT1,Protein ENL,34510,172,0.94 [0.75-1.19],0.611918800265241
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MLN,Promotilin,41085,214,1.09 [0.95-1.25],0.2357870259961548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MME,Neprilysin,40934,210,0.94 [0.81-1.10],0.4569976286900101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP1,Interstitial collagenase,39642,202,1.03 [0.90-1.18],0.6820219267379226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP10,Stromelysin-2,41037,211,0.98 [0.79-1.21],0.8486913580039983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP12,Macrophage metalloelastase,41190,210,1.12 [0.89-1.40],0.345326849576597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP13,Collagenase 3,40166,203,1.16 [0.79-1.71],0.4469977172944904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP15,Matrix metalloproteinase-15,35759,178,1.17 [0.92-1.48],0.2135939897447522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP3,Stromelysin-1,41134,210,1.27 [0.99-1.62],0.0561296371759304
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP7,Matrilysin,40330,204,1.25 [0.96-1.63],0.0938516887754465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP8,Neutrophil collagenase,41420,211,1.15 [0.98-1.36],0.0894431032240759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP9,Matrix metalloproteinase-9,41073,210,1.12 [0.92-1.37],0.2678446005055474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",34635,172,0.98 [0.73-1.32],0.893314748739815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MN1,Transcriptional activator MN1,34803,173,1.07 [0.85-1.36],0.5603576511212581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MNAT1,CDK-activating kinase assembly factor MAT1,35099,171,1.16 [0.86-1.57],0.3204239970104694
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MNDA,Myeloid cell nuclear differentiation antigen,41063,211,1.07 [0.95-1.19],0.2593445437356173
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MOCS2,Molybdopterin synthase catalytic subunit,34994,173,1.02 [0.81-1.27],0.8918002481881224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MOG,Myelin-oligodendrocyte glycoprotein,41501,211,1.18 [0.82-1.72],0.3719634754720872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORC3,MORC family CW-type zinc finger protein 3,35691,178,1.27 [0.80-2.00],0.3069591979889257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORF4L1,Mortality factor 4-like protein 1,35099,171,0.95 [0.66-1.39],0.8053597568925988
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORF4L2,Mortality factor 4-like protein 2,34510,172,1.28 [0.91-1.79],0.1549905355302115
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORN4,MORN repeat-containing protein 4,34510,172,0.93 [0.76-1.14],0.4723569940461233
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPHOSPH8,M-phase phosphoprotein 8,40395,204,1.01 [0.86-1.19],0.8817358816633563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPI,Mannose-6-phosphate isomerase,40934,210,0.95 [0.82-1.10],0.4808053900830846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,41231,212,0.90 [0.77-1.04],0.1629788942801943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPO,Myeloperoxidase,41134,210,1.08 [0.84-1.40],0.5383557217963753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPRIP,Myosin phosphatase Rho-interacting protein,35528,179,0.81 [0.58-1.14],0.2235365383883675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRC1,Macrophage mannose receptor 1,35784,179,1.16 [0.70-1.93],0.5583957133655681
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRI1,Methylthioribose-1-phosphate isomerase,34803,173,1.06 [0.85-1.32],0.6057435943614915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL24,"39S ribosomal protein L24, mitochondrial",34635,172,0.84 [0.55-1.28],0.4040246317790372
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL28,"39S ribosomal protein L28, mitochondrial",35709,180,1.01 [0.69-1.47],0.9575143006604728
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL46,"39S ribosomal protein L46, mitochondrial",40166,203,0.88 [0.55-1.41],0.5934556590340667
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL52,"39S ribosomal protein L52, mitochondrial",34444,172,0.94 [0.53-1.67],0.8404708401329459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",35709,180,0.88 [0.71-1.10],0.269651482807657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPS16,"28S ribosomal protein S16, mitochondrial",34730,174,0.85 [0.49-1.47],0.5621983786287501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSLN,Mesothelin,40873,210,1.10 [0.89-1.35],0.3685267039575264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSLNL,Mesothelin-like protein,34803,173,0.71 [0.47-1.09],0.1158286580558467
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSMB,Beta-microseminoprotein,41018,208,1.22 [1.02-1.46],0.0281895883636388
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSR1,Macrophage scavenger receptor types I and II,41490,211,0.97 [0.74-1.26],0.8147625560455272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSRA,Mitochondrial peptide methionine sulfoxide reductase,41240,212,0.94 [0.80-1.12],0.5020257588727641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MST1,Hepatocyte growth factor-like protein,35242,176,0.96 [0.78-1.17],0.6635147792494386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSTN,Growth/differentiation factor 8,40395,204,1.23 [0.97-1.55],0.0881235668704217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTDH,Protein LYRIC,34730,174,0.93 [0.79-1.09],0.3418576461677636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",35691,178,1.11 [0.64-1.92],0.7149039820959076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,35099,171,1.01 [0.89-1.15],0.8804657454774933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTIF3,"Translation initiation factor IF-3, mitochondrial",35608,179,0.88 [0.75-1.04],0.132029392116204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTPN,Myotrophin,40395,204,0.98 [0.67-1.44],0.906539415033242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTR,Methionine synthase,34635,172,1.00 [0.80-1.25],0.9942250992714892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTSS1,Protein MTSS 1,35608,179,1.05 [0.93-1.20],0.4346773177305013
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTSS2,Protein MTSS 2,35598,179,0.93 [0.80-1.07],0.2950860720147153
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTUS1,Microtubule-associated tumor suppressor 1,35099,171,1.18 [0.93-1.51],0.1792414331963617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUC13,Mucin-13,40166,203,1.08 [0.84-1.38],0.5425804167180842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUC16,Mucin-16,40934,210,1.00 [0.94-1.07],0.9849460955118244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUC2,Mucin-2,35767,181,0.96 [0.82-1.12],0.588413414136413
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUCL3,Mucin-like protein 3,34510,172,0.94 [0.66-1.34],0.7391812196501566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MVK,Mevalonate kinase,40393,209,0.94 [0.80-1.10],0.4486429162838246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MXRA8,Matrix remodeling-associated protein 8,34994,173,1.09 [0.68-1.77],0.7145536835361587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYBPC1,"Myosin-binding protein C, slow-type",35759,178,1.23 [1.02-1.48],0.0299504369218932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYBPC2,"Myosin-binding protein C, fast-type",34811,171,1.03 [0.87-1.23],0.6903497724975057
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,35709,180,1.10 [0.89-1.35],0.372263742242884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYDGF,Myeloid-derived growth factor,35759,178,0.95 [0.83-1.10],0.5317309201072036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYH4,Myosin-4,34635,172,1.04 [0.76-1.43],0.7958374970676014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYH7B,Myosin-7B,34510,172,1.15 [0.85-1.55],0.3606331075661785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYH9,Myosin-9,35767,181,1.01 [0.89-1.15],0.8392117223945386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",34635,172,1.35 [1.00-1.81],0.0488886978230135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL3,Myosin light chain 3,34811,171,1.17 [0.96-1.43],0.113757744779802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL4,Myosin light chain 4,34811,171,1.22 [0.95-1.57],0.1154953875933998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL6B,Myosin light chain 6B,34803,173,1.03 [0.88-1.20],0.7395176687306365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",34803,173,1.15 [0.88-1.51],0.2983443224011843
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYO6,Unconventional myosin-VI,35709,180,1.49 [1.15-1.94],0.0027725405317827
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYO9B,Unconventional myosin-IXb,40393,209,1.06 [0.88-1.27],0.5615257348760236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOC,Myocilin,41134,210,1.15 [0.87-1.51],0.328232822500231
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOM1,Myomesin-1,34664,171,1.33 [1.06-1.66],0.0143480042509398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOM2,Myomesin-2,34635,172,0.99 [0.74-1.33],0.9706078003189396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOM3,Myomesin-3,34994,173,1.10 [0.94-1.29],0.2324223203586868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MZB1,Marginal zone B- and B1-cell-specific protein,41224,212,1.21 [0.96-1.53],0.1104272434213906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MZT1,Mitotic-spindle organizing protein 1,40196,207,1.15 [0.91-1.44],0.2415269058996469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAA10,N-alpha-acetyltransferase 10,34635,172,0.92 [0.69-1.24],0.5947345846968196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAA80,N-alpha-acetyltransferase 80,34803,173,0.99 [0.88-1.12],0.8847695774358457
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40639,206,1.15 [0.94-1.41],0.1670827663832639
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NACC1,Nucleus accumbens-associated protein 1,35598,179,1.01 [0.78-1.31],0.9393523220355416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NADK,NAD kinase,41128,212,1.07 [0.87-1.32],0.5105733569462669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAGA,Alpha-N-acetylgalactosaminidase,34664,174,1.04 [0.81-1.32],0.7666272101787752
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAGK,N-acetyl-D-glucosamine kinase,34745,170,1.18 [0.92-1.53],0.1969450088370712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,34994,173,0.93 [0.47-1.84],0.8321492961420136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAMPT,Nicotinamide phosphoribosyltransferase,40196,207,1.09 [0.89-1.35],0.3927451979247733
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAP1L4,Nucleosome assembly protein 1-like 4,35542,179,1.18 [0.83-1.67],0.3644404931080119
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAPRT,Nicotinate phosphoribosyltransferase,35691,178,1.01 [0.66-1.55],0.9635642716562872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NARS1,"Asparagine--tRNA ligase, cytoplasmic",35709,180,0.93 [0.69-1.25],0.630828451777097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NBL1,Neuroblastoma suppressor of tumorigenicity 1,41240,212,1.63 [1.04-2.56],0.0345254706550323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NBN,Nibrin,40393,209,1.10 [0.89-1.35],0.3749686969944941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCAM1,Neural cell adhesion molecule 1,41278,211,1.17 [0.79-1.74],0.4219714098473488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCAM2,Neural cell adhesion molecule 2,41134,210,0.88 [0.56-1.38],0.5666683978785539
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCAN,Neurocan core protein,41490,211,0.95 [0.68-1.31],0.7358997837206478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCF2,Neutrophil cytosol factor 2,41018,214,1.04 [0.91-1.20],0.5521358062994735
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCK2,Cytoplasmic protein NCK2,41291,212,0.94 [0.84-1.05],0.289449682997082
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCLN,Nicalin,40393,209,1.02 [0.81-1.29],0.8735413124156632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCR1,Natural cytotoxicity triggering receptor 1,41025,212,0.93 [0.66-1.30],0.6652294386211894
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,35608,179,1.16 [0.76-1.78],0.4899984787021443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCS1,Neuronal calcium sensor 1,41501,211,1.16 [0.75-1.79],0.5024876008918671
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDRG1,Protein NDRG1,40166,203,0.96 [0.79-1.17],0.7184012231101802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,35598,179,0.99 [0.79-1.25],0.9608295746265002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,34667,174,1.47 [0.99-2.17],0.055103262477678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,35608,179,0.92 [0.78-1.08],0.2928307941851016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",40196,207,0.93 [0.79-1.11],0.4348400458369678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEB,Nebulin,34635,172,1.25 [0.89-1.75],0.1904072450850015
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECAP2,Adaptin ear-binding coat-associated protein 2,34635,172,0.99 [0.79-1.23],0.911319595667399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECTIN1,Nectin-1,34730,174,1.04 [0.67-1.60],0.8768006956386933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECTIN2,Nectin-2,41074,212,1.50 [1.00-2.25],0.0489467654128995
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECTIN4,Nectin-4,41240,212,1.68 [1.17-2.41],0.0050965620591325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,34730,174,1.00 [0.74-1.36],0.9851475122617278
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEDD9,Enhancer of filamentation 1,34730,174,0.91 [0.58-1.41],0.6717308379206552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEFL,Neurofilament light polypeptide,40035,203,1.12 [0.85-1.49],0.4160066225815585
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEK7,Serine/threonine-protein kinase Nek7,35099,171,1.01 [0.83-1.22],0.9445233717580442
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NELL1,Protein kinase C-binding protein NELL1,41240,212,0.96 [0.71-1.28],0.7715315272143053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NELL2,Protein kinase C-binding protein NELL2,41291,212,0.99 [0.65-1.52],0.9709725484057126
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NENF,Neudesin,35598,179,1.02 [0.91-1.15],0.7187227462728151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEO1,Neogenin,35709,180,1.14 [0.61-2.12],0.6816769333960881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEXN,Nexilin,35784,179,1.11 [0.90-1.36],0.3394772581982308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFASC,Neurofascin,41597,213,0.88 [0.56-1.36],0.5568008030844457
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFAT5,Nuclear factor of activated T-cells 5,34730,174,1.15 [0.98-1.35],0.0964111070935066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",41085,214,0.96 [0.84-1.08],0.4871441622488734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40393,209,0.90 [0.73-1.12],0.3508502417516551
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFE2,Transcription factor NF-E2 45 kDa subunit,34811,171,1.13 [0.93-1.38],0.2183313007092501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFIC,Nuclear factor 1 C-type,35709,180,1.19 [0.94-1.52],0.1545817222310336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFKB1,Nuclear factor NF-kappa-B p105 subunit,34635,172,0.98 [0.80-1.19],0.8107163079510525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFKB2,Nuclear factor NF-kappa-B p100 subunit,35099,171,1.12 [0.89-1.40],0.339007980728724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFKBIE,NF-kappa-B inhibitor epsilon,40196,207,1.07 [0.83-1.38],0.5917676221690236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",35608,179,0.95 [0.82-1.09],0.4514726197007224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFX1,Transcriptional repressor NF-X1,34635,172,0.92 [0.73-1.15],0.4609746443499463
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFYA,Nuclear transcription factor Y subunit alpha,34635,172,1.02 [0.71-1.46],0.9324907354683564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NGF,Beta-nerve growth factor,40826,208,1.06 [0.39-2.87],0.9032878422005404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NGFR,Tumor necrosis factor receptor superfamily member 16,35759,178,1.36 [0.91-2.04],0.135603928657158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NGRN,Neugrin,35691,178,1.04 [0.55-1.98],0.8991850115076248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NHLRC3,NHL repeat-containing protein 3,34147,170,1.15 [0.71-1.87],0.5611728459444298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NID1,Nidogen-1,41147,211,0.95 [0.69-1.31],0.7575361177017508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NID2,Nidogen-2,41134,210,0.91 [0.78-1.08],0.2836732932717599
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NINJ1,Ninjurin-1,40196,207,1.01 [0.81-1.27],0.9075563818216804
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NIT1,Deaminated glutathione amidase,34811,171,1.05 [0.77-1.45],0.7428069961265267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NIT2,Omega-amidase NIT2,35630,178,0.98 [0.80-1.19],0.8174297095137598
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NLGN1,Neuroligin-1,34803,173,0.87 [0.68-1.12],0.2734857572084215
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NLGN2,Neuroligin-2,34664,171,1.06 [0.79-1.42],0.7071514310562919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NME1,Nucleoside diphosphate kinase A,34730,174,2.01 [1.12-3.62],0.0191591547955857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NME3,Nucleoside diphosphate kinase 3,41164,212,0.97 [0.57-1.65],0.922875255689489
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMI,N-myc-interactor,35461,179,0.98 [0.80-1.19],0.8167241928136907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40826,208,1.12 [0.97-1.30],0.1218638576255822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMRK2,Nicotinamide riboside kinase 2,34510,172,0.76 [0.50-1.18],0.2217164897561003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,35709,180,0.97 [0.78-1.21],0.804015751646697
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOMO1,Nodal modulator 1,41134,210,1.47 [0.87-2.47],0.1483401510964326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOP56,Nucleolar protein 56,34635,172,1.07 [0.95-1.21],0.2515010753164192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOS1,"Nitric oxide synthase, brain",40166,203,1.27 [1.02-1.58],0.0340679354053453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOS2,"Nitric oxide synthase, inducible",34635,172,1.16 [0.82-1.66],0.4008390714282641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOS3,"Nitric oxide synthase, endothelial",40166,203,1.17 [0.94-1.46],0.1672666484477798
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOTCH1,Neurogenic locus notch homolog protein 1,41624,209,1.47 [0.67-3.21],0.3314649598664337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOTCH2,Neurogenic locus notch homolog protein 2,35767,181,0.98 [0.49-1.96],0.9498691533109892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOTCH3,Neurogenic locus notch homolog protein 3,41624,209,1.38 [0.95-1.99],0.0880208461498393
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPC2,NPC intracellular cholesterol transporter 2,35168,178,1.19 [0.76-1.88],0.4511917565408648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPDC1,Neural proliferation differentiation and control protein 1,41128,212,1.30 [0.89-1.91],0.1712600747229453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPHS1,Nephrin,34730,174,0.73 [0.46-1.15],0.1776862974525008
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPHS2,Podocin,34730,174,1.11 [0.98-1.26],0.090910215643362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPL,N-acetylneuraminate lyase,35759,178,1.04 [0.75-1.43],0.814603464760854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPPB,Natriuretic peptides B,40395,204,1.07 [0.98-1.18],0.1485800674188765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPPC,C-type natriuretic peptide,41085,214,0.95 [0.73-1.22],0.6706341636210217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPR1,Atrial natriuretic peptide receptor 1,34635,172,1.09 [0.77-1.54],0.6199371369775442
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTN,Neuroplastin,40196,207,1.00 [0.85-1.17],0.9624021075380066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTX1,Neuronal pentraxin-1,41134,210,0.85 [0.62-1.16],0.3005194561634001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTX2,Neuronal pentraxin-2,35767,181,0.74 [0.48-1.13],0.1653570650293821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTXR,Neuronal pentraxin receptor,41128,212,1.13 [0.80-1.61],0.4846104257465321
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPY,Pro-neuropeptide Y,41501,211,0.92 [0.77-1.11],0.4004440721685014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRCAM,Neuronal cell adhesion molecule,41128,212,1.19 [0.77-1.83],0.4315647855496424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRGN,Neurogranin,35784,179,0.93 [0.80-1.09],0.3987168381946622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRN1,Neuritin,35709,180,1.06 [0.72-1.55],0.7690779290060823
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRP1,Neuropilin-1,41354,211,0.85 [0.54-1.33],0.4776040175888622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRP2,Neuropilin-2,41134,210,1.37 [0.90-2.08],0.1385281768769413
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRTN,Neurturin,40393,209,1.02 [0.80-1.30],0.8881508036455885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRXN3,Neurexin-3,34803,173,0.88 [0.57-1.37],0.5693106781183328
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NSFL1C,NSFL1 cofactor p47,41490,211,1.06 [0.88-1.28],0.5176714353002232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",35759,178,1.02 [0.84-1.24],0.8365581582857072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5C1A,Cytosolic 5'-nucleotidase 1A,35691,178,1.47 [1.02-2.14],0.0408322986614895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5C3A,Cytosolic 5'-nucleotidase 3A,41017,213,0.98 [0.85-1.12],0.757675147224079
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5E,5'-nucleotidase,41240,212,0.90 [0.72-1.13],0.3631311828979877
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTF3,Neurotrophin-3,41085,214,1.12 [0.80-1.58],0.5055886816889938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTF4,Neurotrophin-4,40196,207,1.15 [0.86-1.54],0.3523624685004574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTRK2,BDNF/NT-3 growth factors receptor,41128,212,0.65 [0.40-1.06],0.0856337081958178
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTRK3,NT-3 growth factor receptor,41490,211,1.15 [0.65-2.04],0.6279232398360526
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTproBNP,N-terminal prohormone of brain natriuretic peptide,41128,212,1.22 [1.10-1.36],0.0001868598356761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUB1,NEDD8 ultimate buster 1,41085,214,0.99 [0.86-1.15],0.9119484323769114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,35598,179,1.06 [0.92-1.21],0.4242335572620408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUCB2,Nucleobindin-2,41431,210,0.93 [0.67-1.30],0.6827748630845679
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDC,Nuclear migration protein nudC,41597,213,0.97 [0.80-1.18],0.772428780564631
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,34811,171,1.35 [0.85-2.16],0.2080574508570932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,34635,172,0.78 [0.56-1.10],0.1582962115680342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT16,U8 snoRNA-decapping enzyme,35546,178,0.97 [0.83-1.15],0.7553887318937813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40934,210,1.00 [0.80-1.23],0.9641048383698864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT5,ADP-sugar pyrophosphatase,41134,210,1.13 [0.89-1.44],0.3157623786490626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUMB,Protein numb homolog,34730,174,0.94 [0.79-1.12],0.4977172976168329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUP50,Nuclear pore complex protein Nup50,34635,172,1.32 [0.93-1.87],0.1228292752022079
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NXPE4,NXPE family member 4,34635,172,1.07 [0.70-1.64],0.7505516935739215
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NXPH1,Neurexophilin-1,40166,203,1.04 [0.75-1.43],0.8271615541722752
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NXPH3,Neurexophilin-3,34730,174,1.05 [0.64-1.71],0.8518649428363112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OBP2B,Odorant-binding protein 2b,40694,205,0.96 [0.78-1.19],0.7330886293755521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OCLN,Occludin,35709,180,1.09 [0.78-1.52],0.5990866853208267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ODAM,Odontogenic ameloblast-associated protein,40106,203,0.98 [0.78-1.24],0.8963213342514694
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OFD1,Oral-facial-digital syndrome 1 protein,35099,171,0.94 [0.74-1.19],0.5937356191793708
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGA,Protein O-GlcNAcase,35608,179,0.98 [0.80-1.21],0.8830326943416977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGFR,Opioid growth factor receptor,40934,210,1.02 [0.69-1.49],0.9293591308405642
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGN,Mimecan,41134,210,1.50 [1.12-1.99],0.0057314004261531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,35099,171,0.88 [0.68-1.13],0.3194827525387888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OLFM4,Olfactomedin-4,33677,167,1.06 [0.93-1.20],0.377490077193559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OLR1,Oxidized low-density lipoprotein receptor 1,40727,211,1.09 [0.89-1.33],0.4036546734571434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OMD,Osteomodulin,41291,212,1.07 [0.80-1.44],0.6566045886275158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OMG,Oligodendrocyte-myelin glycoprotein,40934,210,1.09 [0.91-1.30],0.3686240151186452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OMP,Olfactory marker protein,34664,171,1.06 [0.80-1.41],0.6847414958945847
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OPHN1,Oligophrenin-1,35691,178,0.97 [0.85-1.10],0.6189689386684588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OPLAH,5-oxoprolinase,34811,171,1.09 [0.88-1.35],0.4181060809743521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OPTC,Opticin,40934,210,0.99 [0.75-1.30],0.9216539530668628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ORM1,Alpha-1-acid glycoprotein 1,35684,179,1.01 [0.49-2.08],0.9759538486029148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSBPL2,Oxysterol-binding protein-related protein 2,35691,178,1.31 [0.99-1.73],0.0581166149999573
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSCAR,Osteoclast-associated immunoglobulin-like receptor,41164,212,1.45 [1.01-2.08],0.0439444740066574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSM,Oncostatin-M,40888,213,1.07 [0.90-1.28],0.4315830599879626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSMR,Oncostatin-M-specific receptor subunit beta,41354,211,0.74 [0.40-1.37],0.3343537485487858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSTN,Osteocrin,34803,173,1.17 [0.85-1.62],0.3291673450934725
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTOA,Otoancorin,34664,171,1.37 [1.12-1.67],0.0018897879586749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTUD6B,Deubiquitinase OTUD6B,35608,179,1.03 [0.81-1.32],0.8147047073890497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTUD7B,OTU domain-containing protein 7B,35709,180,0.90 [0.71-1.13],0.3664487064343614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",34811,171,1.06 [0.85-1.31],0.605748660367667
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OXT,Oxytocin-neurophysin 1,41490,211,1.12 [1.02-1.21],0.0120331002430602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,P4HB,Protein disulfide-isomerase,40911,209,1.05 [0.76-1.44],0.7697746109567641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PACS2,Phosphofurin acidic cluster sorting protein 2,34635,172,1.07 [0.84-1.36],0.5798757242244409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PADI2,Protein-arginine deiminase type-2,40393,209,1.15 [0.96-1.37],0.1245993235628427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PADI4,Protein-arginine deiminase type-4,40106,203,1.14 [0.99-1.31],0.0690910155016689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAEP,Glycodelin,40826,208,1.02 [0.92-1.14],0.6937622050380103
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,35709,180,1.05 [0.94-1.17],0.4299305448990744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",35099,171,1.17 [0.88-1.54],0.2809327016132926
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40395,204,0.94 [0.75-1.18],0.6037906372295563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAGR1,PAXIP1-associated glutamate-rich protein 1,34811,171,1.11 [0.80-1.54],0.5270183110923493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,34445,172,1.02 [0.77-1.35],0.8846166353278979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAK4,Serine/threonine-protein kinase PAK 4,40166,203,0.98 [0.80-1.21],0.8646818708427317
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALLD,Palladin,34730,174,0.88 [0.59-1.32],0.5285984232242686
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALM,Paralemmin-1,35408,179,1.15 [0.71-1.86],0.5613468827031488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALM2,Paralemmin-2,35691,178,1.01 [0.68-1.50],0.957351075816303
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALM3,Paralemmin-3,34635,172,1.04 [0.86-1.24],0.7116705874155265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAM,Peptidyl-glycine alpha-amidating monooxygenase,41414,209,1.37 [0.87-2.15],0.1705605230908807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAMR1,Inactive serine protease PAMR1,41134,210,0.63 [0.40-0.99],0.0459178900945469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAPPA,Pappalysin-1,40393,209,0.98 [0.76-1.28],0.9061338966476844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PARD3,Partitioning defective 3 homolog,35099,171,0.98 [0.80-1.20],0.8510403210079385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PARK7,Parkinson disease protein 7,41134,210,1.09 [0.86-1.38],0.4587116588791894
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PARP1,Poly [ADP-ribose] polymerase 1,41085,214,1.04 [0.85-1.28],0.685443650183264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAXX,Protein PAXX,34994,173,0.97 [0.70-1.35],0.8630236396231176
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBK,Lymphokine-activated killer T-cell-originated protein kinase,34510,172,1.67 [1.06-2.66],0.0284992511676457
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBLD,Phenazine biosynthesis-like domain-containing protein,40166,203,1.02 [0.80-1.31],0.8726919004313147
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,35608,179,1.24 [0.79-1.95],0.3388936119788097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCARE,Photoreceptor cilium actin regulator,34664,171,1.12 [0.97-1.29],0.1317001484409591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,34920,173,0.93 [0.67-1.29],0.6624386507319142
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCBP2,Poly(rC)-binding protein 2,35709,180,0.99 [0.81-1.21],0.9447327880119624
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH1,Protocadherin-1,41461,212,1.73 [1.08-2.78],0.0228992850102266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH12,Protocadherin-12,35709,180,1.49 [0.87-2.57],0.1484471295537771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH17,Protocadherin-17,41128,212,1.44 [1.03-2.01],0.0313064680851073
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH7,Protocadherin-7,35608,179,1.45 [1.06-1.99],0.0202714080761343
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH9,Protocadherin-9,35608,179,1.14 [0.74-1.74],0.5469320096134112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDHB15,Protocadherin beta-15,35598,179,1.41 [1.02-1.96],0.0385729617594912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCNA,Proliferating cell nuclear antigen,34510,172,0.96 [0.75-1.22],0.7247864921925337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCSK7,Proprotein convertase subtilisin/kexin type 7,35598,179,0.92 [0.67-1.28],0.6311437022665697
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCSK9,Proprotein convertase subtilisin/kexin type 9,41624,209,0.72 [0.53-0.99],0.0414637843428359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCYT2,Ethanolamine-phosphate cytidylyltransferase,35608,179,0.97 [0.80-1.17],0.7638415693869836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDAP1,28 kDa heat- and acid-stable phosphoprotein,35759,178,0.99 [0.85-1.14],0.8522512578380639
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD1,Programmed cell death protein 1,41437,211,0.96 [0.71-1.30],0.8024028705484353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD1LG2,Programmed cell death 1 ligand 2,40934,210,0.99 [0.67-1.47],0.9564188647841552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD5,Programmed cell death protein 5,41490,211,1.03 [0.83-1.26],0.8090949281500744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD6,Programmed cell death protein 6,41128,212,0.95 [0.81-1.12],0.5647088132307734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCL2,Phosducin-like protein 2,34510,172,1.05 [0.80-1.37],0.7195640524416915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",34510,172,0.98 [0.75-1.30],0.9107583532209664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",34635,172,1.05 [0.83-1.32],0.7006475469168512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",34994,173,0.95 [0.83-1.10],0.4981415212227446
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFA,Platelet-derived growth factor subunit A,41624,209,0.86 [0.73-1.02],0.0822585759398899
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFB,Platelet-derived growth factor subunit B,41291,212,0.89 [0.77-1.02],0.0996302780400972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFC,Platelet-derived growth factor C,40196,207,0.83 [0.53-1.30],0.4183575907057824
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFRA,Platelet-derived growth factor receptor alpha,41128,212,1.17 [0.76-1.81],0.4723589541450692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFRB,Platelet-derived growth factor receptor beta,41624,209,1.36 [0.95-1.95],0.0914461722609624
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA2,Protein disulfide-isomerase A2,34510,172,0.99 [0.69-1.42],0.950462736805932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA3,Protein disulfide-isomerase A3,34994,173,0.60 [0.32-1.12],0.1090758839226989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA4,Protein disulfide-isomerase A4,35767,181,0.91 [0.71-1.15],0.4266241658406525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA5,Protein disulfide-isomerase A5,34510,172,0.90 [0.70-1.17],0.4344943981943391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDLIM5,PDZ and LIM domain protein 5,35709,180,0.98 [0.87-1.11],0.7654281306842063
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDLIM7,PDZ and LIM domain protein 7,41291,212,0.98 [0.89-1.08],0.6312821461898217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",40196,207,0.98 [0.76-1.26],0.8758188505691049
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDRG1,p53 and DNA damage-regulated protein 1,34803,173,0.93 [0.69-1.24],0.6164239630572919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,34510,172,1.02 [0.79-1.33],0.8616453544315719
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDZD2,PDZ domain-containing protein 2,34635,172,1.23 [0.98-1.55],0.0719371546182977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,34730,174,0.93 [0.66-1.32],0.6844760774486576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PEAR1,Platelet endothelial aggregation receptor 1,41624,209,1.05 [0.61-1.80],0.8599345076300114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PEBP1,Phosphatidylethanolamine-binding protein 1,41134,210,1.09 [0.89-1.35],0.3995161562947004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PECAM1,Platelet endothelial cell adhesion molecule,41134,210,1.22 [0.82-1.82],0.3315364480826768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PECR,Peroxisomal trans-2-enoyl-CoA reductase,34811,171,1.07 [0.64-1.78],0.7956843335227843
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PENK,Proenkephalin-A,34994,173,1.09 [0.68-1.75],0.7304638094002949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PEPD,Xaa-Pro dipeptidase,35784,179,0.76 [0.44-1.32],0.3303146991064881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PER3,Period circadian protein homolog 3,34730,174,0.92 [0.81-1.04],0.1798965572043099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PF4,Platelet factor 4,35548,178,0.87 [0.75-1.01],0.0750122020668929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFDN2,Prefoldin subunit 2,40166,203,0.99 [0.79-1.24],0.9345887578615992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFDN4,Prefoldin subunit 4,34510,172,1.15 [0.89-1.48],0.2789646279566956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFDN6,Prefoldin subunit 6,34803,173,1.06 [0.86-1.31],0.5849452865963046
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40868,210,0.96 [0.82-1.12],0.5903226314525134
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGA4,Pepsin A-4,35784,179,1.04 [0.86-1.26],0.7128386835589723
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",35759,178,1.03 [0.79-1.34],0.8344838554690666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGF,Placenta growth factor,41597,213,2.06 [1.41-3.01],0.0001970665915479
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP1,Peptidoglycan recognition protein 1,41427,209,1.28 [0.97-1.69],0.0777909369045943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,35358,178,0.80 [0.50-1.28],0.3537038606484434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP4,Peptidoglycan recognition protein 4,34635,172,1.08 [0.85-1.36],0.5328598878711222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGM2,Phosphoglucomutase-2,34803,173,0.85 [0.64-1.14],0.2810415925705886
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGR,Progesterone receptor,34730,174,1.01 [0.88-1.16],0.8697724783106082
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHACTR2,Phosphatase and actin regulator 2,35709,180,0.95 [0.83-1.07],0.3840461450029062
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHLDB1,Pleckstrin homology-like domain family B member 1,35608,179,1.23 [0.94-1.62],0.138330543913298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHLDB2,Pleckstrin homology-like domain family B member 2,34510,172,1.10 [0.96-1.26],0.1885440281432259
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40826,208,1.54 [1.01-2.35],0.0460904694919992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,34994,173,1.02 [0.71-1.45],0.9186047548506864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PI16,Peptidase inhibitor 16,35784,179,1.16 [0.65-2.09],0.610840155810005
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PI3,Elafin,40586,206,1.23 [1.00-1.52],0.0530404920458744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",35709,180,1.10 [0.92-1.31],0.3132184216376225
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIGR,Polymeric immunoglobulin receptor,40619,208,1.01 [0.72-1.43],0.9488780426202268
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,41085,214,0.96 [0.79-1.17],0.6706130997840548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,41134,210,2.03 [1.35-3.06],0.0006814309941387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,34730,174,1.06 [0.82-1.36],0.6748603950728186
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PILRA,Paired immunoglobulin-like type 2 receptor alpha,41134,210,1.41 [1.05-1.90],0.0243705682640425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PILRB,Paired immunoglobulin-like type 2 receptor beta,41128,212,1.25 [1.00-1.57],0.0491822870042059
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,34994,173,0.98 [0.80-1.21],0.867086244037844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PITHD1,PITH domain-containing protein 1,34445,172,0.98 [0.81-1.19],0.8679777800257309
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKD1,Polycystin-1,35759,178,1.23 [0.71-2.13],0.4641069147694345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKD2,Polycystin-2,34635,172,1.10 [0.86-1.41],0.4339588689873779
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKLR,Pyruvate kinase PKLR,41163,212,1.13 [0.94-1.35],0.1943059591117372
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKN3,Serine/threonine-protein kinase N3,35099,171,1.01 [0.83-1.22],0.9435624258915029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G10,Group 10 secretory phospholipase A2,40826,208,0.76 [0.62-0.93],0.0086236434503748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G15,Phospholipase A2 group XV,41240,212,1.88 [1.21-2.92],0.0050794174630655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G1B,Phospholipase A2,41560,208,1.06 [0.80-1.41],0.6757740613385508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G2A,"Phospholipase A2, membrane associated",41033,206,1.10 [0.89-1.37],0.3756484726713113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G4A,Cytosolic phospholipase A2,41291,212,0.92 [0.80-1.06],0.2309589181923678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G7,Platelet-activating factor acetylhydrolase,41134,210,1.09 [0.74-1.60],0.6665186686513883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAT,Tissue-type plasminogen activator,41496,209,0.97 [0.76-1.23],0.7846257810001404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAU,Urokinase-type plasminogen activator,41134,210,1.43 [1.02-1.99],0.036633871451933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAUR,Urokinase plasminogen activator surface receptor,40837,212,1.14 [0.73-1.79],0.5688000076778514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLB1,"Phospholipase B1, membrane-associated",35691,178,0.84 [0.67-1.06],0.1496149464586715
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",34730,174,0.90 [0.63-1.29],0.5605786303739817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",35691,178,0.97 [0.84-1.13],0.7192439272440698
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLEKHO1,Pleckstrin homology domain-containing family O member 1,35691,178,0.99 [0.81-1.23],0.9514729386243422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLG,Plasminogen,34900,176,0.70 [0.36-1.36],0.2935818285829704
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLIN1,Perilipin-1,40166,203,1.08 [0.76-1.53],0.6797899893873116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLIN3,Perilipin-3,41128,212,1.09 [0.82-1.44],0.5701151761478254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLPBP,Pyridoxal phosphate homeostasis protein,41128,212,1.04 [0.87-1.24],0.6903334895264891
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLSCR3,Phospholipid scramblase 3,35633,178,1.13 [0.88-1.44],0.3358373076645812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLTP,Phospholipid transfer protein,41479,209,0.93 [0.67-1.31],0.6926507480844146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXDC1,Plexin domain-containing protein 1,40196,207,1.05 [0.73-1.50],0.7979147809457077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXDC2,Plexin domain-containing protein 2,35691,178,0.68 [0.39-1.18],0.16684406628283
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNA4,Plexin-A4,41085,214,0.95 [0.82-1.10],0.510117376525946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNB2,Plexin-B2,41440,209,1.53 [0.92-2.54],0.1024153048385493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNB3,Plexin-B3,40999,210,0.90 [0.70-1.17],0.4467930157975367
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40947,212,1.06 [0.99-1.13],0.1221884110298972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMCH,Pro-MCH,34635,172,0.84 [0.67-1.06],0.1428575557424653
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMM2,Phosphomannomutase 2,34635,172,0.97 [0.75-1.24],0.7959735099252047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMS1,PMS1 protein homolog 1,34803,173,1.00 [0.75-1.33],0.9790077336829988
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMVK,Phosphomevalonate kinase,40099,203,0.97 [0.87-1.09],0.6074334625051673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIP,Pancreatic triacylglycerol lipase,35784,179,0.97 [0.77-1.22],0.7875586627399545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIPRP1,Inactive pancreatic lipase-related protein 1,35691,178,1.11 [0.93-1.34],0.2387926588596497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIPRP2,Pancreatic lipase-related protein 2,41092,212,1.04 [1.00-1.09],0.0539768092643326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNMA1,Paraneoplastic antigen Ma1,34811,171,0.96 [0.74-1.25],0.77166581265577
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNMA2,Paraneoplastic antigen Ma2,34664,171,1.06 [0.77-1.46],0.7067307920576169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40393,209,0.97 [0.87-1.08],0.5415295075800949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PODXL,Podocalyxin,40934,210,0.67 [0.30-1.50],0.3337478316527069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PODXL2,Podocalyxin-like protein 2,41240,212,1.70 [1.11-2.61],0.015233380998074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POF1B,Protein POF1B,34730,174,1.30 [0.98-1.73],0.0640509619014995
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POLR2A,DNA-directed RNA polymerase II subunit RPB1,34730,174,0.61 [0.35-1.04],0.0680499973521897
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40934,210,1.09 [0.78-1.53],0.608078597459722
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POMC,Pro-opiomelanocortin,34811,171,1.07 [0.86-1.32],0.5553956386824113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PON1,Serum paraoxonase/arylesterase 1,35784,179,1.12 [0.65-1.94],0.6743850482453777
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PON2,Serum paraoxonase/arylesterase 2,40395,204,0.87 [0.61-1.24],0.4438472492443569
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PON3,Serum paraoxonase/lactonase 3,41291,212,1.05 [0.67-1.64],0.8354054981897774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POSTN,Periostin,35767,181,1.18 [0.81-1.73],0.3819215952421596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPBP,Platelet basic protein,35543,178,0.88 [0.74-1.04],0.1395343159710288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPCDC,Phosphopantothenoylcysteine decarboxylase,41490,211,1.12 [0.86-1.45],0.4057399429201422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPIB,Peptidyl-prolyl cis-trans isomerase B,41145,209,0.93 [0.81-1.05],0.2284323117061893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPIE,Peptidyl-prolyl cis-trans isomerase E,35099,171,1.13 [0.92-1.39],0.2483863349431702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",35767,181,0.89 [0.71-1.13],0.3533563972411492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPL,Periplakin,34730,174,1.24 [0.82-1.87],0.3051202289156253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1A,Protein phosphatase 1A,40196,207,0.81 [0.53-1.24],0.3297329158502673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1B,Protein phosphatase 1B,34730,174,1.10 [0.89-1.35],0.384851220618432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1F,Protein phosphatase 1F,35759,178,0.92 [0.70-1.21],0.5345562869399465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPME1,Protein phosphatase methylesterase 1,40934,210,1.13 [0.92-1.39],0.2288277775661275
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,35598,179,0.96 [0.81-1.15],0.6884462158655336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,41240,212,0.98 [0.86-1.11],0.7692184215930734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,35099,171,0.76 [0.59-0.98],0.0353018179468532
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,35709,180,1.11 [0.93-1.31],0.2451305297730321
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,35709,180,0.92 [0.62-1.34],0.6501976837969861
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R2,Protein phosphatase inhibitor 2,41128,212,0.93 [0.79-1.08],0.3256023641702428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R9B,Neurabin-2,41597,213,0.98 [0.86-1.12],0.7780415054901546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,35608,179,0.99 [0.88-1.12],0.9281556572517692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP3R1,Calcineurin subunit B type 1,40826,208,0.95 [0.70-1.29],0.7384688019974934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPT1,Palmitoyl-protein thioesterase 1,34803,173,0.93 [0.75-1.14],0.47433854141555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPY,Pancreatic prohormone,41049,212,1.03 [0.92-1.16],0.6160803973978115
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PQBP1,Polyglutamine-binding protein 1,40196,207,1.07 [0.88-1.32],0.4867328531466313
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRAME,Melanoma antigen preferentially expressed in tumors,34510,172,1.12 [0.63-2.00],0.7000418544150703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRAP1,Proline-rich acidic protein 1,35767,181,0.99 [0.69-1.42],0.9540537174869422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRC1,Protein regulator of cytokinesis 1,35598,179,0.99 [0.72-1.36],0.9466588749306836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRCP,Lysosomal Pro-X carboxypeptidase,41374,208,0.86 [0.58-1.28],0.468189871516075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX1,Peroxiredoxin-1,39983,202,1.11 [0.97-1.27],0.1389513738824291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX2,Peroxiredoxin-2,35180,174,1.16 [0.93-1.46],0.1832910577557532
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40393,209,0.88 [0.74-1.05],0.1591204947476913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX5,"Peroxiredoxin-5, mitochondrial",41597,213,0.94 [0.79-1.12],0.5025341920847782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX6,Peroxiredoxin-6,41501,211,1.12 [0.92-1.36],0.26413732239273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PREB,Prolactin regulatory element-binding protein,40393,209,1.26 [0.85-1.86],0.2534475852861245
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRELP,Prolargin,41092,212,1.38 [0.80-2.38],0.2441701502560429
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRG2,Bone marrow proteoglycan,35767,181,0.93 [0.70-1.23],0.5902012915681984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRG3,Proteoglycan 3,35767,181,0.80 [0.60-1.07],0.1322757452701405
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40393,209,0.92 [0.73-1.17],0.5037220003914371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,34803,173,1.12 [0.72-1.74],0.605465693036516
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,41128,212,0.92 [0.80-1.07],0.2746381643622411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,35621,178,1.06 [0.88-1.26],0.5465414738731154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKCQ,Protein kinase C theta type,40393,209,1.02 [0.77-1.36],0.8684166677989135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKD2,Serine/threonine-protein kinase D2,34635,172,1.06 [0.78-1.44],0.7201489768715812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKG1,cGMP-dependent protein kinase 1,34994,173,1.00 [0.89-1.13],0.96822784413721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,40196,207,1.01 [0.84-1.21],0.9286121328757322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRL,Prolactin,41490,211,0.99 [0.84-1.17],0.8844163921700284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRND,Prion-like protein doppel,35691,178,1.19 [0.90-1.58],0.2197163898169346
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROC,Vitamin K-dependent protein C,41219,211,0.84 [0.52-1.36],0.4768805857435571
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROCR,Endothelial protein C receptor,34635,172,1.10 [0.75-1.63],0.61483147541458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROK1,Prokineticin-1,41085,214,1.03 [0.83-1.29],0.7609434172272554
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROS1,Vitamin K-dependent protein S,35814,180,0.55 [0.32-0.97],0.0385629908644946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRR4,Proline-rich protein 4,34746,173,1.23 [1.01-1.50],0.043836946357876
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRR5,Proline-rich protein 5,34730,174,1.09 [0.80-1.48],0.5770404624924319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRRT3,Proline-rich transmembrane protein 3,34811,171,0.96 [0.64-1.43],0.8244927237532451
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS2,Trypsin-2,41278,211,1.17 [0.93-1.46],0.1765247648032449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS22,Brain-specific serine protease 4,34730,174,1.53 [1.13-2.07],0.0064217261134078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS27,Serine protease 27,41001,212,0.91 [0.67-1.24],0.5600478461002636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS53,Serine protease 53,35691,178,0.88 [0.59-1.29],0.5083254611400558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS8,Prostasin,40965,212,1.14 [0.85-1.54],0.3846927446767014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,40166,203,1.00 [0.89-1.11],0.9492461031142904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRTG,Protogenin,41501,211,1.03 [0.63-1.69],0.9035781233251132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRTN3,Myeloblastin,40081,205,0.93 [0.72-1.22],0.6149226788707163
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRUNE2,Protein prune homolog 2,35099,171,0.84 [0.50-1.44],0.5346846406907608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSAP,Prosaposin,35437,179,0.96 [0.57-1.62],0.8662063494782045
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSAPL1,Proactivator polypeptide-like 1,35608,179,1.37 [1.03-1.82],0.0284239023235815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSCA,Prostate stem cell antigen,35608,179,1.01 [0.95-1.06],0.8182407538632539
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40826,208,0.98 [0.89-1.09],0.7676996233788083
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSIP1,PC4 and SFRS1-interacting protein,41085,214,1.00 [0.83-1.21],0.9939727830450078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMA1,Proteasome subunit alpha type-1,40196,207,0.76 [0.57-1.02],0.0701069403894616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMC3,26S proteasome regulatory subunit 6A,34510,172,0.77 [0.47-1.26],0.3017321110832809
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD1,26S proteasome non-ATPase regulatory subunit 1,35709,180,1.13 [0.86-1.48],0.3932789347061818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD5,26S proteasome non-ATPase regulatory subunit 5,34803,173,1.07 [0.83-1.38],0.5937445203631839
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40934,210,1.17 [0.95-1.44],0.1382342446559648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSME1,Proteasome activator complex subunit 1,40766,208,1.08 [0.78-1.50],0.6398108176252224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSME2,Proteasome activator complex subunit 2,40639,208,1.23 [0.88-1.72],0.2229065800170735
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMG3,Proteasome assembly chaperone 3,41085,214,1.04 [0.82-1.32],0.7255237163897743
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMG4,Proteasome assembly chaperone 4,34730,174,1.10 [0.86-1.41],0.4620084132329303
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSPN,Persephin,41085,214,1.10 [0.97-1.25],0.15180557209673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSRC1,Proline/serine-rich coiled-coil protein 1,40196,207,1.08 [0.88-1.33],0.439972323003188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,33743,163,0.96 [0.83-1.10],0.5712139427772299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",40166,203,0.88 [0.58-1.34],0.562112139458363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTGDS,Prostaglandin-H2 D-isomerase,40821,209,1.54 [1.05-2.26],0.0259921183648002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTGES2,Prostaglandin E synthase 2,34464,171,1.01 [0.77-1.32],0.9514896874190232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTGR1,Prostaglandin reductase 1,35759,178,0.88 [0.74-1.05],0.1690679310439908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTH,Parathyroid hormone,34803,173,1.06 [0.88-1.27],0.5654597221273718
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,41085,214,1.20 [0.92-1.56],0.1864067019430757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTK7,Inactive tyrosine-protein kinase 7,40166,203,0.89 [0.64-1.24],0.4756189381308182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTN,Pleiotrophin,40395,204,1.23 [0.96-1.58],0.0939141248213212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTP4A3,Protein tyrosine phosphatase type IVA 3,34730,174,0.86 [0.63-1.16],0.3137377286702182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40826,208,1.02 [0.88-1.20],0.7688221366445985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,41231,212,0.92 [0.81-1.05],0.1980422209426475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,34666,174,0.89 [0.59-1.33],0.5623185604984968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRB,Receptor-type tyrosine-protein phosphatase beta,35759,178,0.64 [0.39-1.04],0.0719874743094522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRC,Receptor-type tyrosine-protein phosphatase C,35767,181,0.93 [0.49-1.77],0.8272117127885237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRF,Receptor-type tyrosine-protein phosphatase F,41624,209,1.19 [0.77-1.82],0.4308894945751066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRH,Receptor-type tyrosine-protein phosphatase H,35608,179,1.07 [0.79-1.43],0.6677209616903669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,35608,179,0.87 [0.44-1.72],0.685497277994721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRM,Receptor-type tyrosine-protein phosphatase mu,41016,214,1.02 [0.61-1.68],0.9503257489145398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40684,206,1.12 [0.76-1.64],0.5757955415847626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRR,Receptor-type tyrosine-protein phosphatase R,35691,178,0.95 [0.64-1.42],0.8138848669895029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRS,Receptor-type tyrosine-protein phosphatase S,41624,209,1.11 [0.68-1.82],0.6868006406651257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,35759,178,1.01 [0.65-1.59],0.9486181709149588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,34994,173,1.06 [0.83-1.36],0.6268148018149318
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39983,203,1.14 [0.91-1.42],0.2634130764594665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTTG1,Securin,35099,171,0.95 [0.66-1.36],0.7739920113953704
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTX3,Pentraxin-related protein PTX3,41085,214,0.87 [0.69-1.10],0.2451036083632957
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PVALB,Parvalbumin alpha,41313,210,0.96 [0.86-1.06],0.4109430645414641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PVR,Poliovirus receptor,41490,211,1.06 [0.76-1.48],0.7231093988439401
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PXDNL,Peroxidasin-like protein,35598,179,0.96 [0.74-1.25],0.7549911479397093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PXN,Paxillin,40166,203,1.02 [0.81-1.30],0.8364812092583108
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PYDC1,Pyrin domain-containing protein 1,34811,171,1.27 [0.92-1.74],0.1409453288988157
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PYY,Peptide YY,34635,172,0.91 [0.78-1.06],0.2148534577267906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PZP,Pregnancy zone protein,35814,180,1.20 [0.90-1.59],0.2203227746508534
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QDPR,Dihydropteridine reductase,40936,211,1.00 [0.75-1.33],0.9815200474898834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QPCT,Glutaminyl-peptide cyclotransferase,41179,208,1.62 [1.02-2.58],0.0405041213808545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QSOX1,Sulfhydryl oxidase 1,35086,175,1.00 [0.70-1.43],0.9978188647968562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB10,Ras-related protein Rab-10,35759,178,0.94 [0.72-1.24],0.6680199017379951
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB11FIP3,Rab11 family-interacting protein 3,35759,178,0.98 [0.86-1.13],0.8231211394600337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB27B,Ras-related protein Rab-27B,35759,178,0.97 [0.82-1.16],0.7580666842727828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB2B,Ras-related protein Rab-2B,35598,179,1.00 [0.79-1.27],0.9755094627149016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB33A,Ras-related protein Rab-33A,34635,172,1.02 [0.81-1.27],0.884395782696854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB37,Ras-related protein Rab-37,40393,209,0.95 [0.81-1.12],0.5502852080542113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB39B,Ras-related protein Rab-39B,34635,172,1.17 [1.04-1.32],0.010201708832321
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,34664,171,1.04 [0.82-1.32],0.7616601998479289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB44,Ras-related protein Rab-44,35598,179,1.17 [0.91-1.50],0.2348713586883209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB6A,Ras-related protein Rab-6A,41085,214,1.03 [0.80-1.35],0.7987473395709648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB6B,Ras-related protein Rab-6B,40166,203,1.19 [0.95-1.49],0.1396555099023533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RABEP1,Rab GTPase-binding effector protein 1,34994,173,1.01 [0.83-1.22],0.951532943329084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RABEPK,Rab9 effector protein with kelch motifs,40196,207,1.04 [0.84-1.27],0.7425686556945874
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RABGAP1L,Rab GTPase-activating protein 1-like,40393,209,1.03 [0.84-1.26],0.7920410906028977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAC3,Ras-related C3 botulinum toxin substrate 3,34803,173,1.07 [0.88-1.30],0.5048551777755805
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAD23B,UV excision repair protein RAD23 homolog B,40196,207,0.89 [0.68-1.17],0.3957789872878594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAD51,DNA repair protein RAD51 homolog 1,35099,171,1.06 [0.82-1.36],0.6608832279933246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RALB,Ras-related protein Ral-B,34730,174,1.29 [0.81-2.05],0.2841500857056602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RALY,RNA-binding protein Raly,35598,179,1.22 [0.96-1.56],0.100982638805049
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RANBP1,Ran-specific GTPase-activating protein,34811,171,1.01 [0.76-1.33],0.9705768153682344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RANBP2,E3 SUMO-protein ligase RanBP2,34664,171,1.07 [0.69-1.66],0.759431027018359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RANGAP1,Ran GTPase-activating protein 1,40196,207,0.95 [0.72-1.24],0.6848809817663388
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAP1A,Ras-related protein Rap-1A,34730,174,0.92 [0.73-1.16],0.4911314619053386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAPGEF2,Rap guanine nucleotide exchange factor 2,35099,171,1.00 [0.75-1.33],0.99443596362634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RARRES1,Retinoic acid receptor responder protein 1,40196,207,1.04 [0.72-1.50],0.8272098944985429
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RARRES2,Retinoic acid receptor responder protein 2,41354,211,1.12 [0.87-1.44],0.3802212859077984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RASA1,Ras GTPase-activating protein 1,40166,203,1.11 [0.77-1.60],0.5639418538712584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,34510,172,1.16 [0.84-1.60],0.3721450571071492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RASSF2,Ras association domain-containing protein 2,40196,207,1.08 [0.89-1.32],0.4246309596698593
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBFOX3,RNA binding protein fox-1 homolog 3,35709,180,1.33 [0.95-1.86],0.1018668071479194
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBKS,Ribokinase,40160,201,1.17 [0.91-1.50],0.2230580850936914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBM17,Splicing factor 45,35709,180,0.97 [0.80-1.16],0.7129962394577631
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBM19,Probable RNA-binding protein 19,34635,172,1.05 [0.78-1.42],0.742952385948542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBM25,RNA-binding protein 25,34510,172,1.12 [0.83-1.53],0.4591219159824561
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP1,Retinol-binding protein 1,34803,173,1.11 [0.93-1.34],0.2388805795403391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP2,Retinol-binding protein 2,40934,210,1.07 [0.91-1.25],0.4141386847361513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP5,Retinol-binding protein 5,40934,210,1.07 [0.86-1.34],0.5442961319397843
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP7,Retinoid-binding protein 7,35608,179,1.27 [1.04-1.55],0.0187915381689845
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBPMS,RNA-binding protein with multiple splicing,34730,174,1.09 [0.89-1.33],0.3941125816348662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBPMS2,RNA-binding protein with multiple splicing 2,34811,171,1.09 [0.94-1.26],0.2420591134184386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RCC1,Regulator of chromosome condensation,35598,179,1.13 [0.88-1.45],0.3440243931393331
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RCOR1,REST corepressor 1,40395,204,0.88 [0.64-1.22],0.4490990843625421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,34811,171,1.41 [0.70-2.86],0.3369686760730264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REEP4,Receptor expression-enhancing protein 4,35709,180,1.10 [0.87-1.38],0.4243870454056877
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG1A,Lithostathine-1-alpha,40882,210,1.21 [0.95-1.54],0.1169923044835434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG1B,Lithostathine-1-beta,41624,209,1.14 [0.93-1.40],0.2172257268713287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG3A,Regenerating islet-derived protein 3-alpha,41624,209,1.00 [0.82-1.22],0.992025594537148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG3G,Regenerating islet-derived protein 3-gamma,35598,179,1.24 [0.88-1.74],0.2246506169201524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG4,Regenerating islet-derived protein 4,41164,212,0.82 [0.64-1.06],0.1222121557276852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RELB,Transcription factor RelB,34730,174,1.14 [0.87-1.50],0.3353464119611273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RELT,Tumor necrosis factor receptor superfamily member 19L,41134,210,1.66 [1.10-2.51],0.0156697290374107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REN,Renin,41128,212,0.99 [0.84-1.16],0.8808162379250375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REPS1,RalBP1-associated Eps domain-containing protein 1,34730,174,1.08 [0.75-1.56],0.6628715494668314
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REST,RE1-silencing transcription factor,34510,172,1.03 [0.67-1.56],0.9059768379789392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40934,210,0.79 [0.58-1.09],0.1544476669099515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RETN,Resistin,41024,208,1.36 [1.04-1.79],0.0260721258015759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REXO2,"Oligoribonuclease, mitochondrial",34635,172,0.84 [0.60-1.18],0.3263874663905627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RFC4,Replication factor C subunit 4,35598,179,0.74 [0.37-1.50],0.4095918920107744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGCC,Regulator of cell cycle RGCC,35709,180,0.91 [0.75-1.09],0.3082440267996944
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,35099,171,0.98 [0.77-1.24],0.8487317267582491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGMA,Repulsive guidance molecule A,41490,211,1.07 [0.73-1.58],0.7332906444176013
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGMB,RGM domain family member B,41490,211,1.79 [1.15-2.78],0.0097839443450772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGS10,Regulator of G-protein signaling 10,35709,180,0.97 [0.76-1.24],0.8058707486948463
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGS8,Regulator of G-protein signaling 8,40393,209,0.90 [0.73-1.11],0.3224557203169587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RHOC,Rho-related GTP-binding protein RhoC,40574,207,0.97 [0.87-1.08],0.5701930229240052
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RICTOR,Rapamycin-insensitive companion of mTOR,34730,174,1.18 [0.92-1.52],0.1979913328141314
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,34994,173,1.15 [0.86-1.53],0.3562919206671449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RILP,Rab-interacting lysosomal protein,41380,211,1.03 [0.84-1.26],0.7817526759504305
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RILPL2,RILP-like protein 2,35759,178,0.98 [0.85-1.13],0.7945691361466185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,34635,172,1.15 [0.96-1.38],0.1377803070835459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RLN1,Prorelaxin H1,35709,180,1.15 [0.93-1.41],0.2006828379905373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RLN2,Prorelaxin H2,34934,173,1.18 [1.02-1.36],0.021375435003676
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE1,Ribonuclease pancreatic,35784,179,1.40 [0.82-2.39],0.2144007469626182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE10,Inactive ribonuclease-like protein 10,34811,171,1.21 [0.91-1.61],0.1955852253205454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE3,Eosinophil cationic protein,40936,211,1.03 [0.92-1.14],0.6395288351603926
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE4,Ribonuclease 4,34610,175,1.25 [0.74-2.13],0.4073935549093039
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE6,Ribonuclease K6,35522,179,1.37 [0.95-1.99],0.0915473781165003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASEH2A,Ribonuclease H2 subunit A,35709,180,1.09 [0.83-1.42],0.5460160792028288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASET2,Ribonuclease T2,41438,208,1.52 [0.98-2.35],0.0601818581301966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF149,E3 ubiquitin-protein ligase RNF149,34811,171,1.40 [0.88-2.24],0.1588762285744046
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF168,E3 ubiquitin-protein ligase RNF168,34730,174,0.82 [0.56-1.21],0.323130997702538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF31,E3 ubiquitin-protein ligase RNF31,34730,174,0.99 [0.66-1.48],0.957081236135228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF4,E3 ubiquitin-protein ligase RNF4,35099,171,0.98 [0.78-1.22],0.8517502225542593
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF41,E3 ubiquitin-protein ligase NRDP1,40196,207,1.07 [0.89-1.28],0.480924206116236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF43,E3 ubiquitin-protein ligase RNF43,35099,171,1.07 [0.85-1.36],0.5634341392520239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF5,E3 ubiquitin-protein ligase RNF5,34811,171,0.89 [0.73-1.09],0.2512388244176426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROBO1,Roundabout homolog 1,41164,212,1.01 [0.60-1.69],0.9702452568183504
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROBO2,Roundabout homolog 2,41490,211,0.87 [0.51-1.50],0.6153820570874047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROBO4,Roundabout homolog 4,34811,171,1.76 [0.77-4.02],0.1780097325938953
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,41128,212,1.42 [0.97-2.10],0.07487977446144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RP2,Protein XRP2,40934,210,0.93 [0.70-1.25],0.6471522681348731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPA2,Replication protein A 32 kDa subunit,34730,174,1.19 [0.77-1.86],0.4343351734028272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPE,Ribulose-phosphate 3-epimerase,35099,171,1.05 [0.86-1.28],0.6298977032458122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPGR,X-linked retinitis pigmentosa GTPase regulator,34803,173,1.04 [0.73-1.48],0.8175125903720488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPL14,60S ribosomal protein L14,34811,171,1.15 [0.81-1.62],0.442088203469923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPS10,40S ribosomal protein S10,34635,172,1.30 [0.97-1.74],0.0776423025224133
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRAS,Ras-related protein R-Ras,34803,173,0.97 [0.87-1.09],0.6417112492981327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRM2,Ribonucleoside-diphosphate reductase subunit M2,40196,207,1.01 [0.78-1.30],0.9338437248003484
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,40196,207,0.89 [0.74-1.08],0.2324992239430564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRP15,RRP15-like protein,34664,171,1.19 [1.03-1.38],0.0166598293982011
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RSPO1,R-spondin-1,40826,208,1.22 [0.85-1.75],0.2781742095888626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RSPO3,R-spondin-3,41501,211,1.20 [0.77-1.87],0.4209675556931903
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTBDN,Retbindin,40934,210,1.02 [0.66-1.56],0.9449072724917706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTKN2,Rhotekin-2,34635,172,0.83 [0.60-1.16],0.2768869287419456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",35709,180,0.91 [0.78-1.06],0.2223052412561851
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTN4R,Reticulon-4 receptor,41501,211,1.21 [0.85-1.72],0.2894511365979433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RUVBL1,RuvB-like 1,40196,207,0.95 [0.84-1.07],0.3963200817525307
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RWDD1,RWD domain-containing protein 1,41490,211,0.96 [0.79-1.17],0.7000282331395473
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RYR1,Ryanodine receptor 1,34635,172,0.70 [0.42-1.14],0.1523785322795702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A11,Protein S100-A11,40812,211,1.00 [0.77-1.29],0.9958340355539048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A12,Protein S100-A12,40550,206,0.96 [0.82-1.14],0.6680849686498478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A13,Protein S100-A13,34730,174,1.46 [1.00-2.12],0.0490650382700476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A14,Protein S100-A14,35709,180,1.06 [0.81-1.38],0.679875110321762
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A16,Protein S100-A16,40106,203,1.03 [0.84-1.26],0.7692003307076087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A3,Protein S100-A3,35598,179,0.75 [0.50-1.14],0.1801011988787125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A4,Protein S100-A4,41240,212,0.94 [0.76-1.17],0.5941193666426998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100G,Protein S100-G,35709,180,1.20 [0.90-1.59],0.2088873954842831
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100P,Protein S100-P,40395,204,1.06 [0.86-1.32],0.5716822603445317
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAA4,Serum amyloid A-4 protein,35814,180,0.62 [0.29-1.33],0.2211844015155194
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAFB2,Scaffold attachment factor B2,35709,180,1.31 [0.85-2.02],0.2163763416080734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAG,S-arrestin,34664,171,0.94 [0.70-1.25],0.6541835165322618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAMD9L,Sterile alpha motif domain-containing protein 9-like,41085,214,0.98 [0.83-1.16],0.8364150433781038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAP18,Histone deacetylase complex subunit SAP18,35099,171,1.11 [0.93-1.33],0.2306867110483387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SARG,Specifically androgen-regulated gene protein,35634,177,0.96 [0.84-1.09],0.5376978103442676
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SART1,U4/U6.U5 tri-snRNP-associated protein 1,34635,172,1.18 [0.85-1.64],0.3300375616280944
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAT1,Diamine acetyltransferase 1,34635,172,1.16 [0.89-1.50],0.2679345267690141
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAT2,Thialysine N-epsilon-acetyltransferase,35099,171,1.09 [0.89-1.33],0.4175496512904542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SATB1,DNA-binding protein SATB1,35709,180,1.00 [0.62-1.60],0.996154556136956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SBSN,Suprabasin,35698,180,1.05 [0.70-1.58],0.8162625573986064
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCAMP3,Secretory carrier-associated membrane protein 3,40934,210,0.99 [0.86-1.15],0.9442959826194556
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARA5,Scavenger receptor class A member 5,41490,211,1.00 [0.66-1.51],0.9924374942728106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARB1,Scavenger receptor class B member 1,40166,203,0.82 [0.63-1.07],0.1492507901469195
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARB2,Lysosome membrane protein 2,40047,201,1.32 [0.87-1.99],0.187840594187992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARF1,Scavenger receptor class F member 1,41624,209,1.01 [0.75-1.35],0.964635975799103
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARF2,Scavenger receptor class F member 2,41490,211,1.39 [0.90-2.14],0.1377454263434469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCG2,Secretogranin-2,41310,210,0.81 [0.55-1.20],0.2979743045277655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCG3,Secretogranin-3,41164,212,0.98 [0.68-1.40],0.8941830326505185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB1A1,Uteroglobin,41164,211,1.13 [0.90-1.42],0.2855616191751194
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB2A2,Mammaglobin-A,34635,172,1.33 [0.90-1.96],0.1504040018754221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB3A1,Secretoglobin family 3A member 1,34994,173,1.22 [0.69-2.17],0.490897675951661
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB3A2,Secretoglobin family 3A member 2,41231,212,0.95 [0.81-1.10],0.4811686662454059
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGN,Secretagogin,40393,209,1.39 [1.06-1.81],0.0161598316799017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCIN,Adseverin,34664,171,1.03 [0.84-1.25],0.7836406668535464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCLY,Selenocysteine lyase,41380,211,0.87 [0.67-1.14],0.3266867384671591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN2A,Sodium channel protein type 2 subunit alpha,34664,171,0.95 [0.69-1.30],0.7360567776666458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN2B,Sodium channel subunit beta-2,34803,173,1.02 [0.61-1.71],0.9312973499664052
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN3A,Sodium channel protein type 3 subunit alpha,34803,173,0.72 [0.45-1.14],0.1616087067668913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN3B,Sodium channel subunit beta-3,34664,171,1.15 [0.87-1.51],0.3260692099156658
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN4B,Sodium channel subunit beta-4,34811,171,1.11 [0.78-1.58],0.5548586333371868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCP2,Non-specific lipid-transfer protein,40196,207,1.02 [0.87-1.20],0.7662404350861555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCPEP1,Retinoid-inducible serine carboxypeptidase,34685,170,1.02 [0.76-1.37],0.9006439927601064
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCRG1,Scrapie-responsive protein 1,35759,178,1.29 [0.77-2.14],0.3314256493963235
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCRIB,Protein scribble homolog,34811,171,1.11 [0.96-1.28],0.170965794969534
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCRN1,Secernin-1,41085,214,1.00 [0.81-1.25],0.9697539885916994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCT,Secretin,34803,173,1.13 [0.84-1.54],0.4161950684304283
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDC1,Syndecan-1,41128,212,0.96 [0.70-1.33],0.8240378835362638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDC4,Syndecan-4,41128,212,0.77 [0.60-1.00],0.0528981521191763
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDCCAG8,Serologically defined colon cancer antigen 8,35598,179,1.06 [0.94-1.21],0.3360757096972127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDHB,Succinate dehydrogenase,35608,179,0.88 [0.70-1.12],0.2971665715176449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDK2,Protein sidekick-2,34994,173,1.36 [0.95-1.93],0.0923922325717979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEC31A,Protein transport protein Sec31A,34811,171,0.98 [0.81-1.18],0.7950047760919339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEL1L,Protein sel-1 homolog 1,34811,171,1.24 [0.84-1.84],0.2871795591976603
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELE,E-selectin,41624,209,1.06 [0.83-1.36],0.6154152687772998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELENOP,Selenoprotein P,35814,180,1.07 [0.58-2.00],0.8275394505829626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELL,L-selectin,35814,180,1.09 [0.58-2.05],0.7938118551723227
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELP,P-selectin,41278,211,0.86 [0.69-1.07],0.1792449328115647
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELPLG,P-selectin glycoprotein ligand 1,41085,214,0.88 [0.55-1.39],0.5760250519395513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA3F,Semaphorin-3F,41128,212,1.12 [0.70-1.79],0.6463415758652942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA3G,Semaphorin-3G,34994,173,1.47 [1.08-2.01],0.0137845349918607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA4C,Semaphorin-4C,40934,210,1.12 [0.73-1.70],0.6073017151485202
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA4D,Semaphorin-4D,41490,211,0.86 [0.58-1.29],0.4707067046523761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA6C,Semaphorin-6C,34730,174,1.18 [0.70-1.98],0.5294493689135567
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA7A,Semaphorin-7A,41496,209,1.64 [1.06-2.52],0.0253116016187434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN3,Neuronal-specific septin-3,35709,180,0.96 [0.79-1.16],0.6543135106995195
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN7,Septin-7,35099,171,1.13 [0.89-1.43],0.3217030090478381
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN8,Septin-8,35618,178,1.37 [0.90-2.09],0.1467278765772895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN9,Septin-9,40934,210,0.93 [0.61-1.43],0.7494554042110716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA1,Alpha-1-antitrypsin,35132,178,0.88 [0.14-5.40],0.8926679492601106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA11,Serpin A11,41624,209,0.91 [0.68-1.23],0.5563278027438613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA12,Serpin A12,39963,205,0.92 [0.80-1.05],0.2257647080644872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA3,Alpha-1-antichymotrypsin,35691,180,0.53 [0.20-1.44],0.2133495288034307
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA4,Kallistatin,35145,176,0.96 [0.52-1.77],0.8950206850523887
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA5,Plasma serine protease inhibitor,35272,177,0.99 [0.62-1.57],0.9531938777624422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA6,Corticosteroid-binding globulin,35814,180,0.79 [0.32-1.93],0.6071508178207102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA7,Thyroxine-binding globulin,35814,180,0.72 [0.33-1.56],0.4010202137253242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA9,Serpin A9,40724,209,0.90 [0.75-1.08],0.2624311465830418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB1,Leukocyte elastase inhibitor,41007,209,1.01 [0.89-1.16],0.8452326774461993
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB5,Serpin B5,40395,204,0.92 [0.72-1.18],0.5205092841223481
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB6,Serpin B6,41357,211,0.92 [0.75-1.14],0.4557089474737038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB8,Serpin B8,41597,213,1.07 [0.88-1.29],0.5204560308674513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB9,Serpin B9,40826,208,1.00 [0.69-1.45],0.9993187441797532
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINC1,Antithrombin-III,35744,179,0.43 [0.16-1.13],0.0855679857720561
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPIND1,Heparin cofactor 2,35744,179,0.58 [0.35-0.96],0.0351486287345892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINE1,Plasminogen activator inhibitor 1,41624,209,0.84 [0.70-1.00],0.0490695061052772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINE2,Glia-derived nexin,35759,178,0.90 [0.72-1.12],0.344530889603253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINF1,Pigment epithelium-derived factor,35273,177,0.88 [0.51-1.53],0.6545989171296814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINF2,Alpha-2-antiplasmin,35130,177,0.81 [0.28-2.35],0.6946211281153385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPING1,Plasma protease C1 inhibitor,35744,179,0.64 [0.30-1.39],0.2585231295776657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINH1,Serpin H1,35099,171,1.02 [0.91-1.14],0.7763441741072655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINI1,Neuroserpin,34924,173,1.36 [0.85-2.18],0.1983179604512856
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINI2,Serpin I2,35608,179,1.11 [0.86-1.43],0.4197740861528363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,40166,203,1.11 [0.92-1.34],0.2928968306615971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SETMAR,Histone-lysine N-methyltransferase SETMAR,40694,205,0.92 [0.60-1.40],0.690613733431817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEZ6,Seizure protein 6 homolog,34803,173,0.84 [0.51-1.38],0.4968042038845003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEZ6L,Seizure 6-like protein,41240,212,1.19 [0.76-1.86],0.4463725727150656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEZ6L2,Seizure 6-like protein 2,40934,210,1.31 [0.79-2.19],0.2963493878590356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SF3B4,Splicing factor 3B subunit 4,40934,210,1.07 [0.91-1.25],0.4398463268898427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFRP1,Secreted frizzled-related protein 1,40688,203,1.25 [0.95-1.66],0.1121192121954642
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFRP4,Secreted frizzled-related protein 4,34994,173,1.36 [0.94-1.97],0.0998216597275343
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPA1,Pulmonary surfactant-associated protein A1,40196,207,1.01 [0.81-1.25],0.9597781488627763
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPA2,Pulmonary surfactant-associated protein A2,40196,207,1.30 [1.04-1.63],0.0224582049518187
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPD,Pulmonary surfactant-associated protein D,41128,212,1.01 [0.84-1.21],0.9003934203757862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SGSH,N-sulphoglucosamine sulphohydrolase,35157,176,1.04 [0.80-1.34],0.7890034780043952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH2B3,SH2B adapter protein 3,40196,207,0.95 [0.84-1.08],0.4444421436501942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH2D1A,SH2 domain-containing protein 1A,41085,214,0.86 [0.68-1.08],0.1898981183174586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,34664,171,0.89 [0.68-1.17],0.4131392131433863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3BP1,SH3 domain-binding protein 1,35608,179,0.98 [0.73-1.30],0.8739352306588234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3GL3,Endophilin-A3,34898,170,1.04 [0.87-1.24],0.6645749618141943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3GLB2,Endophilin-B2,35691,178,1.14 [0.92-1.41],0.2235612456138672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHBG,Sex hormone-binding globulin,35784,179,1.16 [0.86-1.56],0.3290256557730126
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHC1,SHC-transforming protein 1,34510,172,0.96 [0.84-1.09],0.5173679873186148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHD,SH2 domain-containing adapter protein D,34568,172,1.02 [0.86-1.20],0.846659346090644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHH,Sonic hedgehog protein,34730,174,0.66 [0.46-0.96],0.029241406085847
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHISA5,Protein shisa-5,35767,181,1.21 [0.69-2.12],0.5070987898303745
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHMT1,"Serine hydroxymethyltransferase, cytosolic",41231,212,0.94 [0.81-1.08],0.3723505810217764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHPK,Sedoheptulokinase,35099,171,1.38 [1.03-1.83],0.0294300470350288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIAE,Sialate O-acetylesterase,41175,212,1.05 [0.81-1.37],0.7189547759585558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC1,Sialoadhesin,41291,212,1.14 [0.85-1.53],0.375094756225433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC10,Sialic acid-binding Ig-like lectin 10,41085,214,1.04 [0.71-1.51],0.8561386535796006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC15,Sialic acid-binding Ig-like lectin 15,40166,203,0.93 [0.78-1.11],0.4462991667030019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC5,Sialic acid-binding Ig-like lectin 5,41134,210,1.14 [1.01-1.29],0.0379885470993455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC6,Sialic acid-binding Ig-like lectin 6,41501,211,1.41 [0.98-2.04],0.0648819748181464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC7,Sialic acid-binding Ig-like lectin 7,41128,212,0.69 [0.44-1.08],0.1023776384870271
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC8,Sialic acid-binding Ig-like lectin 8,34811,171,0.92 [0.66-1.29],0.6407875098345633
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC9,Sialic acid-binding Ig-like lectin 9,41442,211,0.78 [0.52-1.18],0.2443665644880471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIL1,Nucleotide exchange factor SIL1,34811,171,1.15 [0.77-1.72],0.4824157898634638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,41224,209,1.07 [0.86-1.33],0.5356127769325951
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRPB1,Signal-regulatory protein beta-1,41024,212,1.21 [0.93-1.57],0.1514410317257651
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRT1,NAD-dependent protein deacetylase sirtuin-1,34730,174,0.94 [0.78-1.13],0.5239972059711324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40934,210,0.99 [0.86-1.13],0.845529664611098
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",40166,203,0.74 [0.56-0.96],0.0250261951885228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIT1,Signaling threshold-regulating transmembrane adapter 1,40393,209,0.89 [0.71-1.12],0.3202758798478816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SKAP1,Src kinase-associated phosphoprotein 1,40750,208,0.94 [0.79-1.11],0.4687520798579169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SKAP2,Src kinase-associated phosphoprotein 2,41291,212,0.96 [0.86-1.08],0.5155616702502746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SKIV2L,Helicase SKI2W,34635,172,1.12 [0.79-1.58],0.5159161031122727
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLA2,Src-like-adapter 2,35709,180,0.93 [0.81-1.07],0.3014152121493749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF1,Signaling lymphocytic activation molecule,40393,209,1.00 [0.81-1.24],0.9715671397771984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF6,SLAM family member 6,40196,207,1.08 [0.78-1.51],0.6323808456599385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF7,SLAM family member 7,41085,214,1.12 [0.91-1.37],0.2985057432146373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF8,SLAM family member 8,40196,207,1.17 [0.92-1.48],0.203189160418841
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC12A2,Solute carrier family 12 member 2,34635,172,1.23 [0.77-1.97],0.3864581990474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC13A1,Solute carrier family 13 member 1,35598,179,0.96 [0.75-1.24],0.7691533453855132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC16A1,Monocarboxylate transporter 1,40166,203,1.17 [0.96-1.42],0.1216862161274296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC1A4,Neutral amino acid transporter A,34803,173,1.06 [0.81-1.39],0.6542275086071515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC27A4,Long-chain fatty acid transport protein 4,40166,203,1.00 [0.82-1.21],0.991775688507435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC28A1,Sodium/nucleoside cotransporter 1,34510,172,0.79 [0.59-1.06],0.1141034553252464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC34A3,Sodium-dependent phosphate transport protein 2C,34510,172,1.09 [0.82-1.46],0.5434968959361453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC39A14,Zinc transporter ZIP14,40166,203,1.29 [0.92-1.80],0.1423178221444369
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC39A5,Zinc transporter ZIP5,41085,214,1.06 [0.84-1.33],0.6417666595167059
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC44A4,Choline transporter-like protein 4,34803,173,0.90 [0.71-1.14],0.3883718269090329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC4A1,Band 3 anion transport protein,35767,181,0.97 [0.72-1.31],0.825843212564418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC51B,Organic solute transporter subunit beta,34635,172,1.01 [0.83-1.23],0.8884862668963537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,34994,173,0.94 [0.79-1.12],0.5159644621532934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,35608,179,0.86 [0.62-1.18],0.3415185179251107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",34510,172,0.97 [0.75-1.27],0.8358087951943892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLIT2,Slit homolog 2 protein,40166,203,1.06 [0.84-1.34],0.6094870259392214
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLITRK1,SLIT and NTRK-like protein 1,34730,174,0.91 [0.58-1.44],0.6972124290988929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLITRK2,SLIT and NTRK-like protein 2,41501,211,0.90 [0.66-1.23],0.5092383463920866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLITRK6,SLIT and NTRK-like protein 6,40395,204,1.21 [0.85-1.72],0.3006997203081948
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLK,STE20-like serine/threonine-protein kinase,35099,171,1.05 [0.88-1.25],0.5917419224810513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLMAP,Sarcolemmal membrane-associated protein,35608,179,1.09 [0.92-1.30],0.3067997255063419
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLURP1,Secreted Ly-6/uPAR-related protein 1,35498,179,1.12 [0.77-1.62],0.5493241537316665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD1,Mothers against decapentaplegic homolog 1,40196,207,1.03 [0.88-1.19],0.7395430221267218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD2,Mothers against decapentaplegic homolog 2,35598,179,0.98 [0.80-1.21],0.8478160853498337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD3,Mothers against decapentaplegic homolog 3,35598,179,0.97 [0.74-1.29],0.8527517315072628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD5,Mothers against decapentaplegic homolog 5,40934,210,0.61 [0.34-1.09],0.0951463499804324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMARCA2,Probable global transcription activator SNF2L2,40166,203,0.92 [0.77-1.10],0.3633077842427877
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMC3,Structural maintenance of chromosomes protein 3,34510,172,1.02 [0.78-1.33],0.9106143219798744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMNDC1,Survival of motor neuron-related-splicing factor 30,35608,179,1.18 [0.97-1.43],0.0945134894859957
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMOC1,SPARC-related modular calcium-binding protein 1,41501,211,0.86 [0.59-1.26],0.4396836748460859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMOC2,SPARC-related modular calcium-binding protein 2,41291,212,1.41 [1.03-1.94],0.0334210990394686
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPD1,Sphingomyelin phosphodiesterase,41284,211,1.30 [1.02-1.64],0.0319677999246792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPD3,Sphingomyelin phosphodiesterase 3,34730,174,1.01 [0.79-1.30],0.9283073509874304
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,41223,212,1.10 [0.91-1.32],0.3339317576155348
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,35598,179,1.11 [0.95-1.31],0.1984150173397834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMS,Spermine synthase,34664,171,1.01 [0.80-1.27],0.9555291954558895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMTN,Smoothelin,35627,178,1.12 [0.97-1.30],0.1308464520789594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP23,Synaptosomal-associated protein 23,41128,212,0.91 [0.79-1.04],0.1708240224475027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP25,Synaptosomal-associated protein 25,34664,171,1.00 [0.73-1.37],0.9973559636652072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP29,Synaptosomal-associated protein 29,41240,212,0.95 [0.83-1.09],0.460074782957513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAPIN,SNARE-associated protein Snapin,35709,180,1.10 [0.86-1.41],0.4353455159111393
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNCA,Alpha-synuclein,34994,173,1.10 [0.97-1.24],0.1575533393617208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNCG,Gamma-synuclein,40826,208,1.06 [0.88-1.28],0.5146616502572163
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",34811,171,1.17 [0.76-1.81],0.4681378702963689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNRPB2,U2 small nuclear ribonucleoprotein B'',35691,178,1.22 [0.98-1.53],0.0754345981295586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNU13,NHP2-like protein 1,34635,172,1.10 [0.89-1.36],0.3905868865075661
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX15,Sorting nexin-15,34994,173,0.99 [0.76-1.30],0.949031561458005
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX18,Sorting nexin-18,35608,179,1.09 [0.80-1.49],0.5883296693001296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX2,Sorting nexin-2,35598,179,1.11 [0.94-1.30],0.2097700042101513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX5,Sorting nexin-5,34811,171,1.24 [0.78-1.97],0.3703383818135586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX9,Sorting nexin-9,41128,212,1.05 [0.87-1.25],0.6230500304567301
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOD1,Superoxide dismutase [Cu-Zn],40303,208,1.08 [0.84-1.39],0.542720552647068
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOD2,"Superoxide dismutase [Mn], mitochondrial",41134,210,1.10 [0.79-1.52],0.5730875555991342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOD3,Extracellular superoxide dismutase,35784,179,1.08 [0.87-1.35],0.4741697221285689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORBS1,Sorbin and SH3 domain-containing protein 1,35709,180,1.35 [1.04-1.76],0.0237206532223765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORCS2,VPS10 domain-containing receptor SorCS2,40196,207,1.35 [0.94-1.93],0.0998767672247628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORD,Sorbitol dehydrogenase,41310,211,0.94 [0.79-1.13],0.51578550081687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORT1,Sortilin,41074,212,0.76 [0.54-1.06],0.1027832806414483
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOST,Sclerostin,41074,212,1.15 [0.84-1.58],0.370358039440223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,34803,173,1.07 [0.81-1.40],0.6502477113597205
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOX2,Transcription factor SOX-2,35644,180,0.77 [0.41-1.44],0.4129973346020591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOX9,Transcription factor SOX-9,34803,173,0.84 [0.49-1.45],0.5361147571282394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,35709,180,1.51 [1.02-2.22],0.0385404638001472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPAG1,Sperm-associated antigen 1,35709,180,1.07 [0.85-1.35],0.5568873066371473
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPARC,SPARC,41240,212,0.84 [0.71-0.99],0.0361361325878109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPARCL1,SPARC-like protein 1,41140,210,1.20 [0.79-1.82],0.3874516845254262
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPART,Spartin,34994,173,1.08 [0.90-1.31],0.4149892189134783
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPESP1,Sperm equatorial segment protein 1,35759,178,1.23 [0.79-1.90],0.3565198771790965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK1,Serine protease inhibitor Kazal-type 1,41134,210,1.47 [1.11-1.95],0.0068077142065078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK2,Serine protease inhibitor Kazal-type 2,34994,173,1.25 [0.83-1.87],0.2807071674774539
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK4,Serine protease inhibitor Kazal-type 4,41085,214,0.93 [0.77-1.13],0.4590043536842567
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK5,Serine protease inhibitor Kazal-type 5,41134,210,1.38 [0.97-1.97],0.0749901510684935
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK6,Serine protease inhibitor Kazal-type 6,41501,211,1.13 [0.90-1.42],0.3039939205718729
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK8,Serine protease inhibitor Kazal-type 8,34635,172,0.90 [0.59-1.38],0.6222226754321865
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT1,Kunitz-type protease inhibitor 1,41001,207,1.44 [0.88-2.35],0.1482818578020547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT2,Kunitz-type protease inhibitor 2,41291,212,0.83 [0.61-1.12],0.2256257277741965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT3,Kunitz-type protease inhibitor 3,35608,179,0.95 [0.87-1.04],0.2877779079978637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPOCK1,Testican-1,40826,208,0.91 [0.56-1.48],0.7099141506460276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPON1,Spondin-1,41164,212,1.03 [0.70-1.52],0.8637890938690302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPON2,Spondin-2,40947,212,1.43 [1.00-2.04],0.0494295186744612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPP1,Osteopontin,41555,209,0.82 [0.62-1.09],0.1713831425443128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",34730,174,1.20 [0.87-1.64],0.2701963131218996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRING1,SREBP regulating gene protein,34510,172,1.05 [0.84-1.32],0.6695611599679662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRR1B,Cornifin-B,35099,171,1.05 [0.89-1.24],0.5374398030179409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRR3,Small proline-rich protein 3,35691,178,0.92 [0.74-1.14],0.4562915202871102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRY2,Protein sprouty homolog 2,40393,209,0.96 [0.84-1.10],0.5615147322973375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",34664,171,1.13 [0.74-1.73],0.5733576727401615
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPTLC1,Serine palmitoyltransferase 1,35691,178,1.10 [0.77-1.56],0.6095191440396097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRC,Proto-oncogene tyrosine-protein kinase Src,41170,211,0.98 [0.89-1.09],0.7355111237395398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRP14,Signal recognition particle 14 kDa protein,40934,210,1.07 [0.87-1.30],0.5216801960178205
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRPK2,SRSF protein kinase 2,41085,214,0.98 [0.84-1.13],0.7499158132352048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRPX,Sushi repeat-containing protein SRPX,35759,178,1.11 [0.74-1.65],0.6224790233747681
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSB,Lupus La protein,40166,203,1.03 [0.84-1.27],0.7513756756505046
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",34730,174,0.98 [0.64-1.48],0.913232814465904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,41074,212,0.95 [0.85-1.06],0.3409371577377664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,41278,211,0.92 [0.69-1.23],0.5928235830247929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSH3,Protein phosphatase Slingshot homolog 3,34510,172,1.58 [1.04-2.41],0.0332484093786234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSNA1,Sjoegren syndrome nuclear autoantigen 1,35608,179,0.93 [0.70-1.23],0.6080527305660273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST13,Hsc70-interacting protein,34994,173,1.05 [0.81-1.37],0.7044029597605624
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40934,210,1.17 [0.89-1.54],0.2497505623523733
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",41624,209,1.19 [0.80-1.78],0.3949656834256331
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",34730,174,0.89 [0.64-1.24],0.4862051979507034
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAB2,Stabilin-2,35767,181,0.77 [0.47-1.27],0.3080297182809127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAM,Signal transducing adapter molecule 1,35598,179,1.11 [0.77-1.61],0.5752601487062992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAMBP,STAM-binding protein,40750,208,1.04 [0.85-1.26],0.7242962084122656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAT2,Signal transducer and activator of transcription 2,34730,174,0.96 [0.79-1.17],0.6793292094625125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAT5B,Signal transducer and activator of transcription 5B,40934,210,0.95 [0.87-1.04],0.2483355350808291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,34510,172,1.07 [0.87-1.32],0.5103021658740043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STC1,Stanniocalcin-1,41490,211,1.41 [1.08-1.83],0.0108527400974382
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STC2,Stanniocalcin-2,41079,210,1.45 [0.87-2.42],0.1553284295762606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STEAP4,Metalloreductase STEAP4,34664,171,0.96 [0.78-1.19],0.7242519246219132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STIP1,Stress-induced-phosphoprotein 1,41068,209,1.08 [0.89-1.30],0.4452388101461806
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STK11,Serine/threonine-protein kinase STK11,40395,204,1.05 [0.88-1.24],0.6043543753469978
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STK24,Serine/threonine-protein kinase 24,40166,203,1.01 [0.83-1.24],0.901846577268698
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STK4,Serine/threonine-protein kinase 4,41128,212,0.95 [0.82-1.09],0.457206023081614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STOML2,"Stomatin-like protein 2, mitochondrial",34510,172,1.06 [0.91-1.23],0.4646279928919492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX16,Syntaxin-16,40196,207,0.97 [0.78-1.21],0.778884100333366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX1B,Syntaxin-1B,34803,173,1.23 [0.92-1.65],0.1569017296754692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX3,Syntaxin-3,35691,178,0.93 [0.64-1.37],0.7283590170115738
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX4,Syntaxin-4,40934,210,1.11 [0.92-1.34],0.2899460358509719
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX5,Syntaxin-5,34730,174,0.85 [0.57-1.27],0.4265031069487561
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX6,Syntaxin-6,40196,207,1.02 [0.85-1.23],0.8095290595180166
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX7,Syntaxin-7,34730,174,1.19 [0.88-1.59],0.2573511291945437
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX8,Syntaxin-8,41085,214,1.03 [0.80-1.33],0.7960037963379443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STXBP1,Syntaxin-binding protein 1,35709,180,0.99 [0.82-1.18],0.8729070005419216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STXBP3,Syntaxin-binding protein 3,40196,207,0.87 [0.65-1.18],0.3728616890650598
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUGP1,SURP and G-patch domain-containing protein 1,35608,179,1.28 [0.92-1.78],0.1474365228501389
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUGT1,Protein SGT1 homolog,40196,207,1.04 [0.89-1.22],0.6032513022558974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SULT1A1,Sulfotransferase 1A1,41490,211,0.96 [0.87-1.05],0.3814430700063004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SULT2A1,Bile salt sulfotransferase,41085,214,1.07 [0.87-1.32],0.5285098311207068
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUMF1,Formylglycine-generating enzyme,34730,174,1.08 [0.88-1.31],0.4721588938378129
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,41490,211,0.93 [0.74-1.17],0.518802339000004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUOX,"Sulfite oxidase, mitochondrial",35709,180,0.93 [0.74-1.18],0.5553937648813111
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD1,Sushi domain-containing protein 1,40395,204,1.09 [0.84-1.42],0.4994856955362736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD2,Sushi domain-containing protein 2,41134,210,1.13 [0.74-1.73],0.5643479716681234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD4,Sushi domain-containing protein 4,35598,179,1.20 [0.86-1.66],0.2886044518261281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD5,Sushi domain-containing protein 5,34807,173,1.01 [0.66-1.57],0.9503031893524324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SV2A,Synaptic vesicle glycoprotein 2A,34803,173,0.98 [0.77-1.25],0.8791386002381574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SWAP70,Switch-associated protein 70,35608,179,1.23 [0.85-1.76],0.2742084741334203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYAP1,Synapse-associated protein 1,34994,173,0.96 [0.74-1.25],0.7779364101655697
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,34664,171,0.80 [0.59-1.08],0.1424814651506616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYT1,Synaptotagmin-1,35691,178,1.25 [0.94-1.67],0.1209470033968833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYTL4,Synaptotagmin-like protein 4,35759,178,1.01 [0.82-1.23],0.9555068259381346
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,35099,171,1.01 [0.87-1.16],0.9339536589906962
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TACC3,Transforming acidic coiled-coil-containing protein 3,40934,210,0.92 [0.83-1.02],0.1294682821876284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TACSTD2,Tumor-associated calcium signal transducer 2,36484,180,1.27 [0.80-2.01],0.3114306359313471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TADA3,Transcriptional adapter 3,35598,179,0.98 [0.68-1.40],0.8952763724627787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAFA5,Chemokine-like protein TAFA-5,40934,210,1.19 [0.84-1.68],0.3338674639964294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAGLN3,Transgelin-3,34510,172,0.94 [0.73-1.20],0.5996376868968122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TALDO1,Transaldolase,35636,181,1.02 [0.74-1.40],0.9119042867407732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TANK,TRAF family member-associated NF-kappa-B activator,40393,209,0.96 [0.80-1.15],0.6361716259407704
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAP1,Antigen peptide transporter 1,35099,171,1.08 [0.86-1.35],0.5305173185723437
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TARBP2,RISC-loading complex subunit TARBP2,40166,203,1.02 [0.87-1.19],0.8291974464503931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",34803,173,1.15 [0.98-1.36],0.0902833513025918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",35598,179,1.07 [0.74-1.55],0.7088665716247067
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAX1BP1,Tax1-binding protein 1,35691,178,1.16 [0.93-1.45],0.1956214945133453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D17,TBC1 domain family member 17,40166,203,1.25 [0.97-1.61],0.07855424218918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D23,TBC1 domain family member 23,40934,210,0.96 [0.83-1.10],0.5309655303710388
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D5,TBC1 domain family member 5,41085,214,1.08 [0.93-1.25],0.3101890243274893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBCA,Tubulin-specific chaperone A,34994,173,1.06 [0.89-1.26],0.5188268358902918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBCB,Tubulin-folding cofactor B,40826,208,0.96 [0.85-1.08],0.4639454317052143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBCC,Tubulin-specific chaperone C,40826,208,0.96 [0.82-1.12],0.5998579336890887
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBL1X,F-box-like/WD repeat-containing protein TBL1X,40196,207,1.03 [0.89-1.19],0.728212821967765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBR1,T-box brain protein 1,34803,173,1.09 [0.83-1.45],0.5259544382673024
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCL1A,T-cell leukemia/lymphoma protein 1A,40764,208,0.92 [0.81-1.04],0.1945798335517869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCL1B,T-cell leukemia/lymphoma protein 1B,40395,204,0.88 [0.74-1.06],0.175901078157081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCN1,Transcobalamin-1,35059,179,1.12 [0.75-1.69],0.5752561035655477
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCN2,Transcobalamin-2,41555,209,1.32 [0.90-1.94],0.1542032746258757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCOF1,Treacle protein,35759,178,0.67 [0.40-1.10],0.1096688130237239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCP11,T-complex protein 11 homolog,35099,171,0.87 [0.65-1.18],0.3707244065464056
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCTN3,Tectonic-3,35759,178,0.74 [0.46-1.20],0.2246000254506069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDGF1,Teratocarcinoma-derived growth factor 1,40166,203,0.98 [0.90-1.07],0.6408601915292065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDO2,"Tryptophan 2,3-dioxygenase",34803,173,0.82 [0.54-1.25],0.3546705653746441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDP1,Tyrosyl-DNA phosphodiesterase 1,35598,179,1.08 [0.90-1.30],0.3902646679177783
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDRKH,Tudor and KH domain-containing protein,40166,203,1.01 [0.87-1.17],0.9148090274431422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEF,Thyrotroph embryonic factor,34635,172,0.94 [0.66-1.34],0.7416488868769066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEK,Angiopoietin-1 receptor,41240,212,1.34 [0.77-2.33],0.303961954505846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TERF1,Telomeric repeat-binding factor 1,34730,174,1.32 [0.83-2.10],0.2323934294517379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TET2,Methylcytosine dioxygenase TET2,35034,171,1.02 [0.88-1.17],0.8272866057822262
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEX101,Testis-expressed protein 101,34803,173,1.01 [0.77-1.33],0.9224404060600938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEX33,Testis-expressed protein 33,35099,171,1.27 [0.96-1.69],0.0951968089001565
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TF,Serotransferrin,35814,180,0.57 [0.30-1.10],0.0946358614590219
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFAP2A,Transcription factor AP-2-alpha,34664,171,1.12 [0.90-1.40],0.3009029251916765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF1,Trefoil factor 1,40947,209,1.02 [0.88-1.20],0.7560663387586289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF2,Trefoil factor 2,41231,212,1.03 [0.83-1.28],0.7827387209068324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF3,Trefoil factor 3,41090,209,1.49 [1.20-1.86],0.0003869176075274
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFPI,Tissue factor pathway inhibitor,41020,211,0.73 [0.49-1.10],0.131529409127813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFPI2,Tissue factor pathway inhibitor 2,41114,212,1.16 [0.87-1.56],0.3149433746735429
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFRC,Transferrin receptor protein 1,41291,211,1.08 [0.78-1.49],0.6399674337221037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TG,Thyroglobulin,35598,179,1.01 [0.88-1.15],0.9209571827199744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFA,Protransforming growth factor alpha,41085,214,0.93 [0.70-1.22],0.5788259562675724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFB1,Transforming growth factor beta-1 proprotein,41523,212,0.93 [0.68-1.29],0.6807491379118952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFB2,Transforming growth factor beta-2 proprotein,35598,179,0.97 [0.74-1.28],0.8534012565524218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40885,210,1.66 [1.06-2.61],0.0272842874313254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBR1,TGF-beta receptor type-1,34730,174,1.67 [1.04-2.68],0.0340933252686375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBR2,TGF-beta receptor type-2,41240,212,1.65 [1.16-2.35],0.0049646402413509
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBR3,Transforming growth factor beta receptor type 3,41624,209,1.02 [0.69-1.53],0.9037807205754442
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGM2,Protein-glutamine gamma-glutamyltransferase 2,41066,212,1.12 [0.96-1.32],0.1602858868911339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGOLN2,Trans-Golgi network integral membrane protein 2,35784,179,1.00 [0.58-1.74],0.998272171361371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THAP12,52 kDa repressor of the inhibitor of the protein kinase,34445,172,0.95 [0.80-1.14],0.6034697857521638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THBD,Thrombomodulin,41128,212,1.37 [0.91-2.08],0.1353669566243834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THBS2,Thrombospondin-2,41134,210,1.29 [0.93-1.78],0.1251083087299066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THBS4,Thrombospondin-4,41147,211,1.27 [0.97-1.67],0.0834266590711503
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THOP1,Thimet oligopeptidase,40941,211,1.00 [0.67-1.49],0.995974306709486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THPO,Thrombopoietin,40395,204,0.84 [0.61-1.16],0.2966867353110787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THRAP3,Thyroid hormone receptor-associated protein 3,34635,172,1.03 [0.91-1.17],0.6494773680773323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THSD1,Thrombospondin type-1 domain-containing protein 1,34466,172,0.85 [0.54-1.33],0.4852291457527267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THTPA,Thiamine-triphosphatase,35532,179,1.03 [0.88-1.21],0.7143246111513859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THY1,Thy-1 membrane glycoprotein,41490,211,1.66 [1.08-2.55],0.0202011608714633
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIA1,Nucleolysin TIA-1 isoform p40,39951,204,0.95 [0.86-1.06],0.3477658323144106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIE1,Tyrosine-protein kinase receptor Tie-1,41624,209,0.86 [0.66-1.13],0.2914537523862713
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",40090,203,0.96 [0.74-1.26],0.790981901617943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,35099,171,1.19 [0.83-1.70],0.3487753926883538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41278,211,1.08 [0.81-1.44],0.5850823170872494
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,35759,178,0.87 [0.60-1.26],0.465613516060461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,35691,178,1.06 [0.90-1.25],0.4885285858753511
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP1,Metalloproteinase inhibitor 1,40684,208,1.13 [0.73-1.76],0.5899403179669769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP2,Metalloproteinase inhibitor 2,35759,178,1.26 [0.85-1.88],0.2489418034065736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP3,Metalloproteinase inhibitor 3,41291,212,0.93 [0.84-1.02],0.1195119797522072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP4,Metalloproteinase inhibitor 4,41134,210,1.19 [0.88-1.61],0.2526197794553759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TINAGL1,Tubulointerstitial nephritis antigen-like,41004,212,1.56 [0.90-2.71],0.115747011531242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TJAP1,Tight junction-associated protein 1,41240,212,0.98 [0.84-1.13],0.7525542167212376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TJP3,Tight junction protein ZO-3,34664,171,0.95 [0.67-1.36],0.7860196665202495
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TK1,"Thymidine kinase, cytosolic",35099,171,0.92 [0.65-1.30],0.6198529903179987
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR1,Toll-like receptor 1,34730,174,1.40 [0.82-2.37],0.2165849359004156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR2,Toll-like receptor 2,35099,171,0.90 [0.48-1.71],0.757102869248997
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR3,Toll-like receptor 3,41597,213,1.00 [0.82-1.21],0.9864285471425808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR4,Toll-like receptor 4,34730,174,1.79 [1.12-2.85],0.014828321553759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,34803,173,1.00 [0.77-1.31],0.9889756975348792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED1,Transmembrane emp24 domain-containing protein 1,35099,171,0.78 [0.58-1.06],0.1074521719210522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED10,Transmembrane emp24 domain-containing protein 10,34635,172,0.91 [0.65-1.28],0.5963230645802555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED4,Transmembrane emp24 domain-containing protein 4,34635,172,0.98 [0.75-1.28],0.8702179838448962
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED8,Protein TMED8,35608,179,0.99 [0.86-1.13],0.8450210342105141
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMEM106A,Transmembrane protein 106A,35598,179,1.02 [0.83-1.24],0.8582018017459605
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMEM132A,Transmembrane protein 132A,34811,171,1.08 [0.86-1.36],0.5168191851167728
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMEM25,Transmembrane protein 25,35709,180,1.07 [0.80-1.45],0.641693873149177
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMOD4,Tropomodulin-4,34510,172,1.00 [0.69-1.44],0.9999597832747572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS11B,Transmembrane protease serine 11B,34664,171,0.92 [0.75-1.13],0.4218614044874649
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS11D,Transmembrane protease serine 11D,35618,178,1.20 [0.83-1.72],0.3291896877182754
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS15,Enteropeptidase,40934,210,1.01 [0.88-1.15],0.91637394602236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS5,Transmembrane protease serine 5,40627,205,1.10 [0.79-1.52],0.5820599315606594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMSB10,Thymosin beta-10,41134,210,0.99 [0.84-1.16],0.8646406882391381
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNC,Tenascin,41278,211,1.08 [0.84-1.39],0.5630593293660895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNF,Tumor necrosis factor,40329,204,1.01 [0.72-1.42],0.9453409768221702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,35608,179,1.10 [0.83-1.46],0.4978801419202597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40393,209,0.81 [0.57-1.14],0.2276293527704333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,34994,173,0.93 [0.73-1.18],0.5460511082521023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40826,208,1.11 [0.76-1.62],0.6055595447535864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40826,208,1.17 [0.93-1.46],0.1753227386504849
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,41201,209,1.17 [0.91-1.51],0.218812082649078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41597,213,1.19 [0.86-1.63],0.2922271063512155
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,41092,212,1.34 [0.88-2.03],0.1726322310596103
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,41240,212,1.59 [1.14-2.22],0.0067900601690126
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41164,212,2.04 [1.51-2.76],3.5992984472903726e-06
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40393,209,1.29 [0.95-1.75],0.1002691739862081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41164,212,1.17 [0.78-1.75],0.4604332293723792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,34994,173,1.49 [1.04-2.14],0.0316962538511723
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,41501,211,1.63 [1.12-2.35],0.0098486413554606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,41134,210,1.56 [1.04-2.32],0.0300538407364882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,41134,210,1.35 [1.03-1.78],0.0316940775379802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41490,211,1.26 [0.80-1.96],0.318514865513586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41523,212,1.16 [0.83-1.62],0.3721821575483084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40826,208,1.15 [0.93-1.43],0.1939165886876461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,41490,211,0.96 [0.72-1.27],0.7586330733671846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40826,208,1.38 [1.03-1.86],0.0314654899333716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF10,Tumor necrosis factor ligand superfamily member 10,41597,213,0.81 [0.51-1.30],0.3842386094629115
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF11,Tumor necrosis factor ligand superfamily member 11,41085,214,0.91 [0.75-1.11],0.357960758009279
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF12,Tumor necrosis factor ligand superfamily member 12,41597,213,0.78 [0.51-1.19],0.2510337904731228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF13,Tumor necrosis factor ligand superfamily member 13,41291,212,0.62 [0.39-0.99],0.044688785212552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41554,209,0.77 [0.48-1.23],0.2721620538649125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40826,208,0.99 [0.80-1.22],0.9141059108073216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF8,Tumor necrosis factor ligand superfamily member 8,35767,181,0.88 [0.59-1.32],0.5499697947769682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNIP1,TNFAIP3-interacting protein 1,35691,178,1.11 [0.94-1.30],0.2163855617139844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNN,Tenascin-N,35767,181,0.73 [0.53-1.02],0.0652500413604359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNNI3,"Troponin I, cardiac muscle",40395,204,0.97 [0.84-1.13],0.7083425728272026
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNPO1,Transportin-1,35099,171,0.90 [0.59-1.37],0.6230860422498012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNR,Tenascin-R,40826,208,1.25 [0.94-1.66],0.1297120930362566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNXB,Tenascin-X,41134,210,0.83 [0.51-1.34],0.4405207504596518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,35759,178,1.00 [0.83-1.20],0.9797867366443844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOP1,DNA topoisomerase 1,35608,179,1.10 [0.97-1.25],0.126493617179561
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOP1MT,"DNA topoisomerase I, mitochondrial",34510,172,0.98 [0.72-1.33],0.8973185584944475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOP2B,DNA topoisomerase 2-beta,34730,174,1.03 [0.85-1.24],0.7699885137949863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOR1AIP1,Torsin-1A-interacting protein 1,34811,171,0.96 [0.73-1.27],0.7967444921523175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53,Cellular tumor antigen p53,40196,207,0.94 [0.71-1.26],0.694167268649701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53BP1,TP53-binding protein 1,34730,174,1.02 [0.86-1.20],0.8224372564632491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53I3,Quinone oxidoreductase PIG3,34228,169,1.05 [0.79-1.40],0.7147656497566053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40395,204,0.82 [0.52-1.29],0.3893266092042475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP73,Tumor protein p73,34803,173,0.94 [0.61-1.45],0.7948584382651928
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPBGL,Trophoblast glycoprotein-like,34803,173,0.95 [0.67-1.37],0.8003565197683529
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPD52L2,Tumor protein D54,34994,173,0.96 [0.84-1.10],0.5740019753813271
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPK1,Thiamin pyrophosphokinase 1,35759,178,0.87 [0.51-1.46],0.5885861149067706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPM3,Tropomyosin alpha-3 chain,34635,172,1.06 [0.77-1.47],0.7037137527055636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPMT,Thiopurine S-methyltransferase,40196,207,1.14 [0.97-1.34],0.1063884894586127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPP1,Tripeptidyl-peptidase 1,40832,211,1.12 [0.86-1.45],0.401240268107188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPPP2,Tubulin polymerization-promoting protein family member 2,35099,171,1.07 [0.90-1.28],0.4193743662993117
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPPP3,Tubulin polymerization-promoting protein family member 3,40166,203,0.83 [0.59-1.18],0.3027028112492179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPR,Nucleoprotein TPR,34635,172,1.22 [0.97-1.52],0.0904501373039065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPRKB,EKC/KEOPS complex subunit TPRKB,34510,172,1.20 [1.01-1.43],0.0363542834492162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPSAB1,Tryptase alpha/beta-1,41533,212,1.09 [0.87-1.38],0.4478265394538924
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPSD1,Tryptase delta,35709,180,0.78 [0.51-1.19],0.2469661106164589
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPSG1,Tryptase gamma,34730,174,0.93 [0.54-1.62],0.808152572806705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPT1,Translationally-controlled tumor protein,40393,209,0.87 [0.70-1.08],0.2020701079250003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRAF2,TNF receptor-associated factor 2,41085,214,1.16 [0.98-1.37],0.0918790414122778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRAF3,"TNF receptor-associated factor 3, Isoform 2",34730,174,1.19 [0.84-1.68],0.3380838427043146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,34635,172,1.01 [0.74-1.36],0.962754062187491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,35099,171,1.04 [0.88-1.22],0.6645062863622504
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREH,Trehalase,35767,181,0.92 [0.76-1.11],0.3772550296760878
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREM2,Triggering receptor expressed on myeloid cells 2,41092,212,0.98 [0.78-1.25],0.8912258612578637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREML1,Trem-like transcript 1 protein,35784,179,0.95 [0.72-1.25],0.7193346498389834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREML2,Trem-like transcript 2 protein,41134,210,1.23 [0.85-1.77],0.2712740576104265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIAP1,TP53-regulated inhibitor of apoptosis 1,41501,211,0.99 [0.81-1.20],0.8807192058564002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM21,E3 ubiquitin-protein ligase TRIM21,41085,214,0.98 [0.83-1.15],0.7842280840039377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM24,Transcription intermediary factor 1-alpha,35029,171,0.95 [0.76-1.20],0.6870165286724647
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,35608,179,1.04 [0.91-1.18],0.5811544407311969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM26,Tripartite motif-containing protein 26,34510,172,1.06 [0.83-1.35],0.6648388052102927
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM40,E3 ubiquitin ligase TRIM40,34803,173,0.75 [0.60-0.92],0.007175988199096
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM5,Tripartite motif-containing protein 5,41085,214,0.94 [0.81-1.08],0.3806743341996663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM58,E3 ubiquitin-protein ligase TRIM58,35598,179,1.12 [0.95-1.32],0.1626213151907707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRPV3,Transient receptor potential cation channel subfamily V member 3,34635,172,1.36 [1.09-1.70],0.00739370050973
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSC1,Hamartin,34730,174,0.94 [0.76-1.16],0.5504091842521689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSC22D1,TSC22 domain family protein 1,35709,180,0.97 [0.78-1.21],0.7985674238256182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSHB,Thyrotropin subunit beta,41128,212,1.07 [0.91-1.25],0.4058406816845342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSLP,Thymic stromal lymphopoietin,40395,204,0.96 [0.78-1.19],0.7343591522158028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSNAX,Translin-associated protein X,34635,172,1.14 [0.79-1.64],0.4848454058369581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN1,Tetraspanin-1,40395,204,1.28 [1.10-1.48],0.0011137277431484
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN15,Tetraspanin-15,34635,172,1.12 [0.86-1.46],0.3967933949051405
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN7,Tetraspanin-7,34664,171,1.02 [0.88-1.19],0.7756684856366165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN8,Tetraspanin-8,35608,179,1.03 [0.89-1.20],0.6564720330240563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPYL1,Testis-specific Y-encoded-like protein 1,34730,174,0.96 [0.67-1.39],0.8431498094056281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TST,Thiosulfate sulfurtransferase,40099,203,1.01 [0.85-1.19],0.927555489253376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TTF2,Transcription termination factor 2,34803,173,0.95 [0.70-1.28],0.7176165376743842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TTN,Titin,34635,172,1.12 [0.93-1.37],0.2345295879375531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TTR,Transthyretin,35425,179,0.54 [0.30-0.95],0.0315262183633471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TUBB3,Tubulin beta-3 chain,34664,171,0.84 [0.49-1.43],0.5184609170754408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TWF2,Twinfilin-2,35767,181,0.93 [0.78-1.10],0.4079123044781484
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXK,Tyrosine-protein kinase TXK,35099,171,1.05 [0.87-1.26],0.6335659625253237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXLNA,Alpha-taxilin,40826,208,0.94 [0.82-1.08],0.3887883391215356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXN,Thioredoxin,35183,174,1.23 [0.91-1.65],0.179289153421246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNDC15,Thioredoxin domain-containing protein 15,41240,212,1.28 [0.83-1.99],0.2644222518229407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNDC5,Thioredoxin domain-containing protein 5,41490,211,0.95 [0.79-1.14],0.5633627763451463
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNDC9,Thioredoxin domain-containing protein 9,35691,178,0.88 [0.66-1.16],0.361758719308481
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNL1,Thioredoxin-like protein 1,34601,171,1.06 [0.92-1.21],0.41646699758743
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",41134,210,0.95 [0.73-1.25],0.734966712236077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TYMP,Thymidine phosphorylase,40868,211,0.89 [0.74-1.07],0.2138116717523452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TYRO3,Tyrosine-protein kinase receptor TYRO3,41128,212,1.19 [0.77-1.83],0.4274366016687427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",34730,174,1.21 [0.95-1.54],0.1168765022555895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBAC1,Ubiquitin-associated domain-containing protein 1,40934,210,1.20 [0.84-1.70],0.3163349376712795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBE2B,Ubiquitin-conjugating enzyme E2 B,35598,179,1.14 [0.71-1.82],0.591329256704573
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,35759,178,1.02 [0.81-1.29],0.8784244241812714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,34730,174,1.01 [0.79-1.29],0.9422791097846852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBQLN3,Ubiquilin-3,34635,172,0.93 [0.69-1.26],0.6372187071410715
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBXN1,UBX domain-containing protein 1,34994,173,1.04 [0.84-1.28],0.7471858930786041
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,35608,179,0.98 [0.89-1.09],0.7117311795835555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UGDH,UDP-glucose 6-dehydrogenase,34635,172,1.07 [0.93-1.22],0.3536031377767525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UHRF2,E3 ubiquitin-protein ligase UHRF2,34635,172,0.84 [0.53-1.34],0.4732303522729435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ULBP2,UL16-binding protein 2,40826,208,1.33 [0.96-1.84],0.0893204788228998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UMOD,Uromodulin,41496,209,0.80 [0.65-1.00],0.0490621303494339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UNC5D,Netrin receptor UNC5D,34730,174,1.13 [0.65-1.96],0.6689035002048612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UNC79,Protein unc-79 homolog,34510,172,1.17 [0.91-1.49],0.2183675631093798
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UNG,Uracil-DNA glycosylase,35598,179,0.98 [0.65-1.47],0.9109649805889096
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UPB1,Beta-ureidopropionase,35759,178,0.98 [0.84-1.16],0.8364642934398454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UPK3A,Uroplakin-3a,34664,171,1.07 [0.80-1.43],0.6453819336733662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UPK3BL1,Uroplakin-3b-like protein 1,35033,171,0.98 [0.74-1.30],0.9031614169517284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UROD,Uroporphyrinogen decarboxylase,34994,173,0.92 [0.74-1.14],0.4409000721352337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UROS,Uroporphyrinogen-III synthase,34803,173,1.15 [0.95-1.40],0.1531306169532665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USO1,General vesicular transport factor p115,40934,210,0.97 [0.85-1.12],0.7002745536508568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP25,Ubiquitin carboxyl-terminal hydrolase 25,35598,179,1.05 [0.86-1.28],0.6576400323937379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP28,Ubiquitin carboxyl-terminal hydrolase 28,35691,178,1.38 [1.01-1.89],0.0408509693337597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP47,Ubiquitin carboxyl-terminal hydrolase 47,34635,172,1.04 [0.88-1.23],0.6464916267644509
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40395,204,0.98 [0.86-1.12],0.7486707679904752
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UXS1,UDP-glucuronic acid decarboxylase 1,40196,207,0.84 [0.65-1.07],0.1645337055834684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAMP5,Vesicle-associated membrane protein 5,40395,204,0.92 [0.72-1.18],0.5215494897905626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAMP8,Vesicle-associated membrane protein 8,34730,174,1.01 [0.85-1.19],0.9210775890380936
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASH1,Tubulinyl-Tyr carboxypeptidase 1,41085,214,0.93 [0.80-1.08],0.3466306951956285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASN,Vasorin,40471,208,1.18 [0.75-1.87],0.4679725140236682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASP,Vasodilator-stimulated phosphoprotein,35784,179,0.96 [0.78-1.17],0.6639551295190455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40934,210,0.90 [0.48-1.69],0.7434552252399729
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAV3,Guanine nucleotide exchange factor VAV3,34664,171,1.04 [0.90-1.21],0.5986152887299943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VCAM1,Vascular cell adhesion protein 1,41219,211,1.45 [0.92-2.29],0.1061965883238431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VCAN,Versican core protein,41490,211,1.33 [0.89-2.00],0.167578024545393
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VCPKMT,Protein-lysine methyltransferase METTL21D,34510,172,1.11 [0.96-1.29],0.1523217552623204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFA,Vascular endothelial growth factor A,41473,213,0.93 [0.75-1.15],0.5119547888440226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFB,Vascular endothelial growth factor B,34730,174,1.06 [0.64-1.78],0.8137819784205219
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFC,Vascular endothelial growth factor C,41240,212,0.90 [0.72-1.11],0.3219879722692054
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFD,Vascular endothelial growth factor D,41530,213,1.61 [1.15-2.25],0.0056708558326232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VGF,Neurosecretory protein VGF,35709,180,0.67 [0.42-1.09],0.1048534146961076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VIM,Vimentin,40395,204,1.03 [0.92-1.15],0.6278244165279006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VIPR1,Vasoactive intestinal polypeptide receptor 1,34811,171,0.79 [0.42-1.49],0.4693076812257266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VIT,Vitrin,35759,178,1.29 [0.87-1.90],0.2021323253872756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VMO1,Vitelline membrane outer layer protein 1 homolog,40934,210,1.25 [1.03-1.51],0.0246533191440791
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VNN1,Pantetheinase,35784,179,0.97 [0.80-1.18],0.788332154831585
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VNN2,Vascular non-inflammatory molecule 2,40934,210,0.87 [0.67-1.13],0.2931630496033701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS28,Vacuolar protein sorting-associated protein 28 homolog,35099,171,1.10 [0.89-1.37],0.374834468481933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS37A,Vacuolar protein sorting-associated protein 37A,40934,210,0.91 [0.78-1.07],0.2515574964983239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS4B,Vacuolar protein sorting-associated protein 4B,35598,179,0.99 [0.85-1.15],0.901340597765676
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40934,210,0.96 [0.82-1.12],0.5869908542025412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG10,V-set and immunoglobulin domain-containing protein 10,35598,179,1.32 [0.93-1.87],0.1226343505710041
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,34635,172,1.09 [0.71-1.67],0.6994087127009979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG2,V-set and immunoglobulin domain-containing protein 2,35598,179,1.08 [0.86-1.36],0.4987184193629201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG4,V-set and immunoglobulin domain-containing protein 4,41079,210,1.25 [0.92-1.69],0.1506240095368366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,41063,211,0.97 [0.79-1.19],0.7715064456757292
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSNL1,Visinin-like protein 1,35691,178,0.72 [0.48-1.07],0.1035089000671179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSTM1,V-set and transmembrane domain-containing protein 1,40166,203,1.24 [0.99-1.57],0.0637737966435617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSTM2B,V-set and transmembrane domain-containing protein 2B,35099,171,1.18 [0.87-1.59],0.2958699655650364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40395,204,0.99 [0.79-1.22],0.8911030544641734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,41490,211,0.92 [0.78-1.10],0.368673545083094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTCN1,V-set domain-containing T-cell activation inhibitor 1,40196,207,1.11 [0.74-1.67],0.6000361049407134
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,34994,173,1.03 [0.80-1.33],0.8100847985387852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWA1,von Willebrand factor A domain-containing protein 1,41439,211,1.09 [0.82-1.45],0.5583453374217365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWA5A,von Willebrand factor A domain-containing protein 5A,34510,172,0.80 [0.63-1.01],0.0654322815168573
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWC2,Brorin,40678,205,1.03 [0.75-1.41],0.8781550823278114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWC2L,von Willebrand factor C domain-containing protein 2-like,35709,180,0.94 [0.68-1.30],0.7231683824566628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWF,von Willebrand factor,41624,209,1.04 [0.88-1.23],0.6254790227807068
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WARS,"Tryptophan--tRNA ligase, cytoplasmic",41134,210,1.00 [0.72-1.39],0.9877304166222972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WAS,Wiskott-Aldrich syndrome protein,40393,209,1.05 [0.87-1.26],0.6119591588504183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASF1,Wiskott-Aldrich syndrome protein family member 1,40395,204,1.03 [0.90-1.18],0.6486085032188833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASF3,Wiskott-Aldrich syndrome protein family member 3,40166,203,0.95 [0.82-1.10],0.4640898835593674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASHC3,WASH complex subunit 3,35691,178,1.06 [0.88-1.28],0.5199998316375027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASL,Neural Wiskott-Aldrich syndrome protein,34730,174,1.04 [0.82-1.31],0.7364703778894095
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WDR46,WD repeat-containing protein 46,35598,179,1.05 [0.71-1.54],0.8079973742989767
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFDC1,WAP four-disulfide core domain protein 1,34876,177,0.95 [0.72-1.25],0.7090087107806093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFDC12,WAP four-disulfide core domain protein 12,41437,210,1.19 [0.98-1.43],0.0756922231902133
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFDC2,WAP four-disulfide core domain protein 2,39025,201,1.35 [0.98-1.86],0.0649069020746664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40694,205,0.79 [0.58-1.08],0.1399346653870443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",41164,212,1.10 [0.77-1.58],0.590387545534595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WIF1,Wnt inhibitory factor 1,41501,211,0.99 [0.69-1.42],0.9692327142226946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WNT9A,Protein Wnt-9a,40393,209,0.95 [0.61-1.47],0.8050626638246764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40826,208,0.99 [0.79-1.25],0.929496325631707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XCL1,Lymphotactin,41501,211,0.90 [0.71-1.13],0.3521037024152892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XG,Glycoprotein Xg,41421,208,1.42 [0.97-2.08],0.0728050969448339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XIAP,E3 ubiquitin-protein ligase XIAP,34730,174,1.14 [0.89-1.46],0.3088907899824336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XPNPEP2,Xaa-Pro aminopeptidase 2,41240,212,1.04 [0.92-1.17],0.5355763283842999
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XRCC4,DNA repair protein XRCC4,40166,203,1.01 [0.73-1.42],0.93248839652514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YAP1,Transcriptional coactivator YAP1,35691,178,1.29 [0.75-2.19],0.3552197905378291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",35608,179,1.01 [0.92-1.12],0.7879304115651526
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YES1,Tyrosine-protein kinase Yes,40934,210,0.93 [0.83-1.03],0.1747146411970764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YJU2,Splicing factor YJU2,35598,179,1.24 [0.82-1.89],0.3070399084705736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YOD1,Ubiquitin thioesterase OTU1,34635,172,1.19 [0.95-1.50],0.1320017779095557
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YTHDF3,YTH domain-containing family protein 3,40393,209,1.00 [0.86-1.15],0.9671173323414276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YWHAQ,14-3-3 protein theta,34994,173,1.07 [0.87-1.30],0.520624197237431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YY1,Transcriptional repressor protein YY1,34730,174,0.88 [0.52-1.49],0.6349572812729791
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZBP1,Z-DNA-binding protein 1,34730,174,1.09 [0.77-1.54],0.6414522187223466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZBTB16,Zinc finger and BTB domain-containing protein 16,40196,207,0.93 [0.77-1.11],0.4043863319421201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZBTB17,Zinc finger and BTB domain-containing protein 17,40395,204,1.26 [0.97-1.63],0.080448239584964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZCCHC8,Zinc finger CCHC domain-containing protein 8,34635,172,1.17 [0.95-1.44],0.132440842761094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZFYVE19,Abscission/NoCut checkpoint regulator,35608,179,0.98 [0.84-1.15],0.8304087407551499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZHX2,Zinc fingers and homeoboxes protein 2,35691,178,1.28 [0.93-1.77],0.1292496403182937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNF174,Zinc finger protein 174,34730,174,1.27 [0.94-1.72],0.1259609939859179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNF75D,Zinc finger protein 75D,35099,171,1.01 [0.80-1.28],0.9199791551927968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNF830,Zinc finger protein 830,35598,179,1.02 [0.85-1.22],0.8351349070330655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNRD2,Protein ZNRD2,35608,179,1.18 [0.97-1.45],0.0977452540786594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,35598,179,0.90 [0.69-1.18],0.4486031265096259
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZP3,Zona pellucida sperm-binding protein 3,34811,171,0.99 [0.93-1.04],0.612642427685826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZP4,Zona pellucida sperm-binding protein 4,34510,172,0.84 [0.51-1.38],0.4977432082119051
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZPR1,Zinc finger protein ZPR1,34664,171,0.88 [0.74-1.05],0.1657436854064643
